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ABSTRACT 
 
CRISPR (clustered regularly interspaced short palindromic repeats) and CRISPR-
associated (Cas) genes comprise an RNA-guided adaptive immune system in prokaryotes. Cas 
proteins can acquire short fragments, called spacers, from the invader DNA or RNA and 
integrate these spacers into the host genomic CRISPR locus. Once transcribed and processed to 
short CRISPR RNAs (crRNA), the crRNA spacers can guide Cas surveillance complexes to 
DNA and/or RNA target sequences, called protospacers, resulting in CRISPR interference 
through target cleavage. In the type I CRISPR system, an existing protospacer can accelerate 
new spacer acquisition from the same invader DNA, a process called priming. We have 
investigated the immune mechanism of the type I-E CRISPR-Cas system in Escherichia coli 
K12. The research presented in this dissertation has focused on how Cascade searches DNA to 
locate the target and how crRNA sequence and Cascade conformation control interference and 
priming activities.  
 The Cascade surveillance complex must locate targets rapidly to ensure timely immune 
response, but the mechanism of this search process remains unclear. We developed a single-
molecule fluorescence resonance energy transfer (FRET) assay to directly visualize the Type I-E 
Cascade surveillance complex searching DNA in real time. We find that Cascade randomly 
samples DNA through short-lived nonspecific electrostatic contacts and quickly dissociates from 
dsDNA. Cascade locates its target by first searching for short recognition sequences called 
protospacer adjacent motifs (PAMs). We find that Cascade dwells longer at PAM sites based on 
interaction with the PAM recognition motif and a lysine-rich loop in Cse1. In addition, we also 
identify a motif in the Cas7 backbone subunit that is essential for the searching process. Our 
findings provide a comprehensive structural and kinetic model for efficient target searching by 
Cascade. 
Once Cascade locates its target, it recruits the trans-acting nuclease Cas3 to trigger 
CRISPR interference. However, mutations in the PAM or the PAM-proximal region of the 
protospacer, termed the seed, can block interference and lead to primed adaptation. The 
importance of the seed region and PAM motif has been studied using a few spacers in Type I-E 
CRISPR system in E. coli K12. However, it is unknown whether spacer sequence has an effect 
on the activities of CRISPR system. We have analyzed CRISPR interference and priming using 
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18 endogenous spacers in E. coli K12 to reexamine the PAM and seed sequence requirements 
and found that CRISPR interference and priming are strongly influenced by spacer sequence. 
Our interference data for these 18 spacers also indicate that CRISPR interference is far more 
tolerant of mutations in the seed and the PAM than previously reported. We further analyzed 
spacer sequence-specific tolerance of seed or PAM mutations. Our results indicate that seed and 
PAM mutational tolerance are highly dependent on spacer sequence. We further show that 
cytosine residue at the -3 and -2 position of the PAM abolishes both interference and priming, 
indicating that CRISPR-Cas systems avoid self-spacer targeting by avoiding the final 3 
nucleotides of the repeat (CCG). In summary, our findings show that CRISPR activities strongly 
depend on the spacer sequence and CRISPR-Cas systems avoid self-spacers targeting by 
avoiding recognize the repeat (CCG).  Our studies reveal that some spacer sequences may more 
readily overcome immune system evasion through invader evolution. 
Surprisingly, some PAM mutations have little effect on the equilibrium binding affinity 
of Cascade, but these mutations still block CRISPR interference. We and other groups have 
found that Cas3 cannot degrade the Cascade-bound target, suggesting that Cascade may adopt an 
alternative conformation that blocks Cas3 recruitment when bound to these targets. To test this 
hypothesis, we developed a novel FRET system to study the conformational dynamics of the 
Cse1 subunit of Cascade, which recognizes the PAM and recruits Cas3. Our results reveal that 
Cascade adopts alternative conformations when bound to targets that promote interference or 
priming in vivo. In addition, we identified Cse1 L1 loop mutations that switch Cascade to the 
priming conformation, changing the functional outcome of Cascade-target binding from 
interference to priming even when bound to interference targets. Our results demonstrate that 
Cascade conformation controls CRISPR immune response following target binding.
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CHAPTER 1 
 INTRODUCTION 
INSIGHTS INTO THE MECHANISM OF TYPE I-E CRISPR-CAS SYSTEMS 
 
In natural environments, bacteria and bacteriophages coexist, and phages outnumber their 
bacterial hosts by 10-100 fold (Rohwer and Thurber, 2009; Suttle, 2005, 2007). Phages have 
evolved diverse strategies to hijack prokaryotic host cells for their own reproduction (Labrie et 
al., 2010). Consequently, bacteria have either evolved or acquired through lateral transfer several 
mechanisms to survive (Makarova et al., 2012, 2013). Indeed, up to 30% of bacterial genomes 
can be made up of integrated mobile genetic elements (Frost et al., 2005; Toussaint and 
Chandler, 2012). Phages fight back by evolving equally diversified strategies, including point 
mutations at specific positions, genome rearrangements, or by inactivating bacterial protection 
mechanisms (Labrie et al., 2010).  
 Due to the expanded database of microbial genomes and metagenomes, comparative 
genomic studies and direct experiments have revealed a wide range of defense mechanisms in 
bacteria (Koonin et al., 2017a; Labrie et al., 2010; Makarova et al., 2013; Samson et al., 2013). A 
direct mechanism for bacteria to preclude phage binding and penetration is through receptor 
masking, including phase variation, physical masking, and receptor mutation (Koonin et al., 
2017a; Makarova et al., 2013; Obeng et al., 2016; Samson et al., 2013). Another strategy is 
dormancy induction and programmed cell death, including the well-known toxin-antitoxin 
mechanisms and the abortive infection mechanisms (ABI) (Chopin et al., 2005; Koonin et al., 
2017a).  
Besides these two non-specific mechanisms, bacteria have evolved mechanisms that can 
distinguish self (bacteria) and non-self (phage), non-specific innate immune system and the 
highly-specific adaptive (acquired) immune system (Koonin et al., 2017a). The best-
characterized innate immune system is restriction-modification (RM), which modify and protect 
self DNA by methylation or phosphorothioation, while cleaving unmodified phage DNA (Kovall 
and Matthews, 1999; Orlowski and Bujnicki, 2008; Williams, 2003)(Wang et al., 2007). Another 
innate immune pathway to protect self DNA is bacteriophage exclusion, which uses an opposite 
mechanism to RM (Barrangou and van der Oost, 2015; Goldfarb et al., 2015). In this system, the 
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phage genome is modified during the first infection and can be recognized and degraded during 
subsequent infections, limiting the phage infection to one cycle. The third innate immune system 
is the prokaryotic Argonaute proteins, which target phage nucleic acid via short guide DNA or 
RNA oligonucleotides derived from the phage (Aravind et al., 2000; Sheng et al., 2014; Swarts 
et al., 2015; Willkomm et al., 2016; Yuan et al., 2005). 
Recently, an adaptive bacterial immune system was discovered: the CRISPR-Cas 
(clustered regularly interspaced short palindromic repeats-CRISPR associated genes) immune 
system (Barrangou et al., 2007; Karginov and Hannon, 2010; Marraffini and Sontheimer, 2008; 
Sorek et al., 2008). The first CRISPR locus, the defining feature of these adaptive immune 
systems, was discovered in 1987 by Ishino (Ishino et al., 1987). However, the function of these 
loci was not appreciated until 20 years later. Due to the expanded database of microbial 
genomes, it was realized that CRISPR loci may represent an adaptive immune system, which 
was first experimentally demonstrated in Streptococcus thermophilus in 2007 (Barrangou et al., 
2007). Since then, numerous studies have demonstrated that CRISPR-Cas systems are RNA-
guided immune systems that memorize past infections by inserting foreign genetic fragments 
into the host CRISPR locus. With the guidance of the RNA transcribed from these foreign 
genetic fragments, phage genomes are specifically destroyed after recognition. In this chapter, I 
outline the current mechanistic understanding of CRISPR-Cas systems. 
 
 
Overview of CRISPR-Cas immune systems 
CRISPR-Cas immune systems have been found in about 85% of archaea and 40% of 
bacteria (Sorek et al., 2013)(Koonin et al., 2017a). A functional CRISPR-Cas immune system 
consists of the clustered regularly interspaced short palindromic repeats (CRISPRs) composed of 
a series of repeats interspaced by variable DNA sequences (spacers), a leader in front of the 
CRISPR locus, and a set of CRISPR-associated (cas) genes (Karginov and Hannon, 2010; Sorek 
et al., 2008, 2013). CRISPR-Cas immunity can be divided into three stages: adaptation, 
expression and maturation, and interference (Fig. 1) (Makarova et al., 2011; Sorek et al., 2013). 
In the adaptation stage, Cas proteins capture short DNA fragments from the invader and integrate 
these fragments into the host CRISPR array (Barrangou et al., 2007). The inserted fragment 
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forms a genetic memory of the infection for subsequent immunity. During the expression and 
maturation stage, the CRISPR array is transcribed into a long pre-CRISPR RNA (pre-crRNA) 
that is further processed to generate CRISPR RNAs (crRNAs) (Brouns et al., 2008; Carte et al., 
2008). Each crRNA contains a single spacer flanked by parts of the adjoining repeat sequences. 
Each crRNA assembles with Cas effector proteins to form the active Cas-crRNA surveillance 
complex. During the interference stage, the Cas-crRNA surveillance complex recognizes the 
targets (protospacers) by complementary base-pairing with the crRNA sequence (Barrangou et 
al., 2007). Target binding triggers subsequent nuclease degradation of the target nucleic acid 
(Westra et al., 2012).  
 
Figure 1. Overview of the three stages of the CRISPR-Cas system in E. coli K12. CRISPRs and cas operon in 
E. coli K12 are indicated. In the adaptation stage, Cas1-Cas2 capture short DNA fragments from phage 
genomic DNA and integrate these fragments into the CRISPR arrays. During the expression stage, the 
CRISPR arrays are transcribed into long pre-CRISPR RNAs (pre-crRNAs). The pre-crRNAs are further 
processed by Cas6e to generate mature CRISPR RNAs (crRNAs) and assembles with Cas proteins to form the 
Cascade complex. During the interference stage, the Cascade complex recognizes the targets by 
complementary base-pairing with the crRNA sequence. Target binding triggers subsequent Cas3 degradation 
of the target nucleic acid. 
 
 
Classification of CRISPR-Cas systems  
CRISPR-Cas systems have evolved into extremely diversified systems through constant 
co-evolution with phages and other mobile genetic elements (Koonin et al., 2017b). Although 
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CRISPR-Cas systems are highly divergent, cas1 and cas2 are notably conserved across almost 
all known CRISPR-Cas systems. Cas1 and Cas2 are the only Cas proteins required for genetic 
recording of past infections through spacer acquisition from invader DNA, indicating a common 
memory generation mechanism across all CRISPR-Cas systems (Datsenko et al., 2012; Yosef et 
al., 2012). Comparative genomics analysis has shown that all known CRISPR-Cas systems 
evolved from a single ancestor (Shmakov et al., 2017b). Based on signature proteins and cas 
locus architecture, currently, CRISPR-Cas systems are divided into two classes (class1 and class 
2) that are subdivided into six types and 33 subtypes (Koonin et al., 2017b). Class 1 CRISPR-
Cas systems are characterized by multi-subunit effector complexes, which are further divided 
into 3 types and 15 subtypes, comprising about 90% of all CRISPR-Cas loci identified in 
bacteria and archaea. Class 2 CRISPR-Cas systems utilize single-protein effectors, and are 
further divided into 3 types and 18 subtypes, comprising the remaining 10% of CRISPR-Cas 
loci. Class 2 systems are found mainly in bacteria instead of both bacteria and archaea.  
Class 2 systems have been developed into versatile tools for biotechnology, such as such 
as genome editing and transcriptional regulation (Cong et al., 2013; Jinek et al., 2012; Mali et al., 
2013a; Shmakov et al., 2017a). In general, precise genome editing requires two major steps: 
introducing a double-stranded DNA break (DSB) at a specific site and subsequent homologous 
recombination using provided DNA templates (Cong et al., 2013; Mali et al., 2013a). 
Homologous recombination can be achieved through the native DNA repair machinery; 
however, until recently introduction of a DSB remained the major issue for precise genome 
editing. The first and second generation of genome editing tools, zinc-finger nucleases (ZFNs) 
and transcription activator-like effector nucleases (TALENs), introduce a DSB at a specific site 
through protein-DNA interactions (Gaj et al., 2013). Targeting to a new site requires engineering 
and cloning a new protein, resulting tedious work, expensive and time consuming. In contrast to 
ZFNs and TALENs, the Type II effector Cas9 is an RNA-guided nuclease and targets specific 
sites through simple DNA-RNA base pairing. Thus, programming the Cas9 endonuclease to 
induce DSBs at specific sites can be easily achieved by changing the guide RNA sequence. 
Cas9-mediated genome editing has been widely used in studying gene functions, disease 
modeling, gene therapy, and genome-wide functional screening. In addition to its role in genome 
editing, the nuclease-deactivated Cas9 (dCas9) can be fused to a variety of effectors, such as 
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transcriptional activators, repressors and epigenetic modifiers, for genomic transcription 
regulation including gene repression through CRISPR interference (CRISPRi) and gene 
activation through CRISPR activation (CRISPRa) (Dominguez et al., 2015; Gilbert et al., 2013; 
Qi et al., 2013). These applications highlight the importance of basic research in CRISPR-Cas 
systems, not just to understand bacteria-phage interactions, but also to potentially develop new 
tools for biotechnology 
 
 
Type I-E CRISPR-Cas system in Escherichia coli K12  
The focus of my work has been on understanding the mechanism of the Type I-E 
CRISPR-Cas system. E. coli K12 contains a Type I-E system, and has served as a model system 
for understanding CRISPR-based immunity (Fig. 1) (Brouns et al., 2008). The CRISPR-Cas 
locus in E. coli K12 consists of a cas operon (8 genes) and two CRISPR arrays (CRISPR 1 and 
CRISPR 2) (Pougach et al., 2010). The endonuclease Cas1 and structural subunit Cas2 form an 
integrase complex that is required for spacer acquisition during adaptation. The multiprotein 
effector complex Cascade comprises five stoichiometrically unequal proteins (Cse11, Cse22, 
Cas76, Cas5e1, and Cas6e1) that assemble with a 61-nt crRNA. Although Cascade is sufficient to 
locate and bind the protospacer target, the nuclease-helicase Cas3 is required for target 
destruction during interference. Cas3 is recruited directly by the Cse1 subunit of Cascade 
following formation of an R-loop between the crRNA and target DNA. 
The expression of the cas operon is controlled by two independent promoters (Pul et al., 
2010). The cas3 promoter controls the expression of the single cas3 gene, while cse1, cse2, cas7, 
cas5e, cas6e, cas1, and cas2 are under the control of the same promoter located upstream of the 
cse1 gene, named cas promoter. The activity of the cas promoter is inhibited by the histone-like 
nucleoid-structuring (H-NS) protein, a global transcriptional repressor, and activated by its 
antagonist LeuO (Westra et al., 2010). Interestingly, the cas3 promoter is under the control of H-
NS in stationary phase growth but is less tightly regulated during mid-log phase (Majsec et al., 
2016). CRISPR 1 and CRISPR 2 arrays are controlled by two individual CRISPR promoters 
located in the AT-rich leader region.  Similar to the cas promoter, the two CRISPR promoters are 
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also repressed by H-NS resulting in very low transcription levels under normal laboratory growth 
conditions.  
Like all other types of CRISPR-Cas systems, the type I-E CRISPR-Cas system in E. coli 
K12 involves three stages: adaptation, expression and processing, and interference (Fig. 1). Here, 
we summarize recent advances in our understanding of the three stages of CRISPR immunity 
and explain how the Type I-E CRISPR-Cas system avoids targeting self DNA. 
 
 
Adaptation 
 CRISPR immunity begins with adaptation by detecting and integrating short DNA 
fragments into the CRISPR arrays on the host chromosome, a process called spacer acquisition. 
The short DNA fragments can come from invader nucleic acid and can also come from the host 
nucleic acid. Because of the complexity of the adaptation stage, while the mechanism of 
integration is established, the details of how spacers are acquired remain unclear (Sorek et al., 
2013; Wright et al., 2016). There are two types of adaptation in Type-I-E CRISPR-Cas system; 
naïve and primed spacer acquisition (Fig. 2) (Datsenko et al., 2012; Savitskaya et al., 2013; 
Swarts et al., 2012). The process by which spacers are acquired from an invader that has not been 
previously encountered is called naïve adaptation. Primed adaptation occurs when a pre-existing 
spacer is present in the CRISPR array, and can strongly promote spacer acquisition from the 
same invader. It has been shown that only Cas1 and Cas2, which form a Cas12-Cas22-Cas12 
complex (hereafter Cas1-Cas2), are required for naïve adaptation (Nuñez et al., 2014), while all 
Cas proteins are required for primed adaptation (Datsenko et al., 2012). Despite the difference 
between naïve and primed adaptation, both mechanisms can be divided into three steps: the 
generation of DNA fragments for spacers, spacer trimming and capturing by Cas1-Cas2, and 
spacer integration. The first two steps are different between naïve and primed adaptation (Fig. 2). 
The mechanism for the third step is the same (Fig. 3), which is that spacers captured by Cas1-
Cas2 are inserted into the junction between the leader sequence and the first repeat of the 
CRISPR array via an integrase mechanism.  
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(1) Generation of DNA fragments source for spacers.  
 Substrates for spacer acquisition are thought to be derived from DNA fragments 
generated through various mechanisms (Amitai and Sorek, 2016). The DNA fragments 
generation pathway plays a fundamental role in allowing the CRISPR-Cas system to distinguish 
self from non-self and destroy invaders without inducing autoimmunity. Spacers acquired from 
the host chromosome cause autoimmunity and are lethal to the host. To avoid this self-targeting 
by its own CRISPR-Cas system, spacers are acquired preferentially from the foreign DNA while 
only a very small fraction are derived from the self-chromosome for both naïve adaptation and 
primed adaptation. 
 A genome-wide study in E. coli has shown that during naïve adaptation, one spacer 
source is DNA degradation products that are formed through RecBCD-catalyzed DNA 
degradation (Levy et al., 2015). When double-stranded breaks (DSBs) form, mainly at stalled 
replication forks, RecBCD binds the exposed dsDNA and processes it to the nearest Chi site 
(Dillingham and Kowalczykowski, 2008). Chi sites are more abundant in the host genome, 
resulting a limited pool of potential chromosomal spacers (Fig. 2). Compared to the host DNA, 
extrachromosomal DNA from phage or plasmids are replicated more frequently, resulting in a 
higher number of DSBs at replication forks (George et al., 2001; Kuzminov, 2001; Michel et al., 
2001; Shee et al., 2013). In addition, extrachromosomal DNA lack Chi sites, resulting in 
continuous degradation by RecBCD. As a result, more potential substrates from 
extrachromosomal DNA are generated for spacer acquisition. Indeed, spacer acquisition from 
foreign DNA can be reduced by adding Chi sites into the foreign DNA. Some extrachromosomal 
DNA, such as phage genomes, enter the host cell as linear dsDNA (Grayson and Molineux, 
2007). The linear end can be recognized by RecBCD directly, resulting in continuous 
degradation and the formation of potential substrates for spacer acquisition.  
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Figure 2. Spacer acquisition process in E. coli K12. During naïve adaptation, substrates generated by RecBCD 
on dsDNA ends are captured by Cas1-Cas2. During priming adaptation, substrates can be generated from two 
pathways. For the interference-dependent pathway, substrates generated by Cas3 degradation are captured by 
Cas1-Cas2. For the interference-independent pathway, Cas1-Cas2-Cas3 has been proposed to directly excise 
double-stranded protospacers from the foreign DNA. Lastly, Cas1-Cas2-protospacer inserts protospacer into 
the leader-proximal repeat.  
 
 Although RecBCD has been implicated in spacer generation, naïve adaptation can occur 
in strains where components of the RecBCD complex are deleted, indicating that other events 
can also promote naïve adaptation (Levy et al., 2015). However, spacer acquisition in the 
RecBCD deletion strain is no longer biased toward extrachromosomal DNA, indicating that 
other spacer generation mechanisms are equally effective against both host and foreign DNA. 
The reduced bias of spacer acquisition from extrachromosomal DNA in RecBCD deleted cells 
further indicates that self vs non-self spacer acquisition is directly related to the mechanism by 
which substrates are generated during naïve adaptation.  
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Figure 3. Cas1-Cas2 and Cascade structures. (A) Structure of Cas1-Cas2-protospacer. (B) Cryo-EM structure 
of Cas1-Cas2-protospacer with IHF and the leader. (C) Structure of apo-Cascade. 
 
 Mutations within the protospacer inactivate immunity through CRISPR interference, but 
promote rapid acquisition of new spacers derived from the escaped mutant genome, a process 
called primed adaptation (expanded in Interference section) (Datsenko et al., 2012). During 
primed adaptation, spacer generation is coupled with the Cascade and Cas3 interference 
machinery. This phenomenon ensures that spacer substrates are derived from the foreign DNA. 
Currently, there are two proposed spacer generation pathways during primed adaptation (Fig. 2). 
One is that the interference pathway provides substrates through Cas3 DNA degradation 
(interference-dependent), similar to RecBCD degradation providing substrates for naïve 
adaptation (Künne et al., 2016; Semenova et al., 2016). Once Cascade binds to the target, the 
formation of an R-loop structure can recruit Cas3 for degradation. We and others have shown 
that spacers are acquired relatively rarely when a perfect target is present (Semenova et al., 2016; 
Xue et al., 2015). The low level of spacer acquisition for a perfect target is caused by limited 
spacer source due to rapid target degradation by Cas3 (Künne et al., 2016; Semenova et al., 
2016). Mutations in the target are thought to slow interference. Thus, a continuous spacer source 
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pool will exist in cells with foreign DNA containing mutant protospacers resulting in rapid 
spacer acquisition.  
Another proposed pathway for spacer generation during primed adaptation is the 
formation of an adaptation complex between Cas3 and Cas1-Cas2 (Fig. 2) (Redding et al., 2015). 
This complex has been proposed to directly excise double-stranded protospacers from the foreign 
DNA (interference-independent). In the Type I-F CRISPR system, Cas2 and Cas3 are fused into 
a single protein (Cas2/3) and form a complex with Cas1, with a Cas14:Cas2/32 stoichiometry 
(Fagerlund et al., 2017; Rollins et al., 2017). Cas1 inhibits processive ssDNA degradation by 
Cas2/3, allowing the Cas1-Cas2/3 complex to dissociate from the binding site and slide away 
from the priming target without degradation (Rollins et al., 2017). As it slides, the Cas1-Cas2/3 
complex may search and excise double-stranded protospacer along its way. A similar mechanism 
is thought to occur in Type I-E, in which Cas3 is recruited to mutated target sites only when 
Cas1-2 are present.  
 
 
(2) Spacer Trimming and Capture by Cas1-Cas2   
 Two structural studies have revealed that the most optimal substrate of Cas1-Cas2 is a 33 
bp protospacer, which contains a central 23 bp double-stranded duplex with 5 nt overhangs on 
each side splayed into ssDNA ends by tyrosine wedges in Cas1 (Fig. 3A) (Nuñez et al., 2015a; 
Wang et al., 2015). The length of the central double-stranded duplex is governed by the fixed 
distances between the two Cas1 wedges. The length of the protospacer is determined by the 
distance between two Cas1 active sites for integration. To be recognized by Cas1-Cas2, it has 
been proposed that ssDNA substrates generated from naïve acquisition (RecBCD degradation) or 
interference-dependent primed adaptation (Cas3 degradation) must anneal to form double 
stranded Cas1-Cas2 substrates (Amitai and Sorek, 2016; Levy et al., 2015; Wang et al., 2015). 
Both RecBCD and Cas3 degrade DNA asymmetrically, yielding various length ssDNA 
fragments for both strands. These DNA fragments putatively re-anneal to provide a dsDNA 
substrate pool for Cas1-Cas2., although it remains unclear whether annealing occurs 
spontaneously or is assisted by Cas1-Cas2 or another host factor. Another possibility proposed 
by Gil et al., is that the Cas1-Cas2 complex initially binds to ssDNA, and then the second strand 
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may be generated by the DNA polymerase to form a dsDNA (Amitai and Sorek, 2016). 
Although it has been shown that the Cas1-Cas2 complex cannot bind ssDNA for the type I-E 
systems in vitro, it is possible that this can happen with the help of other host enzymes, which 
have not been identified (Musharova et al., 2016). Consistently, the type I-E Cas1-Cas2 can 
associate with non-dsDNA in vivo (Musharova et al., 2016). In addition, the Cas14:Cas2/32 
complex in the type I-F system can bind short ssDNA substrates directly with similar affinities as 
for dsDNA, indicating that Cas3 can assist with the capturing of ssDNA by Cas1-Cas2 
(Fagerlund et al., 2017).  
 Analysis of protospacers targeted by type I-E systems has revealed a short 3 bp motif, 
adjacent to the protospacers called the protospacer adjacent motif (PAM), which is critical for 
discrimination between self and non-self DNA (Deveau et al., 2008; Mojica et al., 2009). 
Cascade recognizes the PAM motif, which is absent in the host CRISPR arrays but present next 
to the invader protospacer, allowing the immune system to distinguish self and non-self. The 
PAM is required for optimal Cascade target recognition and degradation by Cas3. Therefore, 
optimal immunity requires that protospacers be selected from sites with correct PAM sequences. 
This specificity is achieved through intrinsic PAM recognition by the Cas1-Cas2 complex, which 
has high binding affinity for protospacer substrates with a canonical PAM (5’-CTT-3’) (Wang et 
al., 2015). Protospacer substrates with canonical PAMs are preferentially captured by Cas1-
Cas2. However, protospacer substrates with non-canonical PAMs can also be captured by Cas1-
Cas2 with low binding affinity, resulting in a lower CRISPR interference immunity (Díez-
Villaseñor et al., 2013; Levy et al., 2015). In fact, over 50% of acquired spacers have a non-
canonical PAM in some studies, depending on the expression level of Cas1 and Cas2 (Levy et 
al., 2015; Nuñez et al., 2014). In contrast, for interference-dependent spacer acquisition, Cas3 
preferentially cleaves T-rich sequences, and therefore generates 30-100 nt ssDNA fragments that 
are enriched for 5’-NTT-3’ PAMs in the 3’-end. Cas1-Cas2 selection of protospacer substrates 
from this 5’-NTT-3’ PAM enriched pool results in a higher PAM specificity (Datsenko et al., 
2012; Künne et al., 2016; Savitskaya et al., 2013; Swarts et al., 2012). 
The fact that dsDNA with a central 23 bp double-stranded duplex and various 3’ and 5’ 
ssDNA ends can be bound by Cas1-Cas2, indicates that re-annealed dsDNA substrates can be 
captured by Cas1-Cas2 prior to being processed to suitable protospacer substrates (Fig. 2) 
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(Nuñez et al., 2015a; Wang et al., 2015). The 23-bp duplex sits on the flat surface of Cas1-Cas2, 
which positions the 3’ ends into the catalytic site of each Cas1 with the guidance of an arginine-
rich channel in Cas1, and the 5’ overhangs are flexible and exposed to the environment (Fig. 
4A). Once loaded into Cas1-Cas2, it remains unclear how these pre-spacer-substrates are 
trimmed to generate suitable substrates that can be used for integration. It has been proposed that 
extra bases on these ssDNA ends are cleaved off by the symmetric active sites in Cas1-Cas2 to 
generate the 5-nt 3’ overhangs with –OH group at both ends, resulting in a total distance of 33 nt 
from one 3’ end to the other (Jackson et al., 2017; Wang et al., 2015). The 5’-ssDNA ends do not 
interact with Cas1-Cas2 and are exposed, and could potentially be degraded by other endo- or 
exonucleases. After processing, the substrates with 5-nt 3’ overhangs are suitable substrates for 
CRISPR locus integration. It is also possible that re-annealed dsDNA substrates can be processed 
to suitable protospacer substrates before capture by Cas1-Cas2 through an unknown mechanism 
(Fig. 2) (Amitai and Sorek, 2016). 
 Currently, there is less evidence for the mechanism of interference-independent spacer 
capture. It has been proposed that the Cas1-Cas2-Cas3 complex searches and excises double-
stranded protospacers as it slides on the dsDNA by recognizing PAM sequences (Fig. 2) 
(Redding et al., 2015). It has been proposed that the uninhibited nicking activity of Cas3 by Cas1 
may excise one site of the protospacer during the process, although the exact mechanism remains 
unclear (Rollins et al., 2017). Several major questions remain to be addressed for this process. 
Are other factors involved in this process? How does this adaptation complex search the 
sequence? How is the PAM recognized? How is the double-stranded protospacer excised by the 
adaptation complex?  
 
(3) Spacer Integration 
The Cas1-Cas2 complex loaded with suitable protospacer (hereafter Cas1-Cas2-
protospacer), must be specifically located to the CRISPR locus site to ensure correct genetic 
recording for immunity. The Cas1-Cas2-protospacer positions two 3’OH groups at each end of 
the protospacer to catalyze two nucleophilic attacks on each strand of the leader-proximal repeat 
(Nuñez et al., 2015b). The two transesterification reactions result in two single-stranded repeats 
flanking the newly integrated spacer (Arslan et al., 2014; Nuñez et al., 2015b). This gapped 
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intermediate is repaired by DNA polymerase I and other enzymes such as DNA ligase (Ivančić-
Bace et al., 2015). In the type I-E CRISPR system of E. coli, effective acquisition of new 
immunity requires a leader and repeat sequence, and IHF (Integration Host Factor), a histone-
like protein, which binds the leader and assists in positioning Cas1-Cas2 to the leader-proximal 
repeat (Nuñez et al., 2015b; Nuñez et al., 2016; Yosef et al., 2012) The leader sequence contains 
three elements: the leader-proximal repeat region (position -1 and -4) recognized by Cas1, the 
IHF binding site from -9 to -35, and an upstream Cas1 binding site from -51 to -55 (Fig. 4A) 
(Moch et al., 2017; Wright et al., 2017; Yoganand et al., 2017). 
Based on the fact that Cas1 can cleave four-way DNA junctions in vitro, it has been 
proposed that Cas1-Cas2-protospacer locates at the correct CRISPR site through the recognition 
of a cruciform structure formed in the palindromic repeat (Babu et al., 2011). However, Cas1-
Cas2-protospacer cannot bind a swapped repeat, which retains the same palindromic structure, in 
vitro (Moch et al., 2017). The swapped repeat also abolished spacer integration in vivo (Arslan et 
al., 2014). These results suggest that the repeat sequence is directly involved in the determination 
of the integration site and Cas1-Cas2-protospacer recognize the repeat sequence instead of a 
cruciform structure. This was further supported by recent structures of Cas1-Cas2 bound to both 
protospacer and half-site or pseudo-full-site target DNA (including the leader sequence and a 
repeat) (Fig. 3B) (Wright et al., 2017). In these structures, Cas1-Cas2 contacts the duplex repeat 
instead of a cruciform structure. Interestingly, Cas1-Cas2 contacts the repeat in a non-sequence-
dependent manner and Cas1-Cas2 binding causes severe bending and under-winding of the 
repeat, indicating that Cas1-Cas2 recognizes the repeat through indirect readout based on the 
repeat’s sequence-dependent deformability. However, it is possible that the twist deformation of 
the repeat is caused by the binding of Cas1-Cas2 to a half-site or pseudo-full-site target DNA 
with protospacer integration. Whether the twist deformation of the repeat serves as a recognition 
marker for Cas1-Cas2 integration or Cas1-Cas2 binding and protospacer integration cause the 
twist deformation requires further study.  
The fact that mutations in the palindromic sequence does not affect leader-repeat side 
integration, but prevents repeat-spacer side integration indicates that the palindromic sequence is 
not important for the recruitment of Cas1-Cas2 (Wright et al., 2017). Mutagenesis studies further 
indicated that the poly-G stretches in the palindromic sequence allow the target to reach the 
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second active site in Cas1 for full-site integration. Without the correct repeat sequence, half-site 
intermediates at the leader-side can be disintegrated, leaving the target sequence intact. However, 
another study using supercoiled DNA instead of linear oligonucleotides as the target DNA 
indicated that mutations in the repeat sequence severely reduced the formation of the ternary 
structure between Cas1-Cas2-protospacer and the CRISPR locus, indicating that the repeat 
sequence is important for Cas1-Cas2-protospacer recruitment (Moch et al., 2017). Further studies 
are needed to elucidate whether the repeat sequence plays a role in Cas1-Cas2 recruitment in 
vivo.  
With the guidance of the repeat sequence, the leader sequence bound by IHF directs 
Cas1-Cas2-protospacer to ensure the integration of new spacer in the correct site and orientation 
(Fig. 4B) (Wright et al., 2017). Deep sequencing data for Cas1-Cas2 integration reactions and 
Cas1-Cas2 in vitro disintegration reactions have revealed the avoidance of a cytosine (C) at the -
1 position and preference of a guanine (G) at position -2 in leader-repeat junction, indicating the 
inherent sequence specificity of Cas1 (Nuñez et al., 2015b; Rollie et al., 2015). The two recent 
structures of Cas1-Cas2 bound to both protospacer and half-site or pseudo-full-site target further 
indicate that there are several residues close to the active site of Cas1 that recognize the leader-
repeat junction directly to define integration specificity. Cas1 directly reads the leader-repeat 
junction (-1 to -4) to ensure newly incoming protospacers are inserted at the leader-proximal 
repeat instead of other repeat sites. In addition to the leader-repeat junction, the upstream 
recognition motif in the leader sequence (-51 to -55) serves as another check point by Cas1 
before integration at the leader-proximal repeat. The cryo-EM structure of the entire integration 
complex including Cas1-Cas2, protospacer, and a 130 bp target sequence bound by IHF has 
shown that the binding of the IHF at the leader region from -9 to -35 induces ~180˚ DNA 
bending (Fig. 3B). The bending of the leader directs the -51 to -55 region close to Cas1 for the 
second specificity check before integration. This is further supported by the fact that spacer 
integration mainly occurs at wrong sites instead of the correct leader-repeat site in the absence of 
IHF without this second specificity confirmation. Additionally, mutation of the upstream 
recognition motif reduced the rate of leader-side integration significantly when target is limiting. 
When target is in excess over Cas1-Cas2-protospacer, the mutation did not affect the rate of 
integration, although a higher level of off-target integration was observed. These results are 
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consistent with the fact that spacer integration was observed at non-leader-adjacent repeats and 
events outside the CRISPR array in the absence of IHF in another in vitro assay (Nuñez et al., 
2016). They further indicated that the nonspecific interactions with the leader region are critical 
for robust Cas1-Cas2 activity and specificity, whereas the weak sequence-specific interactions 
only contribute to some levels of specificity.  It has been proposed that the lack of direct 
sequence recognition of both the repeat and leader upstream recognition motif for correct 
CRISPR location by Cas1-Cas2 might reflect the evolutionary origins of Cas1 as a promiscuous 
transposase (Wright et al., 2017).  
Once Cas1-Cas2-protospacer binds at the CRISPR site, protospacer orientation has to be 
determined before integration to ensure the PAM side is integrated at the correct site for efficient 
CRISPR interference. The canonical PAM of the E. coli Type I-E CRISPR-Cas system has been 
identified as 5’-CHT or CTW-3’, with the C becoming the first nucleotide of the integrated 
spacer after integration (Fineran et al., 2014; Swarts et al., 2012). Interestingly, it has been 
shown that Cas1-Cas2-protospacer preferentially positions the 3’OH C to the repeat-spacer site 
for nucleophilic attack, resulting in correct incoming spacer orientation with a complementary G 
nucleotide as the first 5’-nucleotide (Rollie et al., 2015). Although it has been shown that the 
presence of a PAM in the incoming spacer is sufficient for correct orientation, the mechanism 
guiding spacer orientation is still unclear. Based on the recent cryo-EM structures, it is 
reasonable to propose that the interaction between the leader-repeat junction and Cas1 disfavors 
a 3’-OH C at the leader-repeat site, resulting in correct spacer orientation. This is supported by 
the fact that protospacer sequences can be integrated in both directions when the protospacer 
substrate lacks a C or contains a C at both 3’ ends. Because of the importance of the PAM during 
protospacer orientation, Jackson et al,. proposed that the PAM site 3’ end ssDNA processing 
occurs after Cas1-Cas2 orients itself at the CRISPR (Jackson et al., 2017).  
Cas1-Cas2 catalyzes protospacer integration at the opposite sides of the leader-proximal 
repeat by two nucleophilic attacks using the two 3’ OH groups in the protospacer (Nuñez et al., 
2015b). However, the attack sequence is still unclear. Cas1-Cas2 catalyzes faster disintegration 
at the leader-repeat junction compared to the repeat distal end in vitro, indicating that the first 
attack occurs at the leader-repeat to form a half-site intermediate (Rollie et al., 2015). In the 
presence of IHF, faster integration at the leader-repeat junction also suggests that integration first 
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occurs at the leader-repeat junction (Nuñez et al., 2016). The initiation of integration from the 
leader-repeat junction probably results from additional sequence contacts between the leader and 
Cas1. Consistently, Cas1-Cas2 in the type II system preferentially catalyzes spacer integration at 
the leader-repeat junction without other host factors (Wright and Doudna, 2016). Recent Type II 
Cas1-Cas2-protospacer structure analysis has indicated that the faster integration at the leader-
repeat junction may similarly be due to optimal leader-repeat recognition, which orients the 
protospacer 3’ OH group and the catalytic residue close to the leader-repeat junction (Xiao et al., 
2017a).  
In type I-E, IHF binding introduces severe DNA deformation in the leader-repeat 
junction which facilitate leader-repeat junction recognition for integration at this site (Wright et 
al., 2017). After the first nucleophilic attack, the intrinsic repeat deformation directs the other 3’ 
end across the active site of Cas1 for the second attack to generate the full-site integration 
product. Full-site integration results in a fully integrated spacer flanked by two single-stranded 
repeats. Finally, the reaction is completed by other host enzymes to fill the ssDNA gap, 
putatively DNA polymerase I and a DNA ligase (Fig. 4C), although their direct involvement still 
needs to be confirmed (Ivančić-Bace et al., 2015).  Incorrect protospacer orientation or CRISPR 
site stalls as half-site intermediates, which can be fixed through disintegration by Cas1-Cas2, 
leaving the target site intact and ensuring the fidelity of spacer acquisition (Fig. 4D).   
 
 
CRISPR RNA biogenesis and Cascade complex formation   
The core component of the surveillance complex is the mature crRNA, which guides the 
surveillance complex to the foreign DNA, triggering immunity (Brouns et al., 2008; Carte et al., 
2008). Maturation of crRNAs is a precise process. In E. coil K12, the CRISPR 1 and CRISPR 2 
arrays are first transcribed into long precursor CRISPR RNA (pre-crRNA), that contains stem 
loops in the palindromic repeats, which include 12 and 6 spacers, individually (Fig. 1). The long 
pre-crRNA is recognized and cleaved by Cas6e to yield mature crRNA (Gesner et al., 2011; 
Sashital et al., 2011). The structure of Cas6e from Thermus thermophilus has shown that Cas6e 
contains a N-terminal and a C-terminal RRM (RNA recognition motif) domain indicating Cas6e 
is a nucleic acid-binding protein (Ebihara et al., 2006). The co-crystal structures of Cas6e bound 
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to its crRNA substrate reveals a positive channel that contacts the 3’ strand of the crRNA repeat 
stem-loop (Gesner et al., 2011; Sashital et al., 2011). Cas6e recognizes the crRNA through base-
specific interactions within the stem-loop and nucleotides outside the stem-loop. Cas6e 
undergoes a conformational change after crRNA recognition and binding resulting in the correct 
positioning of the scissile phosphate close to Cas6e catalytic site for cleavage (Sashital et al., 
2011). Like other pre-crRNA biogenesis enzymes, Cas6e is a metal-independent 
endoribonuclease indicating that Cas6e uses a general acid/base catalytic mechanism, in which 
the nucleophilic attack is initiated by the deprotonated hydroxyl at the 2’ position of the ribose 
on the scissile phosphate.  
Pre-crRNA maturation can be divided into two steps.  First, Cas6e recognizes the stem-
loop through structure and sequence-specific contacts with the conserved repeats within the pre-
crRNA. Second, Cas6e undergoes a conformational change and performs the cleavage by 
hydrolyzing a single phosphodiester bond in the repeat sequences within the pre-crRNA to 
generate mature crRNAs, which are 61 nt long with 5’ –hydroxyl- and 2’, 3’ –cyclic phosphate 
ends (Jore et al., 2011). A mature crRNA is composed of a 8 nt repeat-derived 5’ handle, 
followed by a 32 nt spacer sequence, and a 21 nt repeat-derived RNA section with a seven base 
pair stem-loop in the end. Cas6e has high binding affinity for the cleaved crRNAs and binds to 
the cleaved crRNA resulting in a single turnover (Gesner et al., 2011; Sashital et al., 2011).  
The Cascade complex assembles along the length of the mature crRNA (Jackson et al., 
2014a; Zhao et al., 2014). Although the order of Cascade backbone and tail assembly steps is not 
clear, it has been proposed as follows (Fig. 1). After cleavage, as a single turnover enzyme, 
Cas6e remains bound to the 3’ stem-loop of the crRNA cleavage product.  Cas5e binds to the 5’ 
handle of the mature crRNA. Six copies of Cas7 subunits, containing the RRM (RNA 
Recognition Motif) fold, polymerize non-specifically along the crRNA to form the backbone of 
the complex (Fig. 3C). Two copies of Cse2 interact with Cas7 subunits through salt bridges to 
form the belly that helps stabilize the crRNA and target DNA. Lastly, the largest subunit Cse1 
caps the Cas5e side to form the complete seahorse-like shape complex, Cascade (Fig. 3C). 
Notably, in addition to the canonical Cascade complex, more or less Cas7 subunits, correlating 
with the length of the bound spacer, can be assembled into the crRNA in the backbone of the 
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complex, further suggesting that Cas7 subunit interact with crRNA through a non-sequence 
dependent manner and determines the length of the crRNA.  
 
Figure 4. A proposed model of spacer integration by Cas1-Cas2 in E. coli K12. (A) Schematic of the leader 
sequence in E. coli K12. (B) Repeat and leader bended by IHF recruits Cas1-Cas2-protospacer to the CRISPR 
locus. (C) Two nucleophilic attacks result in a full-site integration and ssDNA gap is repaired by DNA 
polymerase I and a DNA ligase. (D) Incorrect half-site intermediates are fixed by Cas1-Cas2 disintegration. 
 
Interference 
During the interference stage, the Cascade complex targets DNA for degradation, thereby 
preventing the propagation of mobile genetic elements. In Type I-E CRISPR-Cas systems, 
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Cascade and Cas3 are responsible for target DNA recognition and degradation, respectively 
(Westra et al., 2012). The interference stage can be divided into three steps: PAM searching and 
recognition, target DNA binding and R-loop formation, and Cas3 recruitment and target DNA 
degradation.  
 
 
PAM searching and recognition 
The first and crucial step during interference is target recognition by the surveillance 
complex. To initiate timely response against phage, the surveillance complex must be able to 
efficiently locate foreign targets among the vast amount of DNA in the cell. At the same time, 
the surveillance complex has to avoid targeting complementary sequences in the bacterial 
genome. To distinguish self and non-self, the Cse1 subunit in Cascade first recognizes PAM sites 
in the target strand of foreign DNA (Sashital et al., 2012). Sasthital et al. demonstrated that Cse1 
is required for both nonspecific interactions with DNA and specific target binding by Cascade. 
The dual function of Cse1 suggested that the nonspecific DNA binding activity and PAM 
recognition are functionally linked. It was proposed that Cascade searches the target by initially 
scanning PAM sites and PAM scanning must be a transient process because of the abundance of 
PAM sites in the genome.  
Sternberg et al. using a single molecule imaging technique DNA curtain assay suggested 
that the type II CRISPR system Cas9 locates target sequences by recognizing PAMs through 3D 
diffusion without any measurable 1D sliding, hopping, and/or intersegmental transfer (Sternberg 
et al., 2014). The potential PAM-dependent searching process has been proposed as a dominant 
mechanism for target searching by RNA-guided DNA surveillance complexes. Redding et al. 
used the same DNA curtain assay to observe a similar PAM-dependent searching process for 
Cascade (Redding et al., 2015). Binding kinetic analyses performed by Rollins et al. 
demonstrated that the recognition of the PAM site is a prerequisite for target binding by the Csy 
complex in the type I-F CRISPR system (Rollins et al., 2015). Together, these studies suggest 
that the target searching process is accelerated by rapid dissociation and association rates on non-
specific dsDNA.  
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During the PAM searching process, the surveillance complex must somehow sense the 
non-PAM region and PAM sites. Although the mechanism of Cascade target searching remains 
unknown, it has been proposed that several regions of Cascade that may be involved in this 
process. These regions have been identified based on Cascade crystal structures and molecular 
dynamics simulations of Cascade bound to a dsDNA target. Cascade first recognizes PAM sites 
through specific interactions with Cse1 (Van Erp et al., 2015; Hayes et al., 2016; Sashital et al., 
2012). The first research about Cse1 PAM recognition by Sashital et al. proposed that the L1 
motif in Cse1 may be involve in PAM recognition. Sashital et al. demonstrated that the L1 motif 
is important for Cascade target binding and interference. However, the E. coli Cascade-dsDNA 
structure suggested that the L1 motif is buried and unavailable for PAM recognition, although a 
recent structure of a full Thermobifida fusca Cascade shows that L1 contacts the PAM in the full 
R-loop structure (Xiao et al., 2017b). The comparison between apo-Cascade and Cascade-
ssDNA structure suggested that the L1 motif is important for stabilizing Cascade closed 
conformations, which has been demonstrated in Chapter 4.  
The Cascade-dsDNA crystal structure revealed a PAM recognition motif in Cse1 that 
recognizes PAM sites (Hayes et al., 2016). During the target searching process, the non-PAM 
regions and PAM sites may be recognized by the PAM recognition motif before target binding. 
Sashital et al. demonstrated that the non-specific interaction between Cse1 and dsDNA is 
important for target binding (Sashital et al., 2012). Van Erp et al. further identified two lysine-
rich loops in adjacent Cas7.5 and Cas7.6 subunits of the Cascade backbone form a vise that 
contacts with the DNA backbone through non-specific electrostatic interaction (Van Erp et al., 
2015). The lysine-rich vise is necessary for dsDNA binding. It has been proposed that the lysine-
rich vise is involved in target searching. In Chapter 2, we visualized this searching process 
directly and investigated three protein motifs, the PAM recognition motif in Cse1, the lysine-rich 
vise in Cas7, and a new identified lysine-rich β hairpin in Cse1, that are involved in the Cascade 
target search process. Our results indicate that Cascade randomly samples dsDNA with rapid on 
and off rates through short-lived nonspecific electrostatic contacts between two lysine-rich loops 
in Cas7 and the phosphate backbone of the dsDNA. The dsDNA is positioned close to the PAM 
recognition motif in Cse1 with the guidance of a lysine-rich loop in Cse1. Cascade quickly 
dissociates from dsDNA in the absence of PAM. At PAM sites, favorable interactions with the 
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PAM recognition motif stalls Cascade, allowing for interrogation of the adjacent DNA for 
complementarity with the crRNA.  
 
 
Target DNA binding and R-loop formation  
Phage escape studies identified a short PAM-proximal region in the target sequence, 
named the seed region (1-5 and 7-8 nt) (Semenova et al., 2011). Point mutations in either the 
seed region (1-5 and 7-8 nt) of the protospacer or PAM block interference (Fineran et al., 2014; 
Makarova et al., 2011) This may occur through the reduction of Cascade-DNA binding affinity 
or through inhibition of Cas3 nuclease recruitment/cleavage activity. The importance of the seed 
region suggests that the it acts as the next checkpoint following PAM recognition. Due to the 
importance and seed and PAM region, phage can accumulate spontaneous mutations in these 
regions to escape CRISPR interference. However, some of these mutations can promote rapid 
spacer acquisition from the invader DNA through primed adaptation as described 
above(Datsenko et al., 2012) . In this way, CRISPR-Cas systems are able to rapidly adapt to 
phage evolution that may result in immune system evasion.  
Single mutations in the seed or PAM region strongly inhibit CRISPR interference, while 
priming can occur in the presence of several protospacer mutations (Fineran et al., 2014). 
Datsenko et al. found that double mutations in the PAM and seed region abolished primed 
adaptation (Datsenko et al., 2012). However, a subsequent high-throughput study indicated that 
up to five mutations in the PAM and seed region could still promote primed adaptation, while up 
to 13 mutations across the whole protospacer could still elicit a priming response (Fineran et al., 
2014). This study also suggested that PAM recognition by Cascade is promiscuous, identifying 
at least 27 PAMs that can be recognized by Cascade and at least 22 that can promote rapid 
priming. The Cascade-dsDNA structure has rationalized this promiscuity, as the PAM is mainly 
read out through minor-groove contacts that do not provide high sequence specificity. These 
studies of CRISPR interference and priming activity in E. coli have used a limited number of 
spacer sequences and could not distinguish sequences that promote interference versus priming. 
In the type II CRISPR system, it has been shown that spacer sequences influence Cas9 activity 
(Fu et al., 2013; Hsu et al., 2013; Mali et al., 2013b; Pattanayak et al., 2013; Wu et al., 2014). In 
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Chapter 3, we analyzed the effect of spacer sequence on CRISPR in interference and priming 
activity using 18 spacers in E. coli. we also reexamined the PAM and seed tolerance of the E. 
coli CRISPR immunity using a high throughput screening method that decouples interference 
and priming, enabling identification of the exact sequence determinants for each mechanism.  
PAM and seed recognition are prerequisite for target binding. When Cascade locates a 
PAM site, favorable interactions between Cse1 and the PAM may enable dsDNA bending, 
destabilizing the dsDNA at the PAM-proximal region (Hayes et al., 2016; Sashital et al., 2012; 
Xiao et al., 2017b). This destabilization may drive local dsDNA melting, enabling strand 
invasion and the formation of a crRNA-DNA heteroduplex within the seed region to initiate R-
loop formation. PAM recognition by Cse1 causes instability of PAM region resulting in DNA 
bending. The subsequent unwinding of the bent dsDNA is helped by the insertion of a conserved 
Gln-wedge in Cse1 (Hayes et al., 2016; Xiao et al., 2017b). The energy loss during DNA 
bending and unwinding is compensated by base pair formation between the crRNA and target 
DNA in the seed region (Gorski et al., 2017). A recent Cascade structure snapshot of the seed 
crRNA-DNA duplex demonstrated this R-loop intermediate before full R-loop formation (Xiao 
et al., 2017b). In this snapshot, two 5-bp crRNA-DNA stretches, including the whole seed 
region, were captured. It has been hypothesized that dsDNA may melt in 6-bp steps and the 
unwound non-target DNA strand travels along with the target strand.  
The unwinding of the DNA duplex during R-loop formation has been observed using 
single molecule magnetic tweezers (Rutkauskas et al., 2015, 2017; Szczelkun et al., 2014). These 
magnetic tweezers data have shown that the melting of dsDNA at the PAM-proximal region 
follows by directional dsDNA melting resulting in directional R-loop formation. The R-loop 
expands from the PAM-proximal region to the PAM-distal end by zipping the crRNA and target 
strand. R-loop formation stalls when it meets non-complementary sequence. Cascade can either 
overcome the non-complementary energetic barrier and continue R-loop formation triggering 
further directional and sequential unwinding of the target DNA, maintain an unstable, partial R-
loop, or dissociate from the target. Targets with mismatches at the PAM-distal end mainly form 
unstable R-loops. Complete base pairing between the crRNA and target sequence triggers a 
conformational change in Cascade, resulting in a highly stable R-loop structure. During this 
conformational change, Cse1-CTD undergoes a conformation to a locked position and the Cse2 
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dimer sliding toward the tail of the complex (Van Erp et al., 2015; Xiao et al., 2017b). At the 
same time, the non-target DNA strand is stabilized by the backside of the Cse2 dimer. The 
unstable R-loop is an intermediate prior to full R-loop formation. This instability occurs because 
Cascade does not undergo a conformational change to lock the R-loop, as observed in the 
Cascade structure snapshot of the seed crRNA-DNA duplex (Xiao et al., 2017b).  
 
 
Cas3 recruitment and target DNA degradation 
The conformational change in Cascade locks the R-loop and is a recruitment signal for 
Cas3 nuclease/helicase (Westra et al., 2012). The rotation of the CTD of Cse1 during the 
conformational change of Cascade is responsible for Cas3 recruitment through the exposure of a 
direct interaction region with Cas3 (Gong et al., 2014; Hayes et al., 2016). Once recruited to 
target site bound by Cascade, Cas3 is responsible for target degradation. The N-terminal 
nuclease domain exhibits metal-dependent nuclease activity on ssDNA and the C-terminal 
helicase domain has ATP- and magnesium-dependent 3’-5’ unwinding activity (Gong et al., 
2014; Huo et al., 2014; Jackson et al., 2014b; Sinkunas et al., 2011). Target degradation requires 
both the nuclease and helicase activities of Cas3. Structures of Cascade bound to a full R-loop 
showed that full R-loop formation triggers bulging of the non-target strand (nt 8-16th) (Xiao et 
al., 2017b). The ssDNA bulge facilitates the initial nicking on the non-target strand by Cas3. The 
initial nicking is not ATP dependent but can be stimulated by the presence of ATP (Mulepati and 
Bailey, 2013). After nicking, Cas3 generates a short ssDNA gap (200-300 nt) upstream of the 
protospacer (Redding et al., 2015). It has been proposed that the ssDNA gap was generated 
through a looping manner. During this process, Cas3 repeatedly loops the DNA to degrade the 
non-target strand. Once ssDNA gap is generated, additional Cas3 can be recruited to the ssDNA 
gap and processively degrade upstream of the target in 3’-5’ direction, resulting in a 
unidirectional degradation of the target (Mulepati and Bailey, 2013; Redding et al., 2015). 
During this processive degradation, the helicase domain generates ssDNA substrate for the 
nuclease domain. Under higher ATP concentration (quicker helicase activity), the nuclease 
domain cuts the ssDNA less frequently, while the nuclease domain cuts the ssDNA more 
frequently under lower ATP concentration (slower helicase activity) (Mulepati and Bailey, 
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2013). Due to the deleterious effect of Cas3 could have on the host genome, Cas3 activity is 
under tight regulation through both expression and recruitment. 
For some PAM and seed mutations, Cascade adopts distinct conformations (Xue et al., 
2016). These alternative conformations may not recruit Cas3 directly or recruit Cas3 in a slow 
way, resulting primed adaptation. In Chapter 4, we have shown that the conformation of Cascade 
controls CRISPR interference and priming. When Cascade is bound to a canonical target, Cse1 
prefers to adopt the ‘closed’ conformation which can recruit Cas3 directly to degrade the target 
DNA rapidly. When Cascade is bound to a mutated target, Cse1 prefers to adopt an ‘open’ 
conformation. The ‘open’ conformation of Cse1 inhibits or fully blocks direct Cas3 recruitment 
resulting in slow interference and rapid priming.  
 
 
Organization of the dissertation 
The aim of this dissertation is to understand how Cascade searches for and recognizes the 
target, and how Cascade binding triggers either interference or priming. In Chapter 2, we 
developed a single-molecule FRET assay to directly visualize how Cascade searches the target. 
Then, we used mutagenesis to study what protein regions in Cascade are responsible for Cascade 
target searching. Finally, we developed a structural model to simulate how Cascade may bind to 
dsDNA during the target-search process. In Chapter 3, we studied the effect of spacer sequences 
on CRISPR activity using the 18 endogenous spacers in E. coli K12. In addition, we developed a 
high-throughput screening method to systematically study PAM and seed mutational tolerance. 
In Chapter 4, we developed a FRET system to measure different conformations of Cse1 and 
determine how these conformations are related to interference and priming activity. We 
demonstrated that the open and closed conformations of Cse1 are controlled by the target 
sequence or by L1 motif in Cse1. The function of Cascade can be switched from interference to 
priming by mutating the target sequence or the Cse1 L1 motif. In Chapter 5, I summarized the 
work and future directions. In the Appendix, I briefly describe the development of a single-
molecule FRET assay to visualize how Cas1-Cas2 locate the CRISPR locus prior to spacer 
integration.   
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SURVEILLANCE COMPLEX CASCADE 
 
Chaoyou Xue, Yicheng Zhu, Xiangmei Zhang, Yeon-Kyun Shin, Dipali G. Sashital 
 
 
Abstract 
CRISPR-Cas systems defend bacteria and archaea against infection by bacteriophage and other 
threats. The central component of these systems are surveillance complexes that use guide RNAs 
to bind specific regions of foreign nucleic acids, marking them for destruction. Surveillance 
complexes must locate targets rapidly to ensure timely immune response, but the mechanism of 
this search process remains unclear. Here, we used single-molecule FRET to visualize how the 
Type I-E surveillance complex Cascade searches DNA in real time. Cascade rapidly and 
randomly samples DNA through nonspecific electrostatic contacts, pausing at short PAM 
recognition sites that may be adjacent to the target. We identify Cascade motifs that are essential 
for either nonspecific sampling or positioning and readout of the PAM. Our findings provide a 
comprehensive structural and kinetic model for the Cascade target-search mechanism, revealing 
how CRISPR surveillance complexes can rapidly search large amounts of genetic material en 
route to target recognition. 
 
 
Introduction 
CRISPR-Cas (clustered regularly interspaced short palindromic repeats–CRISPR associated) 
adaptive immune systems protect bacteria and archaea by detecting and destroying foreign 
nucleic acids (Marraffini, 2015; van der Oost et al., 2014; Sorek et al., 2013b). CRISPR–Cas 
systems generate immunological memories by inserting short DNA segments from the invader 
DNA as spacers in the host CRISPR array (Barrangou et al., 2007b; Jackson et al., 2017). The 
CRISPR array is transcribed and processed into mature CRISPR RNAs (crRNAs), which 
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assemble with one or more effector Cas proteins (Hochstrasser and Doudna, 2015a; Jackson and 
Wiedenheft, 2015a). This crRNA-guided complex surveys the cell, searching for the 
complementary “protospacer” target in the invader nucleic acid. Following target binding 
through complementary base pairing with the crRNA, the invader is cleaved and degraded 
(Marraffini, 2015; van der Oost et al., 2014).  
 
CRISPR-Cas systems are clustered into six types (Types I-VI), each having distinct Cas proteins 
and immune mechanisms (Koonin et al., 2017c; van der Oost et al., 2014). In the Type I-E 
CRISPR-Cas system of Escherichia coli, five stoichiometrically unequal proteins (Cse11, Cse22, 
Cas76, Cas5e1, and Cas6e1) assemble with a 61-nt crRNA to form the Cascade surveillance 
complex (Fig. 1A) (Brouns et al., 2008; Hayes et al., 2016; Jackson et al., 2014c; Jore et al., 
2011b; Mulepati et al., 2014a; Zhao et al., 2014b). Similar to the Type II surveillance complex 
Cas9, Cascade searches for targets by first recognizing a short sequence called the protospacer-
adjacent motif (PAM) (Mojica et al., 2009a; Redding et al., 2015; Sashital et al., 2012; 
Semenova et al., 2011b; Sternberg et al., 2014). PAM recognition destabilizes the DNA duplex 
by inserting a glutamine wedge located in the large Cse1 (Cas8e) subunit into the dsDNA 
adjacent to the PAM, enabling strand invasion and formation of an RNA-DNA heteroduplex in 
the seed region (positions 1-5 and 7-8 of the crRNA spacer) (Hayes et al., 2016; Xiao et al., 
2017b). Complementary base pairing in the seed region efficiently promotes further R-loop 
formation (Semenova et al., 2011b; Szczelkun et al., 2014b). Cascade bound to the dsDNA 
triggers the recruitment of Cas3, which degrades the non-target strand in a 3’-5’ direction 
(Hochstrasser et al., 2014; Mulepati and Bailey, 2013; Redding et al., 2015; Sinkunas et al., 
2011b; Westra et al., 2012).  
 
Single-molecule studies have provided remarkable insight into how Cascade binds dsDNA 
targets (Blosser et al., 2015a; Jung et al., 2017; Redding et al., 2015; Rutkauskas et al., 2015; 
Szczelkun et al., 2014b). Magnetic tweezers experiments have revealed directional R-loop 
formation by the Cascade complex during dsDNA binding (Rutkauskas et al., 2015; Szczelkun et 
al., 2014b). Single-molecule fluorescence resonance energy transfer (smFRET) studies using 
FRET pairs on each strand of the dsDNA target revealed two distinct Cascade-DNA binding 
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modes for bona fide and mutant targets (Blosser et al., 2015a). These studies provided 
mechanistic details of Cascade R-loop formation following the initial target encounter, but did 
not probe the mechanism by which Cascade locates its target. Single-molecule imaging 
experiments using DNA curtains have been used to visualize Cascade target search and binding 
with intermediate spatial resolution (~30 nm) (Redding et al., 2015). This study suggested that 
Cascade dwells at potential PAM sites located throughout the DNA during target searching, 
providing Cascade with time to interrogate the adjacent DNA sequence for complementarity with 
the crRNA. However, it is still unclear how Cascade locates PAM sites and whether it employs 
other target searching mechanisms to accelerate the surveillance process. It has been proposed 
that target searching begins by Cascade randomly sampling dsDNA through three-dimensional 
diffusion and rapidly dissociating from non-PAM sites (Redding et al., 2015), although this 
process has not been observed by existing single-molecule systems.  
 
Detecting putative transient searching events requires a highly sensitive experimental system that 
enables observation of both the location and duration of Cascade-dsDNA binding. Here, we 
developed a smFRET assay that meets these requirements, enabling the direct visualization of 
the Cascade target-searching process in real time. We observed that Cascade randomly samples 
dsDNA through short-lived nonspecific electrostatic contacts between two lysine-rich loops in 
two of the Cas7 subunits and the phosphate backbone of the dsDNA. In the absence of a PAM, 
Cascade quickly dissociates from dsDNA, but this interaction is significantly stabilized through 
interactions between PAM sequences and two motifs within the Cse1 subunit. Together, these 
results provide a kinetic and structural model that explains how Cascade is able to rapidly locate 
DNA targets. 
 
 
Results 
Single-molecule FRET assay for Cascade target binding 
Using a previously developed fluorescently-labeled Cascade (Xue et al., 2016), we established a 
system to directly observe individual Cascade complexes binding to a complementary target 
dsDNA in real time using smFRET  (Fig. 1A). We initially sought to observe Cascade binding to 
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a bona fide target (dsDNAtarget) containing a perfectly complementary protospacer and canonical 
PAM (5’-AAG-3’ on the non-target strand). We immobilized biotinylated dsDNAtarget labeled 
with donor (Cy3) fluorophore at the 5’ end of the non-target strand on a passivated quartz surface 
(Fig. 1B, 2A).  Cascade bearing a complementary crRNA was labeled with an acceptor (Cy5) 
fluorophore in the Cas5e (E102C) subunit (Fig. 1A, 2B). Bulk Cascade binding experiments 
showed that the fluorescent label on Cas5e did not affect Cascade DNA binding activity (Fig. 
2C).  
 
Figure 1. Real-time observation of Cascade target searching and binding by smFRET. (A) Schematic of Cascade 
labeled with Cy5 in the Cas5e subunit. (B) Schematic of smFRET experiment using dsDNAtarget and targeting 
Cascade. (C) A representative smFRET time trajectory of long-lived FRET event for targeting Cascade and 
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dsDNAtarget. (D) A representative smFRET time trajectory of short-lived FRET events for targeting Cascade and 
dsDNAtarget. (E) Schematic of smFRET experiment using dsDNAtrunc and targeting Cascade. (F) A representative 
smFRET time trajectory of long-lived FRET for targeting Cascade and dsDNAtrunc. (G) Transition density plot of 
long-lived FRET events for targeting Cascade and dsDNAtarget with a FRET peak centered at 0.51. (H) Transition 
density plot of short-lived FRET events for targeting Cascade and dsDNAtarget with a FRET peak centered at 0.46. 
(I) Transition density plot of all FRET events for targeting Cascade and dsDNAtrunc with a FRET peak centered at 
0.52. 
 
Figure 2. Development of smFRET assay. (A) Schematic of two crRNAs correspond to targeting Cascade and non-
targeting Cascade and a surface-immobilized, Cy3 labelled dsDNA that contains the target sequence (green) and the 
PAM (red). A 33-nt biotinylated adaptor is used as an anchor for surface immobilization. (B) Cy3 (green dot) and 
Cy5 (red dot) labelling locations shown in the Cascade-dsDNA bound crystal structure (PDB ID: 5H9F). (C) 
Electrophoretic mobility shift assay for WT Cascade and Cy5 labelled Cascade (labelling efficiency > 90%) (1, 2, 5, 
10, 20, 50, and 500 nM) binding to plasmid containing target sequence.  
 
Injection of Cascade into a flow cell with immobilized dsDNAtarget resulted in long-lived FRET 
between Cy3-dsDNAtarget and Cy5-Cascade for ~20% of single-molecule trajectories (n = 512), 
reflecting binding of Cascade to the target (Fig. 1C). This long-lived FRET state persisted until 
fluorophore photobleaching after ~190 s (Fig. 3), consistent with the formation of a stable R-
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loop. The FRET efficiency value of 0.5 was consistent with the distance between Cy5 and Cy3 
fluorophores as measured in the Cascade-dsDNA crystal structure (Fig. 2B).  For the remaining 
trajectories, we observed short-lived FRET events, suggesting that Cascade quickly dissociates 
from the DNA (Fig. 1D and Fig. 4). We interpreted these events as random target sampling or 
incomplete R-loop formation. Previous bulk biochemical studies have shown that Cascade binds 
to full length dsDNA oligonucleotides with low affinity at room temperature, which may account 
for the low percentage of full R-loop formation events (Xue et al., 2016). These results suggest 
that Cascade requires additional energy to efficiently unwind dsDNA for full R-loop formation, 
contributed either by thermal energy or negative supercoiling (Westra et al., 2012). Indeed, 
single-molecule tweezer experiments have shown that DNA supercoiling is necessary for full R-
loop formation by Cascade binding to linear dsDNA at room temperature (Rutkauskas et al., 
2015; Szczelkun et al., 2014b). 
 
Figure 3. Mean donor photobleaching time was obtained from fitting donor survival probability to a single-
exponential decay equation. 
 
We hypothesized that Cascade may more efficiently form a full R-loop in our smFRET assay if 
the double-stranded region of the target were truncated, as has previously been shown in bulk 
biochemical assays (Xue et al., 2016). To test this, we designed a dsDNA target with a truncated 
non-target strand (dsDNAtrunc) forming only 10 base pairs (bp) with the PAM-proximal region of 
the target (Fig. 1E). As expected, we observed long-lived Cascade-target binding for most of the 
trajectories (~90%, n = 445) for dsDNAtrunc. For a small number of trajectories (less than 5%), 
we observed transient FRET events prior to long-lived Cascade-target binding, similar to short-
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lived events observed for the fully double-stranded target (Fig. 1F). Control experiments 
performed for either Cse2-Cas6 or Cse1 labeled with Cy5 had no detectable FRET events (Fig. 
5), indicating that all DNA-binding events require the entire Cascade complex. 
 
 
Figure 4. Representative smFRET trajectories of targeting Cascade with dsDNAtarget. 
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Figure 5. FRET distribution for whole Cascade, Cse1, and Cse2-Cas6 with dsDNAtrunc. (A-C) FRET histograms for 
FRET events existed in all extracted traces of Cascade with Cy5 labelled Cse2-Cas6 (A), Cy5 labelled Cse1 (B), and 
Cy5 labelled Cse2-Cas6 (C). The number of molecules used for FRET histograms was 392 (Cascade), 378 (Cse1), 
and 400 (Cse2). 
Analysis of single-molecule trajectories with dsDNAtarget and dsDNAtrunc revealed the relative 
frequencies of transitions between an unbound state (EFRET ~ 0) and bound states, which we 
visualized using transition density plots (TDPs) (Fig. 1G-I). For dsDNAtarget, we separately 
analyzed trajectories with long-lived (Fig. 1G) or short-lived (Fig. 1H) FRET events. The TDPs 
for the dsDNAtarget long-lived FRET trajectories and for all dsDNAtrunc trajectories are non-
symmetrical (Fig. 1G and I), showing that Cascade binds to the target tightly and does not 
dissociate from the DNA once it finds the target, consistent with the long-lived and highly stable 
formation of an R-loop, as has been previously observed (Rutkauskas et al., 2015; Szczelkun et 
al., 2014b). Almost all binding events initiated from EFRET ~ 0 and ended at EFRET ~ 0.51, 
indicating that Cascade finds and binds the target simultaneously (Fig. 1G and I). For dsDNAtarget 
trajectories containing only short-lived events, the TDP is symmetrical with peaks indicating 
transitions between EFRET ~ 0 and EFRET ~ 0.46 (Fig. 1H).  
 
Real-time observation of Cascade PAM searching process 
The transient FRET events for dsDNAtarget suggests that intermediate states adopted during 
Cascade target search can be observed by our smFRET assay (Fig. 1D, H and Fig. 4). If the 
transient binding events are intermediates along the path to stable target binding, we 
hypothesized that a similar transient Cascade searching process would also be observed with a 
non-matching crRNA-DNA pair. To test this, we prepared Cy5-Cascade bearing a non-matching 
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crRNA (hereafter non-targeting Cascade) and observed binding to various dsDNA substrates 
using our smFRET assay (Fig. 6 and Fig. 2A). We first measured binding of non-targeting 
Cascade to dsDNAtarget, enabling a direct comparison of binding to the same substrate with 
targeting Cascade. As expected, long-lived stable binding events were not observed for non-
targeting Cascade binding to dsDNAtarget. Instead, we observed abundant but highly transient 
events with variable FRET efficiencies, consistent with a rapid search process across the DNA 
target (Fig. 6A).  
 
To determine the binding kinetics of the observed search process, we analyzed the bound-state 
lifetimes and association rates for all short-lived FRET events for targeting and non-targeting 
Cascade binding to dsDNAtarget (Fig. 6B-C). The bound-state lifetimes of FRET events were best 
described by double-exponential decay (Fig. 6B). For both targeting and non-targeting Cascade, 
the shorter bound-state lifetime (τ1) was similar to the 0.1 s frame rate used during data collection 
(Fig. 6C), suggesting that the detection of short events may be limited by the time resolution of 
the experiment. The longer bound-state lifetime (τ2) and the amplitude-weighted lifetime (τavg) 
were both significantly higher (p < 0.05 using unpaired t-test for all significance tests) for 
targeting Cascade, which may be due to partial R-loop formation prior to dissociation (Fig. 6C). 
Consistently, the FRET efficiency distribution for targeting Cascade is relatively narrow in 
comparison to non-targeting Cascade (Fig. 1H, 7A), indicating that Cascade mainly binds at the 
target site when loaded with a matching crRNA but binds at random sites along the DNA in the 
absence of a matching target.  
 
Previous studies have shown that Cascade binds promiscuously to targets with a variety of non-
canonical “functional” PAM sequences (Jung et al., 2017; Leenay et al., 2016; Xue et al., 2015), 
and dsDNAtarget contains functional PAMs throughout the sequence (Table 1). Therefore, it is 
possible that the broad FRET distribution observed for non-targeting Cascade may be due to 
Cascade binding promiscuously at functional PAM sequences, rather than at random non-
specific sites. To address this possibility, we designed three dsDNA substrates containing 0, 1 or 
3 canonical 5’-AAG-3’ PAM sequences (dsDNA0PAM, dsDNA1PAM and dsDNA3PAM, 
respectively), and otherwise consisting mainly of 5’-CCG-3’ triplets, a well-characterized non-
  
42 
functional PAM motif (Fineran et al., 2014; Jung et al., 2017; Leenay et al., 2016; Westra et al., 
2012; Xue et al., 2015) (Table 1). Similar to non-targeting Cascade binding to dsDNAtarget, 
individual FRET trajectories for these three substrates revealed transient FRET events (Fig. 6D-
F), although the frequency and duration of the events varied for each substrate.  
 
Figure 6. Real-time observation of target sampling by non-targeting Cascade on four substrates. (A) Representative 
smFRET time trajectory of non-targeting Cascade binding to dsDNAtarget. (B) Survival probabilities of dwell time 
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distribution of FRET events for non-targeting Cascade and dsDNAtarget (green curve), dsDNA0PAM (gray curve), 
dsDNA1PAM (red curve), and dsDNA3PAM (dark red curve) fit to double-exponential decays (black curve). The 
number of molecules for each decay ranged from 1050 to 4,775. (C) The time and amplitude (longer bound-state 
lifetime) parameters of the double-exponential decays for dsDNAtarget (green), dsDNA0PAM (gray), dsDNA1PAM (red), 
and dsDNA3PAM (dark red). All dwell times are at least two orders of magnitude shorter than fluorophore 
photobleaching under the same measurement conditions (Fig. S2), indicating that the sudden disappearance of FRET 
was caused by the dissociation of Cascade from the dsDNA instead of photobleaching. (D-E) Representative 
smFRET time trajectories of non-targeting Cascade for (D) dsDNA0PAM, (E) dsDNA1PAM, and (F) dsDNA3PAM. 
 
Figure 7. Transition density plots for (A) dsDNAtarget, (B) dsDNA0PAM, (C) dsDNA1PAM, (D) dsDNA3PAM, and (E) 
dsDNA1PAM-12bp. 
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As with dsDNAtarget, the bound-state lifetimes for FRET events measured for the three variable 
PAM substrates were best described by double-exponential decay (Fig. 6B). We again observed 
a short ~0.1 s bound-state lifetime (τ1) for all three substrates. Strikingly, τ2 and τavg both increase 
significantly as the number of PAMs increases, although no significant difference was observed 
for τ1 values (Fig. 6C). The differences in τavg reflects not only the variations in τ2, but also the 
low amplitude of the τ2 component for targets with fewer PAMs. In particular, the amplitude of 
the longer dwell events is less than 2% for dsDNA0PAM, and increases to ~8% for dsDNA1PAM 
and ~25% for dsDNA3PAM (Fig. 6C). These data suggest that the longer-lived binding events are 
PAM-dependent, while the short events are PAM-independent. We also observed a small but 
significant increase in the association rate (kon) in the presence of a large number of canonical 
(dsDNA3PAM) or non-canonical (dsDNAtarget) PAMs, suggesting that the rate of binding for 
Cascade may be dependent on the presence of favorable PAMs (Fig. 6C). Importantly, 
association rates were concentration dependent while concentration had no effect on dissociation 
rates, indicating that FRET transitions were due to Cascade association and dissociation (Fig. 8). 
 
Figure 8. FRET appearance and disappearance at different Cascade concentrations. (A) kbinding for dsDNA0PAM and 
dsDNA1PAM at three different Cascade concentrations (2.5 nM, 5 nM and 10 nM). (B) koff for dsDNA0PAM and 
dsDNA1PAM at three different Cascade concentrations (2.5 nM, 5 nM and 10 nM).   
 
As for dsDNAtarget, non-targeting Cascade binding to the variable PAM substrates exhibited 
broad FRET distributions based on TDP analysis (Fig. 7A-D). A mid-FRET state around 0.4 
(0.35-0.45) was observed for all substrates, and is likely attributable to the short-lived sampling 
that comprised the vast majority of FRET events for dsDNA0PAM. This FRET state may represent 
the time-averaged FRET value arising from local diffusion, as has been previously proposed for 
the Type II Cas9 surveillance complex (Singh et al., 2016). Besides this ~0.4 FRET state, an 
additional FRET state at ~0.61 was observed for dsDNA3PAM (Fig. 7D), consistent with 
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localization of Cascade at the first PAM closest to the Cy3-labeled DNA terminus. PAM-
dependent localization is not observable for dsDNA1PAM because of overlap between the 
expected peak (~0.4) with the main mid-FRET state that arises from the abundant short dwell 
events. When the PAM site was moved to the same position as the first PAM in dsDNA3PAM 
(Table 1), we observed a new FRET state around ~0.62, consistent with the FRET peak observed 
for dsDNA3PAM (Fig. 7E). These data suggest that Cascade specifically localizes at PAM sites 
during the target search process. 
 
Table 1: Oligonucleotides used for smFRET 
Name Sequence (5′-3′) Description 
XCY1018 GTGTATACGTGTGTGATTGGTGGACTGATCGAA/3
Bio/ 
Biotin anchor  
XCY1019 /5Cy3/TCTGTGCAGTGCTCGAAGGCAAAAACCG Truncated non-target strand with 
AAG PAM and S2.1 target, Cy3 
labelled at 5′ end 
XCY1407 /5Cy3/TCTGTGCAGTGCTCGAAGGCAAAAACCGG
GCAATCGCAAAAAGGCGTAATCTGTGGGTG 
Full length non-target strand with 
AAG PAM and S2.1 target, Cy3 
labelled at 5′ end 
XCY1066 CGATCAGTCCACCAATCACACACGTATACACCAC
CCACAGATTACGCCTTTTTGCGATTGCCCGGTTT
TTGCCTTCGAGCACTGCACAGA 
Target strand S2.1 AAG, annealed 
with X1018 and X1019 for 
dsDNAtrunc or X1018 and X1407 for 
dsDNAtarget 
XCY1111 /5Cy3/ACGCCGCCGCCGCCGCCGCCACCGCCGCC
GCATCGCACCAACCCAGTAATCTGTGGGTG 
All CCG, Cy3 labelled at 5′ end 
 
XCY1112 ATCAGTCCACCAATCACACACGTATACACCACCC
ACAGATTACTGGGTTGGTGCGATGCGGCGGCGG
TGGCGGCGGCGGCGGCGGCGT 
All CCG, annealed with X1018 and 
X1111 for dsDNA0PAM 
XCY1156 /5Cy3/ACGCCGCCGCCGCCGAAGCGCCGCCGCCG
CCGCCTCGCACCAACCCAGTAATCTGTGGGT 
One AAG PAM at 16th position, Cy3 
labelled at 5′ end 
 
XCY1157 ATCAGTCCACCAATCACACACGTATACACACCCA
CAGATTACTGGGTTGGTGCGAGGCGGCGGCGGC
GGCGCTTCGGCGGCGGCGGCGT 
One AAG PAM at 16th position, 
annealed with X1156 and X1018 for 
dsDNA1PAM 
XCY1092 /5Cy3/ACGCCGCCGCCAAGCCAAGCAAGCCGCCG
CCATCGCACCAACCCAGTAATCTGTGGGTG 
Three AAG PAMs, Cy3 labelled at 5′ 
end 
 
XCY1093 ATCAGTCCACCAATCACACACGTATACACCACCC
ACAGATTACTGGGTTGGTGCGATGGCGGCGGCTT
GCTTGGCTTGGCGGCGGCGT 
Three AAG PAMs, annealed with 
X1092 and X1018 for dsDNA3PAM 
X1409 /5Cy3/ACGCCGCCGCCAAGCCCGCGCCGCCGCCG
CCGCCTCGCACCAACCCAGTAATCTGTGGGT 
One AAG PAM at 12th position, Cy3 
labelled at 5′ end 
 
X1410 ATCAGTCCACCAATCACACACGTATACACACCCA
CAGATTACTGGGTTGGTGCGAGGCGGCGGCGGC
GGCGCGGGCTTGGCGGCGGCGT 
One AAG PAM at 12th position, 
annealed with X1409 and X1018 for 
dsDNA1PAM-12bp 
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Our kinetic analysis of Cascade-DNA binding suggests that dsDNA targets containing more 
PAM sites may increase the time needed for Cascade to find the target (Fig. 6C). Similarly, 
previous studies have suggested that target recognition by the Type II Cas9 surveillance complex 
is slowed in the presence of competitor DNA containing several PAM sites, although these 
measurements were based on the rate of endonucleolytic cleavage by Cas9 rather than the rate of 
binding (Sternberg et al., 2014). Because Cascade does not have a catalytic readout, we 
developed a competition assay to directly monitor the rate of Cascade-target binding in the 
presence of competitor DNA containing multiple PAM sequences (Fig. 9A, see Materials and 
Methods). To determine the rate of Cascade-target binding, we measured the fraction of 
Cascade-bound target DNA with or without competitor DNA at different incubation times (Fig. 
9B). In control experiments without any competitor, Cascade could bind more than 50% of the 
target within 5 min. To test the effects of competitor DNA containing PAM sequences, we used 
three competitors with 0, 4 or 8 5’-AAG-3’ PAMs. Target binding kinetics were slightly reduced 
in the presence of competitor DNA with 0 PAMs (Fig. 9B-C). However, the target was fully 
bound at the longest time point with the 0 PAM competitor, indicating Cascade can quickly 
sample non-PAM regions of DNA before binding to the target (Fig. 9B-C). Increasing PAM 
density in the competitor correlated with decreased Cascade-target binding, with no binding 
observed in the presence of these competitors until the 30 min time point (Fig. 9B-C). 
Altogether, our smFRET and bulk biochemical results are consistent with a model in which 
Cascade quickly leaves dsDNA in the absence of PAMs, allowing for rapid discovery of the 
target, but is slowed by the presence of PAMs, substantially increasing the amount of time 
required to locate the target. 
 
Figure 9. PAM sampling slows Cascade target binding kinetics. (A) Schematic of competition assay with different 
competitors (PAMs labelled red). (B) Electrophoretic mobility shift assay of Cascade with different competitors. (C) 
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Quantification of competition data. Average fraction bound from three replicates is plotted, with error bars 
representing standard deviation. 
 
Three Cascade motifs are required for target search 
We next sought to identify protein motifs that are involved in the Cascade target search process. 
Crystal structures and molecular dynamics simulations of Cascade bound to a dsDNA target 
have revealed several regions of Cascade that may be important for target searching (Van Erp et 
al., 2015; Hayes et al., 2016). We first investigated motifs in the Cse1 subunit, which is required 
for PAM recognition (Van Erp et al., 2015; Hayes et al., 2016; Sashital et al., 2012) (Fig. 10, Fig. 
11A). In the Cascade R-loop crystal structure, the minor groove of the -1 PAM base pair is 
recognized by the backbone amide of Cse1 G160, an interaction that may also be important for 
PAM recognition during target searching (Hayes et al., 2016). We additionally identified a 
lysine-rich β hairpin in Cse1 (K289, K290, and K296) located close to the PAM recognition 
motif that we hypothesized may be important for dsDNA positioning during PAM binding. To 
test the importance of these motifs on Cascade-PAM searching, we introduced alanine 
substitutions at Cse1 G160 or the lysine residues in the Cse1 β hairpin and measured binding to 
dsDNA1PAM using real-time smFRET. Similar to WT Cascade, the bound-state lifetimes for both 
mutants were best described by a double-exponential decay (Fig. 10A), although the amplitude 
of the longer dwell events was less than 2% for both mutants (Fig. 10B, Fig. 12A). These results 
and TDP analysis of FRET transitions are strikingly similar to WT Cascade binding to 
dsDNA0PAM (Fig. 6C, 5B, 13), and indicate an overall reduction in PAM sampling and dwelling 
when each motif is mutated. Furthermore, the similarity in τavg between the PAM recognition 
motif mutant and Cse1 β hairpin mutant strongly implicates the lysine-rich β hairpin in PAM 
recognition.  
 
The association rates for the two Cse1 mutants were significantly lower (~2.5x) than for WT 
Cascade (Fig. 10B). These results indicate that the PAM recognition motifs in Cse1 are 
important for DNA sampling, and are not simply involved in reading out the PAM. When both 
G160 and the lysine-rich β hairpin were mutated together, no binding events were observed (Fig. 
12C), further implicating PAM recognition in dsDNA sampling. 
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Figure 10. Three protein motifs in Cascade are important for target sampling and PAM recognition. (A) Survival 
probabilities of dwell time of FRET events for non-targeting Cascade with WT Cse1 (red curve), Cascade with Cse1 
G160A mutation (yellow curve), and Cascade with Cse1 Lys-rich β hairpin mutation (K289A, K290A, and K296A) 
(blue curve) on dsDNA1PAM fit to double-exponential decays (black curve). The number of events for each decay 
ranged from 1089 to 4,775. (B) Time parameters of the double-exponential decays and association rates for WT 
Cascade (red), G160A mutant (yellow), Lys-rich β hairpin mutant (blue), and Cas7 lysine-rich loops mutant with a 
single lysine mutation (K137A) (hot pink). (C) Electrophoretic mobility shift assay for Cascade mutants binding at 
different time point (2, 5, and 30 min) and at various Cascade concentrations (1, 5, 10, 50, and 500 nM).  
 
Figure 11. Cascade sampling structural model of Cse1 (green), Cas5e (purple) and Cas7.5 (light blue), and Cas7.6 
(blue). (A) The apo structure. (B) A simulated model of Cascade PAM sampling with Cse1 in the closed 
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conformation (model was fit in PDB 4TVX). The dsDNA helix is bent by ~20º. (C) A simulated model of Cascade 
PAM sampling a linear dsDNA helix with Cse1 in a partially open conformation. Residues for three protein motifs 
are shown as spheres: Lys-rich vise (hot pink) in Cas7, PAM recognition motif (G160 in yellow) and Lys-rich β 
hairpin (blue) in Cse1 subunit. The PAM is colored red. 
 
Figure 12. Cse1 and Cas7 motif mutations abolish target binding. (A) The amplitude (longer bound-state term) in 
the double-exponential decays for WT Cascade (red), G160A mutant (yellow), Lys-rich β hairpin mutant (blue) 
binding to dsDNA1PAM. (B-D) FRET distribution for (B) WT Cascade, (C) G160A and lysine-rich β hairpin 
(K289A, K290A, and K296A) double mutation in Cse1, and (D) Cas7 quadruple Lys-rich vise mutation (K137A, 
K138A, K141A and K144A) binding to dsDNA1PAM. The number of molecules used for FRET histograms was 1517 
(WT Cascade), 850 (Cse1 double mutant), and 744 (Cas7 Lys-rich vise mutant). (E) Electrophoretic mobility shift 
assay for G160A and lysine-rich β hairpin (K289A, K290A, and K296A) double mutation in Cse1 and quadruple 
Lys-rich vise mutation (K137A, K138A, K141A and K144A) in Cas7 at different time point (2, 5, and 30 min) and 
various Cascade concentrations (1, 5, 10, 50, and 500 nM).  
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We next investigated two lysine-rich loops (K137, K138, K141 and K144) in adjacent Cas7.5 
and Cas7.6 subunits of the Cascade backbone, which have previously been implicated in target 
binding (Van Erp et al., 2015) (Fig. 11A). These lysine-rich loops form a vise that positions the 
dsDNA helix upstream of the PAM through electrostatic contacts with the DNA backbone 
(Hayes et al., 2016), an interaction that we hypothesized may also be important for random 
dsDNA sampling. To test the role of these motifs during the target search process, we performed 
smFRET experiments to observe Cascade binding to dsDNA1PAM when mutations were 
introduced in the Cas7 lysine-rich loops. A single lysine mutation (K137A) significantly reduced 
the observed binding rate (11 FRET events in over 4000 trajectories), ~100x lower than for WT 
Cascade (Fig. 10B). No FRET events were observed in over 4000 trajectories when we mutated 
all four residues within the lysine-rich vise (Fig. 12D). These results indicate that Cascade-
dsDNA sampling relies on non-specific interactions between the lysine-rich vise in Cas7 and the 
DNA phosphate backbone. Combined, we propose that the Cas7 lysine-rich vise along with the 
Cse1 lysine-rich β hairpin positions dsDNA in an orientation that enables PAM readout by the 
PAM-recognition motif. 
 
Figure 13. Transition density plots for Cascade with (A) Cse1 G160A mutation and (B) Cascade with Cse1 Lys-rich 
β hairpin mutation (K289A, K290A, and K296A) binding to dsDNA1PAM. 
 
Based on our smFRET data, we hypothesized that target search kinetics would be slowed for the 
Cse1 and Cas7 mutants. We tested this hypothesis by performing bulk binding experiments at 
different Cascade-target incubation times to capture pre-equilibrium binding affinities for the 
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Cascade mutants (Fig. 10C, 12E). At the indicated incubation time, binding reactions were 
quenched by loading onto a gel and immediately initiating electrophoresis at 4º C to detect 
binding based on electrophoretic mobility shift. For long incubation times (30 min), mutation of 
the whole Cas7 Lys-rich vise or the double mutation of both Cse1 motifs completely abolished 
binding, consistent with the lack of observable FRET events for these constructs (Fig. 12E). 
However, individual mutations within each of the motifs cause only modest decreases in binding 
affinity after 30 min incubation (Fig. 10C). Interestingly, while WT Cascade reaches binding 
equilibrium within 2 min, individual mutants take significantly longer to reach equilibrium. For 
all three mutants, binding affinity defects are far more pronounced after 2 min incubation, and 
affinity increases over time. Consistent with our smFRET results, these bulk binding experiments 
strongly indicate that, while equilibrium binding affinity is only partially impaired for these 
mutants, the search kinetics are slowed and mutant Cascade requires substantially longer time to 
reach binding equilibrium.  
 
Structural model for Cascade-DNA sampling 
Our results indicate that the Cas7 lysine vise and the Cse1 PAM recognition motif and lysine-
rich β hairpin interact with dsDNA during target searching (Fig. 11A). Based on these data, we 
developed a structural model to simulate how Cascade may bind to dsDNA during the target-
search process. Using HADDOCK, we created two models to simulate interactions between the 
Cas7 lysine vise and dsDNA or between the Cse1 motifs and dsDNA (Van Zundert et al., 2016). 
The models were then fit to a crystal structures of apo Cascade (Fig. 11B) (Jackson et al., 2014). 
For the apo-Cascade structure, Cse1 adopts a “closed” conformation, and the dsDNA helix must 
be bent by ~20º to accommodate all interactions enforced in our model (Fig. 11B). This model 
suggests that PAM recognition during target searching may be accompanied by a DNA bending 
event that enables local melting of the dsDNA helix. A recent Cascade/seed-bubble structure also 
suggests that PAM recognition is coupled with DNA bending, which drives the melting of 
dsDNA at the seed region (Xiao et al., 2017b). However, this model does not account for how 
Cascade may interact with DNA prior to helical bending. Interestingly, when the two models are 
docked to ensure linearity of the DNA, Cse1 adopts a partially “open” conformation, as has been 
observed in the crystal structure of ssDNA-bound Cascade and through FRET studies of Cse1 
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conformation (Mulepati et al., 2014a; Xue et al., 2016) (Fig. 11C). Together, these models 
suggest that the conformational flexibility of Cse1 may be required to initiate target searching 
prior to DNA bending. 
 
 
Discussion 
A universal question for all CRISPR–Cas immune systems is how subtype-specific surveillance 
complexes are able to locate targets rapidly, enabling timely immune response against infection. 
Here, we developed a smFRET assay to visualize the Type I-E Cascade target searching process 
in real time. We observed that Cascade rapidly and randomly samples DNA in the absence of 
PAMs, and dwells longer on DNA when PAMs are present. Our study reveals the rapidity of 
Cascade binding kinetics during PAM searching, with the majority of binding events exhibiting 
extremely short dwell times in the absence of PAM sites (~0.1 s). Similar transient binding states 
were also observed in a previous smFRET study of the Type II Cas9 surveillance complex 
(Singh et al., 2016). For crRNAs with non-complementary dsDNA target, Singh et al. observed 
short lifetime (~0.1 s) FRET events, which may represent non-specific DNA sampling during 
PAM surveillance similar to the sampling observed in our study. Together, these studies indicate 
distinct CRISPR surveillance complexes employ similar strategies for non-specific target 
searching.  
 
Our single-molecule and bulk biochemical data indicate that the Cascade search kinetics are 
slowed in the presence of increasing numbers of PAM sites. The Cascade dwell time increases 
with the number of PAMs, although all dwell times measured in our study are shorter than the 
transient PAM dwelling (~3 s) observed for Cascade in a previous study using DNA curtains 
(Redding et al., 2015). These differences may be due to different buffer conditions used in each 
study. It is also possible that higher PAM density of the bacteriophage λ genome used in the 
DNA curtain experiment could result in the slightly longer dwell time. Upon PAM recognition, 
the dwell time can be further increased by partial crRNA-target formation. A previous smFRET 
study of Cascade-target binding revealed a longer-lived bound state (~25 s) for mutant targets 
containing mutated PAM sequences or partial complementarity to the crRNA (Blosser et al., 
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2015a). This study relied on target unwinding to detect Cascade binding, and likely reflects 
binding states following partial formation of the crRNA-target duplex. Overall, these studies 
indicate that target searching is likely slowed when Cascade encounters random sites of higher 
PAM density or partial complementarity to the crRNA. Previous studies have suggested that 
partial Cascade R-loops are sufficient to enable primed spacer acquisition (Blosser et al., 2015a; 
Datsenko et al., 2012). Thus, while random complementary regions may slow target discovery, 
Cascade may mitigate these detrimental effects by eliciting an alternative immune response. 
 
Recent structures of Cascade bound to dsDNA have revealed how Cascade engages the PAM 
and target upon R-loop formation (Hayes et al., 2016; Xiao et al., 2017b). However, it remains 
unclear how Cascade recognizes the PAM during target searching. Our smFRET data indicate 
that the Cascade sampling process relies on motifs that maintain contacts with the DNA 
following R-loop formation. The Cas7 lysine-rich loops are hypothesized to be important for 
target positioning during duplex unwinding (Van Erp et al., 2015). Consistent with this 
hypothesis, our data implicate this motif in target sampling, revealing that interactions between 
the lysine vise and dsDNA are initiated prior to duplex unwinding and maintained following R-
loop formation. Similarly, the Cse1 PAM recognition motif identifies PAMs during target 
searching and maintains contact following target binding, an interaction that is thought to be 
important for stabilizing Cse1 in a conformation required for Cas3 recruitment and target 
degradation (Hayes et al., 2016; Xiao et al., 2017b; Xue et al., 2016). In addition to these two 
known motifs, our data also implicate the Cse1 lysine-rich β hairpin in the PAM searching 
process, although this motif does not contact DNA following target binding. We hypothesize that 
the β hairpin is critical for guiding the dsDNA to position the PAM for recognition by Cse1. 
Structural models that account for interactions between the target DNA and these three Cascade 
motifs suggest that DNA can be bound linearly when Cse1 adopts a partially open conformation 
observed in Cascade-ssDNA bound structures (Mulepati et al., 2014a). However, in order to 
accommodate the DNA in the closed Cse1 conformation observed in the apo Cascade structure, 
the DNA must be bent by ~20º. Bending of dsDNA may favor unwinding, allowing for crRNA 
strand invasion and interrogation of the adjacent seed region. Future studies will be required to 
determine which conformation Cse1 adopts during the target search process.  
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Together with previous studies, our smFRET data suggest a model for the Cascade target 
searching process (Fig. 14). Cascade searches the target by randomly sampling the dsDNA and 
dissociates rapidly in the absence of PAM sites, but is slowed in the presence of increasing 
number of PAM sequences. Cascade pauses at PAMs due to favorable interactions between Cse1 
and the PAM, which may enable dsDNA bending based on conformational flexibility of Cse1. 
Helical bending destabilizes the dsDNA and drives local melting at the PAM-proximal region. 
DNA unwinding is facilitated by crRNA strand invasion and the formation of an RNA-DNA 
heteroduplex within the seed region. Favorable energetic conditions, including perfect target 
complementarity and negative supercoiling, efficiently promote further R-loop formation to the 
PAM-distal end, resulting a stable R-loop structure. In contrast, unfavorable energetic 
conditions, including target mismatches, may inhibit complete R-loop formation and allow 
Cascade to dissociate. These findings reveal how Cascade quickly searches PAMs to locate 
targets and uncover several motifs in Cascade that are essential for this process. 
 
Figure 14. Model of Cascade target search process. Cascade randomly samples dsDNA through nonspecific 
electrostatic contacts between phosphate groups and the Lys-rich vise in Cas7. The dsDNA is positioned close to the 
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PAM recognition motif in Cse1 with the guidance of a lysine-rich β hairpin in Cse1. Cascade quickly dissociates 
from dsDNA (within 0.1 s) when no PAM is present, but this interaction is significantly stabilized as PAM density 
increases (dwell time ~1 s or greater). PAM recognition causes a ~20º bend in the DNA, enabling local DNA 
unwinding. In the absence of a target, Cascade rapidly dissociates to continue searching. In the presence of a target 
and under favorable energetic conditions, Cascade forms a seed bubble. Seed sequence complementary promotes 
stable full R-loop formation.  
 
 
Materials and Methods 
Plasmid Construction 
Point mutations were introduced using “round-the-horn” (RTH). K289, K290, and K296 in cse1 
were mutated to alanine using primers XCY1106 and XCY1136 in EcCse1-pSV272. G160 in 
cse1 was mutated to alanine using XCY1075 and XCY1076 in EcCse1-pSV272. K137, K138, 
K141, and K144 in cas7 were mutated to alanine using XCY1102 and XCY1103 in pX1169 to 
produce pX1500. K137 in cas7 was mutated to alanine using XCY1124 and XCY1126 in 
pX1169 to produce pX1534. E102C was introduced to the cas5e gene in the plasmid pX1169 or 
pX1500 for site-specific labeling of Cas5e using XCY713 and XCY798.  
 
Protein purification and Dye labeling 
All proteins were expressed in BL21(DE3) cells. The proteins were purified as described 
previously with minor revisions (Xue et al., 2016). Minimal-Cys Cse2-Cas6 with different 
crRNA sequences containing E102C Cas5e was labeled by Cy5-maleimide (Lumiprobe) as 
previously described (Xue et al., 2016). All labeling reactions were performed in sample storage 
buffer (20 mM Tris [pH 7.5], 100 mM NaCl, 5% glycerol, and 1 mM TCEP). Cse2-Cas6 (25 
µM) and Cy5 (200 µM) were mixed in 5% DMSO. Reactions were incubated in the dark at 4 ºC 
for 1 hr, then quenched by adding 10 mM DTT. Labeled Cse2-Cas6 was separated from free dye 
using a 10K protein concentrator (Corning), concentrated to 2 µM, aliquoted and stored at -80 
ºC.  Each labeled Cse2-Cas6 aliquot was only thawed one time. The labelling efficiency of Cse2-
Cas6 was calculated by measuring the concentration of Cse2-Cas6 at 280 nm and the dye 
concentration at 650 nm after labelling. Labelling efficiency of Cse2-Cas6 was consistently 
greater than 90%.  
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Preparation of dsDNA used for smFRET and EMSA 
DNA oligos were purchased from Integrated DNA Technologies (IDT). Oligos used for 
smFRET were labeled at the 5’ end with Cy3 (performed by IDT) (Table 1). Oligos were 
dissolved in ddH2O to 100 µM. Two complementary oligos used for EMSA experiments were 
mixed in annealing buffer (10 mM Tris, pH 7.5, 50 mM NaCl, 1 mM EDTA) in 1:1 ratio. Two 
complementary oligos and a biotinylated anchor (X1018) used for surface immobilization were 
mixed in annealing buffer (10 mM Tris, pH 7.5, 50 mM NaCl, 1 mM EDTA) in 1:1:1 ratio (Fig. 
2A). Samples were incubated at 95ºC for 5 min in a heat block covered by aluminum foil to 
avoid light. The samples were slow-cooled by turning off the heat block until the block 
decreased to room temperature (2-3 h). Samples were purified on a 6% native polyacrylamide 
gel run at 4 ºC.  
 
Electrophoretic mobility shift assay (EMSA) 
XCY1185 and XCY1186 were 5’ end labeled with γ-32P-ATP using T4 polynucleotide kinase 
(NEB) for 30 min at 37	ºC. PNK was heat denatured at 65	ºC for 20 min, and excess γ-32P-ATP 
was removed using a G-25 spin column (GE Healthcare). All binding experiments were 
performed in binding buffer: 20 mM Tris, pH 7.5, 100 mM NaCl, and 5% glycerol at 37	ºC. For 
Cascade oligonucleotide competition binding assays (Fig. 9B), 10 nM Cascade was incubated 
with 0.5 nM 32P labeled dsDNA with 1 µM indicated competitor for different times at 37	ºC. 
Samples were quenched by adding 50 µM of a competitor with 16 AAG and stored on ice before 
loading. In control experiments, Cascade does not bind the target DNA with the same amount of 
DNA quencher when incubated on ice in 30 mins. Samples were run on 6% native 
polyacrylamide gel for 2 h at 250 volts at 4	ºC. Gels were dried and DNA was visualized by 
phosphorimaging. Bound and unbound DNA fractions were quantified using ImageJ. For 
Cascade plasmid binding assays (Fig. 10F), Cascade at indicated concentrations and 100 ng 
target plasmid (~6 nM) were incubated at 37	ºC	for indicated time. Samples were immediately 
loaded on a 0.8% agarose gel stained with SYBR Safe and run at 15 volts at 4ºC overnight (~18 
hr). 
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Single-molecule FRET set-up 
Single-molecule FRET experiments were performed with a prism-type total internal reflection 
fluorescence microscope at room temperature (23 ± 2ºC). Quartz slides and microfluidic 
chambers were prepared as described (Chandradoss et al., 2014). Cy3 and Cy5 molecules were 
excited with a solid-state laser at 532 nm and a helium-neon (HeNe) laser at 635 nm, 
respectively. Fluorescence signals of Cy3 and Cy5 were collected through a 60× Water 
immersion objective with an inverted microscope and split by a dichroic mirror (T660lpxr, 
Chroma). Cy3 and Cy5 signals were recorded using an EM-CCD camera (iXon DU897E, Andor 
Technology). 
 
For each chamber, 50 µL streptavidin (0.1 mg/mL) was incubated for 1 minute followed by a 
washing step with 500-600 µL of T50 buffer (10 mM Tris-HCl pH 8.0, 50 mM NaCl). Then, 50 
µL of 40 pM Cy3-labeled dsDNA targets were immobilized on the microscope slides using 
biotin-streptavidin conjugation for 5 minutes. After incubation, unbound Cy3-labeled dsDNA 
targets was removed by washing with 500-600 µL of T50 buffer. Before imaging, 200 µL of 
Cascade imaging buffer (10 mM Tris-HCl pH 8.0, 50 mM NaCl, 0.1 mg/mL glucose oxidase, 4 
µg/mL Catalase, 1 mM Trolox ((±)-6-Hydroxy-2,5,7,8, -tetramethylchromane-2-carboxylic acid) 
and 0.8% (v/v) glucose) was flowed into the chamber. For real-time experiments, Cy5-labeled 
Cascade (5 nM or as labelled) in the imaging buffer was flowed into the chamber 10-30 s after 
initiating imaging. 
 
smFRET data acquisition and analysis 
A series of CCD images were acquired with the smCamera software at a time resolution of 0.1 
s/frame. For all smFRET experiments, fluorescence time traces resulting from the excitation of 
Cy3 were recorded and analyzed using smCamera software. FRET efficiencies (E) were 
calculated by the following equation: 
 
E = IA/(IA + ID) 
Where IA and ID represent the fluorescence intensities of acceptor and donor. The background 
signal of Cy3 and Cy5 fluorescence intensities in each trajectory was determined by averaging 
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the background noise intensity after fluorephore photobleaching, and then subtracting this value 
for all trajectories. All smFRET trajectories were idealized based on hidden Markov modeling 
(HMM) analysis using the HaMMy software (McKinney et al., 2006). The dwell times of FRET 
events (τon) and dwell times between FRET events (τoff) of the idealized time traces were 
extracted using custom written RStudio codes. To avoid extracting any background signal, the 
FRET value cut-off was set to 0.2. Dwell time histograms were made in Origin (Origin lab). The 
dwell time histograms were fit by either a single-exponential decay curve or a double-
exponential decay curve. The transition data formats generated from HaMMy were used to 
generate transition density plots using the TDP software (McKinney et al., 2006). For each 
experiment, three data sets were collected using three different slides.  For each data set, 4 
movies were collected for WT Cascade and 15 movies were collected for mutant Cascade. For 
each target, TDPs were generated by combining the three data sets. For dwell time histograms, 
the average of 3 or 4 datasets was shown. Dissociation (koff) and association rate (kon) were 
determined by by the following equations (Singh et al., 2016): 
kbinding = 1/ τoff 
kon =  kbinding/[Cascade] 
τavg = A1*τ1 + A2*τ2 
koff = 1/τavg 
Reported dwell times, amplitudes, koff and kon constants are the average of the values calculated 
for the three data sets, and errors represent the standard deviation of the three values.  The 
photobleaching rate of Cy3 was determined as previously described (Roy et al., 2008).  
 
Structural modelling 
Structural models of Cascade target searching were created using HADDOCK (Van Zundert et 
al., 2016). An idealized 21-bp dsDNA containing an AAG PAM was used to simulate the target. 
To simplify calculations, a minimal Cascade model was used for docking, based on PDB 4TVX 
containing Cse1, Cas7.5, Cas7.6, Cas5e subunits and the crRNA. Two separate models were 
simulated using restraints to enforce interactions between the dsDNA and either (1) the PAM 
recognition motif and β hairpin in Cse1 or (2) the lysine-rich vise in the Cas7 subunits. The top 3 
best scored models for each simulation were selected and docked into apo (PDB 4TVX) and 
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dsDNA-bound (PDB 5H9F) Cascade crystal structures, and the one with no obvious steric 
conflicts was selected. The best fitting model was docked into the apo-Cascade structure (PDB 
4TVX) to create overall structural models for Cascade-PAM binding using UCSF Chimera 
(Goddard et al., 2007). To simulate linear DNA binding, the Cse1-dsDNA model was aligned 
with the Cas7-dsDNA model based on the PAM sequences in the dsDNA. All structure figures 
were made in UCSF Chimera (Goddard et al., 2007).  
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CHAPTER 3 
 CRISPR INTERFERENCE AND PRIMING VARIES WITH INDIVIDUAL SPACER 
SEQUENCES  
 
Chaoyou Xue, Arun S. Seetharam, Andrew J. Severin and Dipali G. Sashital 
(adapted from Nucleic Acids Research (2015) 43 (22): 10831-10847) 
 
Abstract 
CRISPR-Cas (clustered regularly interspaced short palindromic repeats-CRISPR 
associated) systems allow bacteria to adapt to infection by acquiring “spacer” sequences from 
invader DNA into genomic CRISPR loci. Cas proteins use RNAs derived from these loci to 
target cognate sequences for destruction through CRISPR interference. Mutations in the 
protospacer adjacent motif (PAM) and seed regions block interference but promote rapid 
“primed” adaptation. Here, we use multiple spacer sequences to reexamine the PAM and seed 
sequence requirements for interference and priming in the Escherichia coli Type I-E CRISPR-
Cas system. Surprisingly, CRISPR interference is far more tolerant of mutations in the seed and 
the PAM than previously reported, and this mutational tolerance, as well as priming activity, is 
highly dependent on spacer sequence. We identify a large number of functional PAMs that can 
promote interference, priming or both activities, depending on the associated spacer sequence. 
Functional PAMs are preferentially acquired during unprimed “naïve” adaptation, leading to a 
rapid priming response following infection.  Our results provide numerous insights into the 
importance of both spacer and target sequences for interference and priming, and reveal that 
priming is a major pathway for adaptation during initial infection.
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Introduction 
In bacteria and archaea, CRISPR arrays and Cas proteins comprise an RNA-guided immune 
system that silences mobile genetic elements including viruses and horizontally transferred DNA 
(Barrangou and Marraffini, 2014; van der Oost et al., 2014). CRISPR-Cas immune systems 
proceed through three major steps. First, a short segment of invader DNA is inserted as a new 
spacer following the first repeat of the CRISPR array, a process called adaptation (Heler et al., 
2014; Kiro et al., 2013). Second, the CRISPR array is transcribed and processed into short 
CRISPR RNAs (crRNAs), each containing a different spacer sequence (Charpentier et al., 2015; 
Hochstrasser and Doudna, 2015b). Finally, crRNAs guide Cas effector proteins to DNA or RNA 
targets containing protospacers that match the crRNA spacer sequence, and a Cas 
endonucleolytic activity cleaves the target leading to its destruction, a process called CRISPR 
interference (Jackson and Wiedenheft, 2015b; Plagens et al., 2015). 
Based on phylogenetic analysis, CRISPR-Cas systems are clustered into two classes and 
five basic types (Types I-V), which are further divided into 16 subtypes (Types I-A to I-F and I-
U, Types II-A to II-C, and Types III-A to III-D, Types IV and V) (Makarova et al., 2015). Cas1 
and Cas2, the only two proteins that are conserved in all CRISPR-Cas systems, form a stable 
heterocomplex that is required for spacer acquisition (Datsenko et al., 2012; Makarova et al., 
2015; Nunez et al., 2015b; Nuñez et al., 2014b; Yosef et al., 2012). The mechanisms for CRISPR 
interference vary between each type, and subtype-specific interference Cas proteins are common 
(Makarova et al., 2015). Class 1 (Types I, III and IV) systems utilize large, multi-protein 
surveillance complexes as crRNA effectors and in some cases require a separate Cas 
endonuclease (Brouns et al., 1993; Hale et al., 2009; Hatoum-Aslan et al., 2013), while Class 2 
(Types II, V) systems require only a single protein that acts as both crRNA effector and Cas 
endonuclease (Gasiunas et al., 2012; Jinek et al., 2012; Shmakov et al., 2015; Zetsche et al., 
2015) (for a recent review see (Jackson and Wiedenheft, 2015b)). 
Escherichia coli K12 contains a Type I-E CRISPR-Cas system, which utilizes Cas1 and 
Cas2 for spacer acquisition and the crRNA-effector complex Cascade and the signature 
endonuclease Cas3 for interference (Fig. 1A) (Brouns et al., 1993; Hochstrasser et al., 2014; 
Jackson et al., 2014d; Jore et al., 2011a; Mulepati and Bailey, 2013; Mulepati et al., 2014b; 
Nunez et al., 2015b; Westra et al., 2012; Yosef et al., 2012; Zhao et al., 2014a). In this system, 
  
65 
adaptation can occur through two different spacer acquisition processes, termed “naïve” and 
“primed” adaptation (Datsenko et al., 2012; Swarts et al., 2012). Naïve adaptation requires only 
Cas1 and Cas2 (Yosef et al., 2013), and occurs when a bacterium acquires new spacers from 
mobile genetic elements that it has not previously encountered. In contrast, primed adaptation 
also requires the interference machinery and acts as a positive feedback loop, in which spacers 
already present against a target promote acquisition of new spacers from the same target 
(Datsenko et al., 2012; Swarts et al., 2012).  
Primed adaptation was identified as a mechanism that allows the host to overcome invader 
escape from the CRISPR interference pathway (Datsenko et al., 2012). During CRISPR 
interference, the Cascade crRNA spacer base pairs to the target-strand of the protospacer, and the 
non-target strand is displaced forming an R-loop (Fig. 1B) (Jore et al., 2011a). Cas3 is then 
recruited by the Cse1 subunit of Cascade and processively degrades the DNA (25–27). Cascade 
is thought to initially recognize targets based on the presence of a correct protospacer adjacent 
motif (PAM) sequence prior to interrogating the adjacent sequence for complementarity to the 
crRNA, in a mechanism that is analogous to other Type I and II crRNA effectors (Fig. 1B) 
(Rollins et al., 2015; Sashital et al., 2012; Semenova et al., 2011c; Sternberg et al., 2014). R-loop 
formation proceeds directionally away from the PAM, and the first base pairs that form during 
target binding comprise a seed sequence that nucleates target binding (Fig. 1B) (Rutkauskas et 
al., 2015; Szczelkun et al., 2014c). Due to their importance in Cascade-dsDNA binding, 
spontaneous mutations in the PAM and seed regions disrupt high-affinity target binding and can 
lead to invader escape from CRISPR interference (Fineran et al., 2014; Semenova et al., 2011c). 
However, in some cases these mutations promote primed adaptation, which allows the host to 
combat this escape by rapidly acquiring new functional spacers against other regions of the 
invader DNA (Datsenko et al., 2012). In addition, primed adaptation enables the CRISPR-Cas 
system to rapidly respond to any mobile genetic element with imperfect sequence homology to 
an existing spacer, providing an important strategy for combating closely related families of 
viruses and plasmids. 
A recent high-throughput plasmid loss assay of a randomized PAM and protospacer library 
indicated that up to five mutations in the PAM and seed can still promote primed spacer 
acquisition (Fineran et al., 2014). If single mutations within the PAM or seed dramatically 
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decrease the binding affinity of Cascade, it is unclear how Cascade may recognize these types of 
targets in order to promote primed spacer acquisition. Recent single-molecule FRET studies of 
Cascade-DNA binding revealed that Cascade adopts a non-canonical binding mode when bound 
to a target with an incorrect PAM or containing partial complementarity in the seed, suggesting 
that priming targets are bound by Cascade, but in an alternative binding mode as compared to 
bona fide targets (Blosser et al., 2015b). 
Genome editing studies using the Type II crRNA effector endonuclease Cas9 have revealed 
that targets with PAM and seed mutations can still be cleaved by Cas9, but that this mutational 
tolerance is dependent on the spacer sequence of the crRNA (Fu et al., 2013; Hsu et al., 2013; 
Mali et al., 2013b; Pattanayak et al., 2013; Wu et al., 2014). In contrast, the effects of spacer 
sequence on Type I-E interference and priming activity have not been studied systematically. 
Here, we have investigated the priming efficiency of a large variety of spacer sequences in E. 
coli K12 against targets with a single mutation in the seed. Surprisingly, the spacers display 
extremely varied activities against seed mutant protospacers for both priming and direct 
interference. For many of the spacers tested, single seed mutations did not block direct 
interference or promote priming, suggesting that the level of priming and seed mismatch 
tolerance may be dependent on spacer sequence. To test the importance of spacer sequence on 
PAM or seed mutation tolerance, we have developed a high-throughput assay that distinguishes 
between direct interference and priming activity. Our results reveal spacer-specific differences in 
CRISPR activity against both PAM and seed mutant targets, including several mutations that 
completely block CRISPR activity from one spacer but allow robust CRISPR activity from 
another. We find that Type I-E CRISPR-Cas systems can avoid priming against self sequences 
based on the presence of a self-signal in the CRISPR repeat. In addition, PAM authentication for 
targets with PAM sequences that promote priming occurs following Cascade binding but prior to 
Cas3 degradation. Intriguingly, many of the functional PAMs identified in our study are 
preferentially acquired during unprimed “naïve” adaptation, leading to a rapid priming response 
following infection. These findings reveal the importance of both the spacer and target sequence 
in CRISPR-Cas activity, and highlight the sophistication of the adaptive immune response in the 
Type I-E system. 
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RESULTS 
Mutations in the seed region do not abolish CRISPR interference  
 
 
Figure 1. Seed mutations do not completely block CRISPR interference. (A) CRISPRs and cas operon from E. coli 
K12. Genes and stoichiometry of Cascade proteins are indicated. (B) Construct design for priming targets for 18 
endogenous E. coli K12 spacers. PAM/protospacer sequences were inserted into pACYCDuet-1. CRISPR 1 spacer 1 
and target sequence containing a mismatch at the first position of the seed are shown. (C) CRISPR activity of 18 
endogenous E. coli K12 spacers against targets with mismatch at the first seed position. Percent of colonies with 
spacers acquired and plasmid lost after 24 h growth without selection for E. coli BW25113 ∆hns with target 
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plasmids containing a mismatch at seed position one. Position 1 of the crRNA spacer sequence and the 
corresponding mismatched nucleotide in the target are labeled for each spacer. Spacers are named based on their 
CRISPR and position within the CRISPR (e.g. CRISPR 1 spacer 1 is 1.1, CRISPR 2 spacer 1 is 2.1 etc.). (D) 
Plasmid loss rates of spacer 1.1 and 1.6 targets with seed position 1 mismatches in E. coli BW25113 ∆hns and 
BW25113 ∆hns∆cas1 after 24 h growth. The crRNA spacer position 1 sequence and corresponding mismatch in the 
target are labeled. (E) In vitro Cascade-mediated Cas3 degradation of pACYCDuet-1 target plasmids. Cascade 
(Cse1 at 1 µM and Cse2-Cas6e-crRNA complex at indicated concentration) bearing spacer 1.1 or 1.6 crRNA and 
Cas3 concentrations are indicated. The first base pair of the crRNA spacer and target is labeled for each plasmid 
tested. Plasmid DNA is labeled as follows: OC – Open circle; L – Linear; nSC – negatively supercoiled; D – 
Degraded. (F) Spacer acquisition and plasmid loss rates for bona fide spacer 1.1 and 1.6 targets after 24 h growth. 
 
To date, only a limited number of spacers have been used to study priming in E. coli, and it 
is unknown how spacer sequence may affect direct interference or priming efficiency in the 
presence of PAM or seed mutations. To test a larger pool of spacers, we investigated the priming 
efficiency of the 18 endogenous spacers present in the two CRISPR loci of E. coli K12 against 
targets with mutations at the first seed position (Fig. 1A-B). For each spacer, we created a target 
plasmid containing a 35-bp sequence containing an AAG PAM and a 32-bp protospacer with a 
mismatch at the first seed position, which has previously been shown to block interference and 
promote priming (Datsenko et al., 2012; Fineran et al., 2014; Semenova et al., 2011c) (Fig. 1B). 
We then tested the rates of plasmid loss and spacer acquisition for each target plasmid in the 
CRISPR active strain E. coli BW25113 ∆hns (Edgar and Qimron, 2010; Pougach et al., 2010; 
Pul et al., 2010; Swarts et al., 2012; Westra et al., 2010) after 24 h growth without antibiotic 
selection. All 18 target plasmids are stable in a cse1 deletion strain (BW25113 ΔhnsΔcse1), 
which knocks out Cascade DNA-binding activity and CRISPR interference, indicating that any 
observed plasmid loss in BW25113 ∆hns is the result of CRISPR interference.  
 
Surprisingly, the 18 spacers display extremely varied activities for both plasmid loss and 
spacer acquisition (Fig. 1C). Three spacers (spacers 1.1, 1.8 and 2.4) displayed higher rates of 
spacer acquisition than plasmid loss, while most of the remaining spacers exhibited higher rates 
of plasmid loss than spacers acquired. Several plasmids (targets for spacers 1.2, 1.6, 1.7, 2.1 and 
2.2) were lost in all colonies tested. For half of the spacers (1.2, 1.5, 1.6, 1.7, 1.10, 2.1, 2.2, 2.3 
and 2.6), target plasmid loss appears to be largely independent of spacer acquisition, as plasmids 
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were lost in >98% of colonies before even 30% of bacteria had acquired new spacers. Two 
spacers (1.9 and 1.11) displayed low CRISPR activity against both mutant and bona fide targets 
(AAG PAM and no mutations in protospacer) (Fig. 1C and Fig. 2A), but this low activity may be 
due to defects in Cascade assembly due to high G-C content (spacer 1.9) or mutations in the 
repeat (spacer 1.11) (Fig. 2B-C). Overall, these results suggest that the majority of endogenous 
E. coli K12 spacers can direct interference against targets containing a mutation at the first seed 
position, in contrast to numerous reports that base pairing at seed position 1 is strictly required 
for Cascade-directed target binding and interference (Datsenko et al., 2012; Fineran et al., 2014; 
Semenova et al., 2011c).  
To verify that the observed plasmid loss is based on direct CRISPR interference from the 
original spacer and not from newly acquired spacers, we created a cas1 deletion strain 
(BW25113 ∆hns∆cas1), which maintains the interference pathway but knocks out spacer 
acquisition activity. We chose to further analyze mutant targets for two spacers (1.1 and 1.6) that 
displayed substantially different rates of plasmid loss in our initial assay (Fig. 1C). Plasmid loss 
for these targets is similar in the ∆hns and ∆hns∆cas1 strains, indicating that interference can still 
occur for targets containing mismatches at the first position of the seed (Fig. 1D). These data 
indicate that the interference machinery can tolerate mismatches at the first position of the seed, 
although the degree of this tolerance may vary depending on spacer sequence.  
It is possible that differences in the amounts of individual crRNAs in the cell may affect the 
observed variations in plasmid loss in our in vivo assay. To address this possibility, we next 
examined whether the differences in CRISPR interference observed in vivo for spacer 1.1 and 1.6 
mutant targets could be recapitulated in vitro. To test this, we purified Cascade bearing a crRNA 
with either spacer 1.1 or 1.6 and performed Cascade-mediated Cas3 cleavage assays for bona 
fide and seed position 1 mutant targets (Fig. 1E and Fig. 3A). For each target, cleavage was 
measured at varied Cascade (5, 50 and 200 nM) and Cas3 (200 and 1000 nM) concentrations 
(Fig. 1E and Fig. 3A). We observe similar cleavage activity for both bona fide targets and the 
spacer 1.6 target with an rT-dG mismatch, even at low Cascade concentration (5 nM), suggesting 
that Cascade affinity is not perturbed substantially for this mutant target (Fig. 1E). In contrast, 
the spacer 1.1 rC-dA mismatch target plasmid appears to be completely intact at both 5 and 50 
nM Cascade and is only cleaved at the higher concentration (200 nM) regardless of Cas3 
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concentration, suggesting that Cascade has a greatly reduced affinity for this target (Fig. 1E and 
S2A). Accordingly, in the E. coli X019 strain, in which the cellular concentrations of Cascade 
bearing spacer 1.1 is increased by deleting all spacers except for 1.1 and 2.1 (Fig. 3B), CRISPR 
interference against the mutant spacer 1.1 target is increased substantially in comparison to 
BW25113 ∆hns (Fig. 3C). Priming does not increase for the X019 strain (Fig. 3D), suggesting 
that the increased rate of interference may preclude a concurrent increase in spacer acquisition. 
Together, these data indicate that defects in Cascade binding can inhibit CRISPR interference, as 
has been previously proposed (Semenova et al., 2011c), but that seed position 1 mutants do not 
significantly disrupt Cascade binding for all spacer sequences.   
 
Figure 2: Analysis of spacers 1.9 and 1.11. (A) Spacer acquisition and plasmid loss rates for spacer 1.9 and 1.11 
bona fide targets. Data are the average of three separate cultures and error bars are the standard deviation between 
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replicates. No spacer acquisition and plasmid loss were observed for the spacer 1.9 target for n colonies tested, as 
indicated in the graph. (B) Chromatogram traces for Superdex 200 profiles of Cse2-Cas6e complexes bearing 
crRNAs with spacer 1.9 (red) or spacer 2.1 (blue). Void and Cse2-Cas6e elution volumes are marked with dashed 
lines. (C) Predicted secondary structures for spacer 1.9 and 1.11 crRNAs based on mFold prediction. ∆G of 
predicted structures within the spacer sequence are reported. A G18A mutation in the 3’-repeat of spacer 1.11 
crRNA results in a C-A mismatch within the stem, which is boxed. 
 
Figure 3: E. coli BW25113 ∆hns versus X019 plasmid loss rates. (A) In vitro Cascade- mediated Cas3 
degradation of pACYCDuet-1 target plasmids at intermediate (50 nM) Cascade concentration, as in Fig. 1E. (B) The 
E. coli X019 strain contains reduced CRISPR 1 and CRISPR 2 loci, in which spacers 1.2-1.12 and 2.2-2.6 (gray) 
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have been deleted. This reduction of the number of spacers theoretically increases the fraction of cellular Cascade 
containing spacer 1.1 or 2.1 from 1/18 to 1/2. (C) Plasmid loss and (D) spacer acquisition rates for the spacer 1.1 
target containing a rC-dA mismatch at position 1 of the seed. (E) Spacer acquisition and plasmid loss rates after 24 h 
growth for spacer 1.1 or 1.6 targets containing mismatches at positions 2-5, 7 and 8 of the seed. The crRNA spacer 
sequence and corresponding mismatch DNA target sequence are labeled for each position.  
Previous reports have indicated that single point mutations throughout the seed (positions 1-
5, 7 and 8 of the protospacer) inhibit Cascade-target binding and direct interference (Fineran et 
al., 2014; Semenova et al., 2011c). To determine whether the mismatch tolerance we observed at 
seed position 1 is position-specific, we tested the effect of single mutations at each position of 
the seed region for spacers 1.1 and 1.6 on plasmid loss and spacer acquisition. For all targets, we 
observe >90% plasmid loss, and several mutant targets were lost in all colonies tested (Fig. 3E). 
Spacer acquisition for all mutant targets was substantially lower than plasmid loss (Fig. 3E), 
although we observed overall higher rates of priming for spacer 1.1 targets than for spacer 1.6. 
Together, these results indicate that single seed mutations are not sufficient to completely block 
CRISPR interference for these spacers, and that the efficiency of priming may be dependent on 
spacer sequence. 
 
Bona fide targets can promote spacer acquisition through priming 
Based on our initial results, we found that spacer acquisition could occur for all seed 
mutations, even those that do not significantly inhibit direct interference. These results indicate 
that bona fide protospacers may also promote spacer acquisition. To test this, we measured the 
rate of spacer acquisition of bona fide targets for spacers 1.1 and 1.6 in E. coli BW25113 ∆hns, 
which can acquire spacers through naïve or primed acquisition, and E. coli BW25113 
∆hns∆cse1, which can only acquire spacers through naïve acquisition, although this acquisition 
is very rare and unlikely to be observed over the timespan of our experiment (Swarts et al., 
2012). Interestingly, we observe spacer acquisition for both bona fide target plasmids in the ∆hns 
strain (10-25% of colonies tested) but no spacer acquisition in the ΔhnsΔcse1 strain (Fig. 1F). 
These data indicate that spacers were acquired through priming against the bona fide targets in 
the ∆hns strain, and not through naïve acquisition. It is possible that the plasmid may develop 
escape mutations over the course of the experiment, and that these mutant targets could lead to 
the observed priming. However, we observe reproducible variability in the amount of priming 
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for the two targets (Fig. 1F), indicating that priming is not caused by random mutations but is 
instead directed from the bona fide targets. Together with our seed mutation experiments, these 
results reveal that targets that can undergo direct interference can also promote priming.   
 
High-throughput screen for PAM and seed mutation tolerance 
We next wanted to establish a high-throughput system to study spacer sequence-specific 
tolerance of seed or PAM mutations by the CRISPR interference machinery. In order to study a 
large number of mutant sequences, we developed a high-throughput method to detect CRISPR-
dependent loss of a plasmid expressing green fluorescence protein (GFP) using flow cytometry. 
Based on this system, we created a novel high-throughput screening method to determine the 
effects of both seed and PAM mutations on priming and direct interference for multiple spacer 
sequences (Fig. 4A-C). Our screen utilizes two E. coli strains, X019 ∆cas1 and X019, to 
distinguish between targets that can be lost through direct interference and targets that can be lost 
through both direct interference and priming, respectively. In comparison to the control strain 
X019 ∆cse1, libraries of PAM and seed mutants grown in X019 ∆cas1 and X019 will be 
depleted of sequences that are functional, while non-functional sequences may be unchanged or 
enriched.  
Target libraries for spacer 1.1 and 2.1 were created by randomizing the PAM or the seed 
(Fig. 4A). A completely degenerate library was created for the PAM (64 possible sequences). To 
ensure complete coverage of seed mutations (16,384 possible sequences), we created a limited 
degenerate library in which positions 1-5, 7-8 of the protospacer had two possible sequences, 
either the correct sequence or a mismatch, resulting in 128 possible sequences (Fig. 4A). For all 
libraries, we performed a first round selection process by transforming and growing the libraries 
in the control X019 ∆cse1 strain, and the two experimental strains, X019 ∆cas1 and X019 (Fig. 
4B). Following this selection process, libraries were extracted from each strain and were then 
subjected to a second round of CRISPR interference in E. coli X019, to verify the success of the 
first round selection (Fig. 4C).  
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Figure 4:  High-throughput screen for CRISPR activity of PAM and seed mutants. (A–C) Experimental design 
for high-throughput screen. (A) PAM and seed library construction. PAM libraries contained completely degenerate 
sequences at the -3, -2 and -1 positions of the target, resulting in 64 possible sequences. Seed libraries contained two 
potential sequences at each positions 1–5 and 7–8 of the target, resulting in 128 possible sequences. (B) The original 
libraries were transformed to E. coli X019, X019 Δcas1 and X019 Δcse1 and libraries were prepared for each strain 
after an extended growth period in non-selective media. These libraries were used for barcoded PCR as experimental 
samples for high-throughput sequencing analysis. (C) All libraries were transformed to E. coli X019 and grown for 
2 cycles of 6–12 h. Cells were sorted by FACS to measure rates of plasmid loss and the genomic DNA of GFP- cells 
were used for PCR of CRISPRs to determine rates of spacer acquisition. (D) Plasmid loss rates for libraries created 
using this high-throughput experimental design, as measured by percent of GFP- cells for ∼100 000 cells tested. (E) 
Spacer acquisition rates for the libraries. 
 
For both plasmid loss and spacer acquisition (Fig. 4D-E), there is no difference between the 
original libraries and libraries extracted from X019 Δcse1, which indicates that plasmid 
distribution did not change through non-CRISPR-related mechanisms and any changes in the 
X019 and X019 Δcas1 libraries resulted from the CRISPR-Cas immune system. Interestingly, 
differences in the rate of plasmid loss between the X019 ∆cas1 and X019 libraries are larger for 
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the PAM mutant libraries than the seed mutant libraries (Fig. 4D), suggesting that there are 
several PAM mutations that can block interference but still enable priming, while seed mutations 
that promote priming are more likely to also be tolerated for direct interference. 
As expected, GFP- cells grown with the X019 ∆cas1 libraries exhibited high rates of spacer 
acquisition, similar to those observed for the original DH5α and X019 ∆cse1 libraries that 
contain all functional sequences (Fig. 4E). This indicates that the X019 ∆cas1 libraries still 
contain sequences that can promote priming. In contrast, GFP- cells from the X019 library had 
very low rates of spacer acquisition (Fig. 4E), indicating that the majority of sequences that 
promote priming were lost during the first round of growth. Therefore, comparison of sequences 
depleted from the X019 ∆cse1 and X019 libraries should distinguish which sequences can be lost 
through direct interference and which can only be lost through priming. 
 
High-throughput sequencing of libraries 
To determine which sequences can promote direct interference or priming, the 
PAM/protospacer region of each library was amplified with barcoded primers (Fig. 4A-B), 
pooled, and sequenced using MiSeq Illumina sequencing. To determine the relative depletion or 
enrichment of sequences in each library, counts from the X019 ∆cse1, X019 ∆cas1 and X019 
libraries were normalized to the original DH5α library (Fig. 5, 6, 7 and 8). As expected based on 
our second round analysis of the libraries, the original DH5α library and X019 ∆cse1 libraries 
are highly similar, while both the X019 ∆cas1 and X019 libraries have many sequences that are 
highly depleted. In addition, the X019 ∆cas1 and X019 libraries have many sequences that are 
enriched relative to the original libraries, as is expected given the depletion of several sequences. 
Several highly enriched sequences were also observed, especially for the seed mutant libraries. 
This enrichment appears to be sequence specific, as it occurred consistently across three 
biological replicates (Fig. 7 and 8). These sequences may have had a higher transformation 
efficiency in the X019 or X019 ∆cas1 strains, or they may have been relatively stabilized in one 
of the strains during growth. 
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Figure 5: One or two mismatches in the seed can be tolerated for CRISPR activity. (A) Seed libraries tested in 
this study. The crRNA seed sequence and corresponding region of the non-target strand of the protospacer are 
shown. Degenerate DNA labels: Y – cytosine or thymine; R – adenine or guanine; S – guanine or cytosine. (B and 
C) Counts of sequences with one or two mismatches in the seed sequence for X019 Δcse1, X019 Δcas1, and X019 
relative to the reference DH5α library. (B) Spacer 1.1 seed libraries. (C) Spacer 2.1 seed libraries. Mismatch 
position(s) are labeled for each set of data. 
 
For spacer 2.1 we created an additional seed library containing a mismatch at position 6 of 
the protospacer (hereafter called spacer 2.1 6MM) (Fig. 7 A,D,G,J). This position has been 
shown previously to have no effect on interference, as the crRNA of Cascade does not base pair 
with every sixth nucleotide of the protospacer target strand (Fineran et al., 2014; Mulepati et al., 
2014b). Consistently, this library has similar depletion profiles to the seed library with the 
correct sequence at position 6 (Fig. 5C and Fig. 7A). Differences between the two libraries may 
be due to variations in the timing of growth cycles for the two libraries. The overall similarity 
between the datasets indicates that the high-throughput method presented here is largely 
reproducible. 
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Figure 5: Direct interference and priming can be promoted by a large set of PAM sequences. (A and B) Scatter 
plots for relative counts of 64 PAM/Protospacer sequence for libraries extracted from E. coli X019 versus E. 
coli X019 Δcas1 for (A) spacer 1.1 targets and (B) spacer 2.1 targets. Counts are relative to the E. coli DH5α 
reference library. (C and D) PAM sequences colored by groups as defined in (A and B) for (C) spacer 1.1 targets 
and (D) spacer 2.1 targets. Red: Group A, blue: Group B, purple: Group C, black: Group D. (E) Plasmid loss and 
spacer acquisition rates for spacer 1.1 and 2.1 targets with AAA, AAC, ATA or AGA PAMs after 24 h growth. 
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Figure 7-1: Relative read counts for seed sequences with 3 to 7 mismatches. (A-C) Counts relative to reference 
library for sequences containing 3 mismatches for seed libraries with targets for (A) spacer 1.1 (B) spacer 2.1 or (C) 
spacer 2.1 with a mismatch at position 6 (6MM). 
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Figure 7-2: Relative read counts for seed sequences with 3 to 7 mismatches. (D-F) Data for targets with 4 
mismatches. 
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Figure 7-3: Relative read counts for seed sequences with 3 to 7 mismatches. (G-I) Data for targets with 5, 6 or 7 
mismatches. All graphs plot the read counts for X019 ∆cse1, X019 ∆cas1 or X019 relative to DH5α reference 
library. The data are the average of three replicates using separate original libraries, and error bars reflect the 
propagated standard deviations for the experimental and reference library counts. 
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Figure 8: Relative read counts for all PAM sequences. (A) Spacer 1.1 or (B) spacer 2.1 target sequence read 
counts for X019 ∆cse1, X019 ∆cas1 and X019 relative to the DH5α reference library. PAMs are colored by groups 
as in Figure 5. The data are the average of three replicates using separate original libraries, and error bars reflect the 
propagated standard deviations for the experimental and reference library counts. 
 
One or two seed mutations allow CRISPR activity 
Analysis of seed sequence depletion for the spacer 1.1 and 2.1 libraries reveals that almost 
all sequences with one or two mismatches are functional (Fig. 5 and Fig. 7A), while three or 
more mismatches in the seed render the CRISPR immune system nearly completely inactive 
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(Fig. 7B-J). As predicted based on the second round growth experiments with the seed mutant 
libraries (Fig. 4D-E), several functional seed mutant sequences are highly depleted in both the 
X019 and X019 ∆cas1 strain, indicating that many seed mismatches that promote priming do not 
completely block direct interference. For both spacers, a single seed mutation does not block 
interference, with two exceptions: position 1 for spacer 1.1, as observed in our initial 
experiments (Fig. 1A and Fig. 5B); and position 4 for spacer 2.1, which we confirmed in an 
individual assay (Fig. 9, 5C, 7A). These defects are compounded by the addition of another seed 
mismatch, as very little depletion is observed in either X019 or X019 ∆cas1 libraries for 
sequences with two mismatches where one of the mismatches is at position 1 for spacer 1.1 or at 
position 4 for spacer 2.1 (Fig. 5B-C, 7A). This result implies that single seed mismatches that 
inhibit direct interference may reduce the affinity of Cascade for the target, and that a second 
mismatch in the seed blocks Cascade binding completely, such that even priming is not 
observed.  
In contrast, combinations of seed mutations that do not block interference individually 
generally allow some degree of direct interference and often promote efficient priming, based on 
abundance of these sequences in X019 ∆cas1 and X019, respectively (Fig. 5B-C). Notably, the 
spacer 1.1 target with mutations at positions 5 and 7 is highly depleted in both strains, but the 
spacer 2.1 target with mismatches at the same positions is stable in both strains (Fig. 5B-C). 
Similarly, the targets with mutations at positions 2 and 8 are depleted from the spacer 2.1 
libraries but not the spacer 1.1 libraries (Fig. 5B-C). These data suggest that up to two seed 
mismatches can be tolerated for direct interference, and provide further evidence that the 
determinants for position-specific mismatch tolerance is dependent on spacer sequence.  
 
PAM tolerance is highly dependent on spacer sequence 
For the PAM libraries, the counts for X019 Δcas1 and X019 relative to DH5α were plotted 
as a scatter plot, allowing for direct comparison of sequences that promote both direct 
interference and priming (X019) versus sequences that only promote direct interference (X109 
∆cas1) (Fig. 6A-B). Based on their relative amount of CRISPR activity, PAMs were divided into 
four groups (Fig. 6A-D). Group A contains bona fide PAM sequences that are highly depleted in 
both strains. Group B contains PAMs that do not fully block direct interference, resulting in 
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some depletion in X019 ∆cas1 (<0.9 relative to DH5α reference library), but not as significantly 
as for X019. Group C contains sequences that block direct interference but promote priming, 
resulting in depletion in X019 but no change in X019 ∆cas1 (>0.9 relative to DH5α reference 
library). Group D contains sequences that are stable in both strains (>0.9 relative to DH5α 
reference library). Notably, sequences within groups A-C prefer adenine residues at the -3 and -2 
positions and a guanine residue at the -1 position (Fig. 6C-D). In contrast, PAMs with cytosine 
residues at positions -3 or -2 are highly represented in group D, indicating that a C at either 
position disrupts CRISPR-Cas activity (Fig. 6C-D). 
 
 
 
Figure 9: Validation of three sequences exhibiting depletion in X019 libraries from high-throughput studies. 
Plasmid loss and spacer acquisition rates for spacer 2.1 targets with a mismatch at position 4, mismatches at 
positions 2, 3 and 8 or mismatches at positions 2-5 and 7-8. The position 4 mismatch target is consistent with the 
high-throughput experiment, as the plasmid is relatively stable in E. coli X019 ∆cas1 but is lost due to spacer 
acquisition in X019. The other two targets are stable, suggesting that depletion of these sequences in the X019 
libraries is anomalous, and may be due to relative enrichment of several sequences in the X019 strain. The data are 
the average of three separate cultures, and error bars are based on standard deviations between replicates. 
 
In both libraries, group A contains the five previously identified bona fide PAMs (AAG, 
AGG, ATG, GAG, and TAG) located near the origin of the plot, indicating that targets with 
these PAM sequences are lost in both strains through direct interference as expected (Fig. 6A-D 
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and Fig. 8) (Fineran et al., 2014; Westra et al., 2012). Surprisingly, for spacer 1.1, there are three 
additional PAM sequences (AAA, AAC and ATA) located near the origin of the plot, suggesting 
that spacer 1.1 can tolerate eight different PAM sequences for interference (Fig. 6A,C and Fig. 
8A). In individual assays, all three spacer 1.1 targets can be lost through direct interference in 
X019 ∆cas1 (Fig. 6E). However, only the AAA PAM target displays the accompanying low rate 
of spacer acquisition observed for bona fide targets (Fig. 1F), indicating that spacer 1.1 has one 
additional bona fide PAM sequence. Strikingly, for spacer 2.1, the AAA and ATA targets are 
relatively stable in X019 ∆cas1 but promote high efficiency priming (Fig. 6E), suggesting that, 
in contrast to spacer 1.1, direct interference is strongly inhibited for these targets. Thus, similar 
to seed mutations, spacer sequence appears to dictate whether mutant PAM sequences can be 
tolerated for direct interference or mainly promote priming. 
We additionally observed several PAM sequences that are functional for one spacer but 
have no activity for the other spacer. For example, several Group C PAMs (ATT and TAC for 
spacer 1.1, AGA, AGC and CTG for spacer 2.1) are nonfunctional for the other spacer (Fig. 6A-
D and Fig. 8). To validate this observation, we created target plasmids for both spacers 
containing an AGA PAM and tested their CRISPR activity in individual assays (Fig. 6E). 
Consistent with the high-throughput experiment, we observe no CRISPR activity against the 
spacer 1.1 target containing an AGA PAM (Fig. 6E). In contrast, spacer 2.1 can promote 
efficient priming against targets containing an AGA PAM, although direct interference in X019 
∆cas1 is completely blocked (Fig. 6E). These data demonstrate that some potentially functional 
PAM sequences can be rendered completely nonfunctional based on the spacer sequence, and 
may explain differences in functional PAMs identified by high-throughput screens in ours and 
previous studies (Fineran et al., 2014). 
Our high-throughput results indicate that cytosine residues at the -3 and -2 positions of the 
PAM inhibit both interference and priming (Fig. 6C-D). In the E. coli genome, the final three 
nucleotides of the repeat are CCG, indicating that the repeat sequence may encode an inactive 
“PAM” sequence to prevent Cascade binding to the spacer template strand.  
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Differential interference against AGA PAM targets based on spacer sequence 
Our results indicate that spacer sequence can greatly influence the activity of the 
interference machinery against targets with altered PAM or seed sequences. For example, our 
observation that an AGA PAM completely blocks CRISPR activity against spacer 1.1 targets 
suggests that Cascade binding is blocked, while spacer 2.1 AGA PAM targets may still be bound 
by Cascade to promote priming, but not degraded by Cas3 to block interference. To test this, we 
purified Cascade with crRNAs bearing spacer 1.1 or spacer 2.1, and tested binding of their 
respective targets containing AGA PAMs using electrophoretic mobility shift assays (EMSA) 
(Fig. 10A-B). Spacer 2.1 Cascade can still bind the AGA PAM target and there is little 
difference between the affinities for the AGA PAM target and the AAG PAM target (Fig. 10B). 
In contrast, for spacer 1.1 Cascade, AGA PAM target binding is only observed at very high 
concentrations of Cascade (1-2 µM), and is likely due to non-specific DNA binding that is often 
observed at high concentrations of Cascade (Fig. 10A) (Jore et al., 2011a; Sashital et al., 2012; 
Westra et al., 2012). These data reveal that spacer sequence can have a major impact on the 
ability of Cascade to bind targets with incorrect PAM sequences. 
After confirming that Cascade can bind a spacer 2.1 target with an AGA PAM, we next 
investigated whether Cas3 can degrade this Cascade-bound target in vitro. Strikingly, the spacer 
2.1 AGA PAM target is not cleaved at any concentration of Cas3, even up to 2 µM (Fig. 10C). 
These results are consistent with the complete lack of direct interference observed in vivo against 
the AGA PAM target (Fig. 6E). Overall, these in vitro results for a priming PAM are in sharp 
contrast to the seed mutant targets we have tested, in particular the spacer 1.1 position 1 mutant 
target, which, similar to the spacer 2.1 AGA PAM target, promotes priming but strongly inhibits 
direct interference (Fig. 1C, E). For the PAM mutant target, Cascade binding affinity is not 
greatly affected, but Cascade-mediated Cas3 cleavage is completely blocked (Fig. 10B-C). For 
the seed mutant target, inhibition of interference appears to be caused by a defect in Cascade 
binding, but Cas3 cleavage appears to be unaffected for Cascade-bound target (Fig. 1E and Fig. 
3A).  
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Figure 10: Priming PAM blocks Cascade-mediated Cas3 cleavage but not Cas3-Cascade association. (A and 
B) Electrophoretic mobility shift assay for Cascade binding to (A) spacer 1.1 and (B) 2.1 targets with AAG or AGA 
PAMs. Cse2–Cas6e concentration is varied, and concentrations are labeled for each sample. Cse1 concentration was 
held constant at 1 µM to ensure complete formation of the Cascade complex. (C) Cascade-mediated Cas3 cleavage 
of spacer 2.1 targets with AAG or AGA PAMs. Plasmid DNA is labeled as follows: OC – open circle; L – linear; 
nSC – negatively supercoiled; D – degraded. (D–F) Confocal micrographs for BiFC experiments detecting 
interactions between Cse1 and Cas3. (D) E. coli BW25113 Δcse1Δcas3 grown with pACYC-BiFC and empty 
pCDF-1b plasmid. (E) E. coli BW25113 Δcse1Δcas3 grown with pACYC-BiFC and pCDF containing spacer 2.1 
target with an AAG PAM. (F) E. coli BW25113 Δcse1Δcas3 grown with pACYC-BiFC and pCDF containing 
spacer 2.1 target with an AGA PAM. 
 
Cas3 can be recruited to, but does not cleave, a priming PAM target in vivo 
We next wanted to determine whether the lack of Cascade-mediated degradation for the 
spacer 2.1 AGA target occurs because Cas3 cannot be recruited to Cascade bound to this target, 
or instead because Cas3 can be recruited but cannot initiate degradation. To investigate this, we 
used bimolecular fluorescence complementation (BiFC) experiments to monitor the interaction 
between Cascade and Cas3 in vivo (Fig. 10E-G). Previously, BiFC has been used to show that 
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Cascade cannot interact with Cas3 in the absence of an invading DNA sequence containing a 
correct PAM and protospacer (Westra et al., 2012). Cas3 was only recruited to Cascade by the 
Cse1 subunit in the presence of a target DNA. We used a similar experimental design, in which 
we fused Cse1 with N-terminal Venus and Cas3 with C-terminal Venus in a single expression 
vector (pACYC-BiFC). Each fragment of Venus is non-fluorescent, but fluorescence is 
reconstituted upon interaction between Cas3 and Cse1, which brings the two Venus fragments 
into proximity.  
For BiFC experiments, we co-transformed pACYC-BiFC with various target plasmids in E. 
coli X030 (hns, cse1 and cas3 genes deleted). E. coli containing a non-target plasmid (empty 
pCDF-1b) were non-fluorescent, indicating that a target plasmid is necessary for Cas3 and Cse1 
interaction (Fig. 10E). As expected, fluorescent signal is observable in E. coli carrying the bona 
fide target plasmid, indicating that Cascade has bound to the target and recruited Cas3 (Fig. 10F). 
Interestingly, the AGA target plasmid also induces fluorescence at similar levels to those 
observed with the AAG target (Fig. 10G). These results indicate that Cas3 can still be recruited 
to the Cascade-AGA target complex, but in a manner that does not lead to target degradation.  
 
Naïve spacer acquisition leads to rapid primed adaptation  
During naïve adaptation, spacers are acquired at a relatively low rate, and many spacers are 
acquired from protospacer locations containing PAMs that differ from the canonical AAG 
sequence (Datsenko et al., 2012; Diez-Villasenor et al., 2013; Nuñez et al., 2014b; Savitskaya et 
al., 2013; Yosef et al., 2013). We wondered whether functional PAMs are enriched for sequences 
acquired through naïve acquisition. We compared PAM sequences from a previously published 
set of spacers acquired through naïve adaptation with functional PAMs identified in this study 
(Fig. 11A and Fig. 12A) (Yosef et al., 2013). In the previous study, spacers could be acquired 
against both the genomic DNA and a Cas1-Cas2 expression plasmid. Although functional PAMs 
are ~1.8-fold less abundant than nonfunctional PAMs in both source DNAs, spacers derived 
from sequences with functional PAMs are acquired ~2.5-fold more frequently (Fig. 11A). 
Interestingly, functional PAMs are nearly equally divided between AAG and non-AAG 
sequences among the acquired spacers. We also note that some PAM sequences, especially the 
highly enriched ACG, have been identified in another study as priming PAMs, but were not 
  
88 
identified in our high-throughput study potentially due to differences in spacer sequences used in 
the two studies (Fineran et al., 2014).  
Given the high proportion of functional PAMs observed in the previous data set, we 
hypothesized that naïve acquisition should rapidly trigger a primed adaptation response to 
previously unencountered invader DNA. To test this hypothesis, we simulated three adaptation 
scenarios: 1. Invasion by a previously unencountered DNA (empty plasmid) with only naïve 
adaptation (cse1 deletion strain); 2. Invasion by a previously encountered DNA (spacer 2.1 AGA 
target plasmid) with a primed adaptation response; 3. Invasion by a previously unencountered 
DNA with both naïve and primed adaptation responses (Fig. 11B and Fig. 12B). In all three 
scenarios, we increased the rate of naïve acquisition through constitutive overexpression of Cas1 
and Cas2 using an expression plasmid (Yosef et al., 2013).  
As expected, naïve adaptation is significantly slower than priming, based on the number and 
amount of spacers acquired in the scenario 1 versus scenario 2 cultures, respectively (Fig. 11B 
and 12B). Scenario 3 mimics an actual naïve infection event, in which both adaptation and 
interference activities are functional. Initially, the only CRISPR-Cas response against the 
previously unencountered DNA is naïve adaptation, and accordingly spacer acquisition after one 
cycle of growth is very low (Fig. 12B). The slow naïve response observed in the scenario 1 
culture is exacerbated in the scenario 3 culture, as spacers acquired against the genomic DNA or 
Cas1-Cas2 expression plasmid are not permitted when the interference machinery is intact. 
However, over time, adaptation in the scenario 3 culture overtakes the rate of the scenario 1 
culture, based on the amount of spacer acquisition observed after a second cycle of growth (Fig. 
11B and 12B). When priming is active, bacteria can acquire multiple spacers more rapidly, as 
evidenced by the significant increase in product for 2 and 3 acquired spacers in the scenario 3 
analysis versus scenario 1. Together, these results suggest that preferential uptake of spacers 
against targets with any type of functional PAM during naïve adaptation can lead to a rapid 
priming response to infection. 
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Figure 11: Naïve adaptation triggers a rapid priming response. (A) Analysis of PAM sequences for spacers 
acquired in Yosef et al. naïve adaptation study (29). In the study, spacers were acquired from the E. coli genomic 
DNA or a plasmid borne by host. Percentage of reads for spacers derived from sequences with AAG PAMs or other 
functional or nonfunctional PAMs identified in our study are plotted. Total distribution of each type of PAM in each 
source DNA are also plotted. (B) Quantified PCR product resulting from newly acquired spacer from three 
adaptation scenarios following two cycles of growth. Scenario 3 products with significant differences (P < 0.005 
based on unpaired two-tailed t-test, n= 3 cultures) compared to scenario 1 are marked with an asterisk. (C and D) 
Model for adaptation during initial encounter of invader DNA. Naïve adaptation, requiring only the adaptation 
machinery (orange), allows for integration of spacers against the previously unencountered virus. Spacers may be 
against targets with PAMs that promote (C) interference or (D) priming by the interference machinery (blue). 
Cascade bearing newly acquired spacers can bind targets with (C) interference or (D) priming PAMs and recruit 
Cas3. PAM licensing at this step elicits a (C) target degradation or (D) priming response, although rare occurrences 
of the alternative mechanism are also possible for each type of target. 
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Figure 12: Acquisition of spacers promoting priming during naïve adaptation. (A) The relative number of 
counts for each PAM is reported as the percent of total read counts reported in the supplemental data file provided 
by Yosef et al (6). PAM sequences that were identified as functional for spacer 1.1 and 2.1 targets in our high-
throughput screen are shown in red. The sequences are shown in order of most to least number of counts in the 
pCas1+2 dataset. (B) Representative gel for adaptation experiment, quantified for cycle 2 in Figure 7B. The gel 
shows PCR products amplified from the 5′-end of CRISPR 1 for genomic DNA isolated from each culture.  
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DISCUSSION 
In this study, we have reexamined the sequence requirements for CRISPR interference 
and primed spacer acquisition in the Type I-E CRISPR-Cas immune system. Our results reveal 
that single point mutations within the seed sequence of target protospacers do not completely 
block CRISPR interference, and in some cases are highly tolerated. Similarly, some non-
canonical PAM sequences can be tolerated for direct interference, especially those with adenine 
residues at the -3 or -2 position or a guanine residue at the -1 position. Suprisingly, the crRNA 
spacer sequence has a significant effect on the ability of the interference machinery to recognize 
protospacers with seed mutations or non-canonical PAM sequences. Intriguingly, this result 
suggests that spacers that are highly tolerant of mutations throughout the seed may be more 
effective for CRISPR-Cas immunity, as there may be a lower probability of an invader DNA 
developing a point mutation to escape these types of spacers. In the future, it will be interesting 
to evaluate whether bacteria preferentially incorporate spacers with higher tolerance of mutated 
seed or PAM sequences. At present, the determinants for these spacer sequence-specific effects 
are unclear and a more systematic study of spacer/target sequence variations will be necessary to 
decipher the code for mutational tolerance by CRISPR-Cas systems. 
Our results differ from previous studies, which have shown that single point mutations in 
the protospacer seed or PAM sequences block the CRISPR interference pathway (Fineran et al., 
2014; Semenova et al., 2011c; Westra et al., 2013). In many cases, these mutations lead to 
primed spacer acquisition (Datsenko et al., 2012; Swarts et al., 2012), making it difficult to 
deconvolute indirect interference driven by newly acquired spacers from direct interference 
driven by the original spacer. By using a cas1 deletion strain, we decoupled direct interference 
from priming, definitively demonstrating the extent to which seed and PAM mutations can be 
tolerated for interference. In addition, differences between ours and previous studies may be due 
to variations in experimental design between studies. For example, phage infectivity and 
plasmid-based assays have previously been observed to yield differing results when assessing 
CRISPR interference (Semenova et al., 2015; Westra et al., 2013). Seed or PAM mutations that 
are tolerated in plasmid-based assays may sufficiently block CRISPR interference allowing for 
phage escape at high multiplicities of infection, including conditions found in the environment. 
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Going forward, it will be important to assess how mutational tolerance may vary based on the 
outcome of invasion by different types of mobile genetic elements. 
 
Self-sequence avoidance in the Type I-E system 
To prevent autoimmunity, CRISPR-Cas immune systems must distinguish non-self 
protospacer sequences from identical self-spacer sequences present in the CRISPR array. Type 
III-A systems accomplish this self vs. non-self recognition based on differential complementarity 
between the crRNA and sequences flanking the target (Marraffini and Sontheimer, 2010). Type I 
and II CRISPR-Cas immune systems utilize PAM sequences to differentiate targets from non-
targets (Jinek et al., 2012; Sashital et al., 2012; Westra et al., 2013), but a mechanism for 
avoidance of self sequences has not been previously identified. Our high-throughput PAM 
mutant screen revealed that cytosine residues at the -3 and -2 position of the PAM prevents both 
interference and priming. The position of this 3-nucleotide protective element is identical to 
where PAMs reside in target DNA and indicates that PAM recognition is actually more 
sophisticated than previously thought (Sashital et al., 2012; Westra et al., 2013). Apart from 
authenticating bona fide targets for direct interference, many PAM sequences are eligible for 
priming ( Fineran et al., 2014, this work). The repeat-PAM, however, abolishes both pathways 
by providing a genuine self-signal, and this leaves the CRISPR array exempt from detrimental 
autopriming. 
 
Mechanistic insights into CRISPR-Cas immunity 
Overall, the large number of functional PAMs identified in our study, including several 
noncanonical PAMs that allow some degree of direct interference, suggests that Cascade-target 
binding requirements are less stringent than previously thought. We found that Cascade binding 
affinity for targets with noncanonical PAMs is significantly affected by the spacer sequence, and 
that some targets with priming PAMs can be bound with high affinity. When Cascade binds 
priming PAM targets, Cas3 is recruited but does not cleave the DNA. Similarly, a recent single-
molecule study of the Streptococcus thermophilus Type I-E Cascade found that low-affinity, 
non-permissive PAM targets with induced R-loops were cleaved at a very low rate by Cas3 
(Rutkauskas et al., 2015), and bulk biochemical studies have indicated that targets with mutated 
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PAM sequences cannot be cleaved by Cas3 (Blosser et al., 2015b; Hochstrasser et al., 2014; 
Mulepati and Bailey, 2013). Notably, for high-affinity priming PAM targets, PAM 
discrimination apparently occurs not at the target-binding step, but instead at the target cleavage 
step. Thus, targets with noncanonical PAMs may be bound with high affinity by Cascade, but a 
second PAM authentication step following Cas3 recruitment prevents interference from 
occurring. 
The molecular basis for PAM authentication during target cleavage is currently unknown. It 
is possible that interactions between Cascade or Cas3 and the PAM sequence may differ for 
interference and priming PAMs, resulting in alternative conformations that lead to the two 
different immune reactions. This idea is consistent with recent single-molecule FRET studies of 
Cascade-target binding, which revealed that Cascade engages priming targets in a noncanonical 
binding mode (Blosser et al., 2015b). However, the mode of binding observed in that study was 
relatively short-lived, and it is unclear whether the high-affinity Cascade-target interaction we 
observe for the spacer 2.1 AGA target is analogous to this binding event. Our discovery of a 
high-affinity priming PAM target should enable further study into the conformations that 
promote priming and the mechanism of PAM authentication during target cleavage. 
The mechanisms of interference and priming appear to exist in a dynamic equilibrium in 
which targets that block interference promote priming, and targets that allow interference inhibit 
priming. In general, target sequences that are tolerated for direct interference lead to inefficient 
priming, including bona fide targets and several of the seed and PAM mutants tested in our 
study. It is possible that this inefficiency is caused by loss of the target plasmid through rapid 
target degradation through CRISPR interference, thus limiting the amount of invader DNA from 
which to acquire new spacers. In this case, the equilibrium between interference and priming 
favors interference and disfavors priming, whereas mutations that block interference push the 
equilibrium toward priming. Consistently, the short-lived noncanonical binding mode observed 
by single-molecule FRET for priming targets was also observed for bona fide targets (Blosser et 
al., 2015b), suggesting that Cascade can sample an alternative binding mode that promotes 
priming for any type of target. The noncanonical binding mode may occur relatively rarely for 
high-affinity targets that can adopt the interference binding mode, including bona fide targets and 
targets with seed or PAM mutations that are tolerated for direct interference.  
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Priming is a major mechanism for adaptation 
Primed spacer acquisition allows bacteria to mount a rapid defense against infection, even in 
the presence of PAM or protospacer mutations that could allow an invader DNA to escape 
CRISPR interference. In addition, the promiscuity of Cascade in recognizing priming PAMs may 
have implications during the early stages of CRISPR-Cas adaptation. We showed that naïve 
acquisition can lead to a rapid priming response, suggesting that previously identified “incorrect” 
PAMs of sequences acquired during naïve adaptation are likely actually functional PAMs that 
promote priming (Datsenko et al., 2012; Diez-Villasenor et al., 2013; Nuñez et al., 2014b; 
Savitskaya et al., 2013; Yosef et al., 2013). These data suggest that the Cas1-Cas2 acquisition 
complex, like Cascade, may recognize a broad range of PAM sequences that can promote either 
interference or priming in the absence of Cascade and Cas3. Notably, different adaptation 
specificities have been observed for the E. coli K12 and O157:H7 Type I-E variants, which 
preferentially acquire protospacers with AAG and ATG PAMs, respectively (Diez-Villasenor et 
al., 2013). These observations suggest that the closely related Cas1-Cas2 homologs (85% 
identity) in these Type I-E variants bind alternative functional PAMs with variable affinities, 
resulting in different PAM preferences. A recent crystal structure of the E. coli K12 Cas1-Cas2 
complex bound to a PAM-containing protospacer reveals the structural basis for preferential 
AAG PAM recognition, and will be important for guiding future studies of functional PAM 
selectivity (Wang et al., 2015).  
Together with previous results, our findings suggest that naïve adaptation is a mechanism 
for acquiring spacers for both interference and priming, while primed adaptation is a mechanism 
for acquiring only interference spacers (Datsenko et al., 2012; Savitskaya et al., 2013). This two-
tiered strategy may be of particular importance for adaptation against invaders with depleted 
canonical PAM sequences, as has been observed for several bacteriophages with hosts 
containing CRISPR-Cas systems (Kupczok and Bollback, 2014). During initial infection, a naïve 
adaptation strategy in which only protospacers with canonical PAM sequences were acquired 
would severely limit the ability of the host to mount an effective defense. Instead, the CRISPR-
Cas system overcomes this limitation by initially acquiring any sequence adjacent to a functional 
PAM during naïve adaptation, then honing the system for interference through priming. Priming 
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may, in fact, be the major mechanism for adaptation in Type I systems. In the Haloarcula 
hispanica Type I-B system, priming is strictly required for adaptation and naïve adaptation has 
not been observed (Li et al., 2014b). Similar to our observations, this system has relaxed 
stringency for priming PAM sequences, maximizing the adaptation capacity during an invasion 
event (Li et al., 2014a). The Pectobacterium atrosepticum Type I-F system contains a Cas2-Cas3 
fusion, physically linking the naïve and primed acquisition machinery and resulting in extremely 
robust priming in this organism (Richter et al., 2014). It is possible that the Type I-E system also 
uses priming as the main mechanism for adaptation, and that naïve acquisition is simply a means 
to enable priming.  
 
Model for priming and interference dynamics in E. coli 
Overall, our results suggest a model for adaptation during the initial encounter of an invader 
DNA (Fig. 11C-D). The Cas1-Cas2 complex initially acquires new spacers from any region of a 
replicating invader (Levy et al., 2015), preferentially incorporating sequences that are adjacent to 
functional PAMs. Cascade bearing the resulting crRNAs can bind to these targets and recruit 
Cas3. Prior to target degradation, the PAM is authenticated through an unknown mechanism, and 
this leads to either interference (Fig. 11C) or priming (Fig. 11D). Depending on the PAM 
sequence, the frequency of these two responses will vary, with bona fide PAM targets leading to 
a majority of interference and few priming events (Fig. 11C) and priming PAM targets leading to 
rapid spacer acquisition and infrequent interference events (Fig. 11D). Thus, the initial spacers 
acquired during naïve acquisition allow the CRISPR-Cas system to simultaneously mount two 
defensive responses to infection.  
 
 
MATERIALS AND METHODS 
Bacterial strains 
E. coli K12 BW25113 was used as background for all constructed strains (Baba et al., 2006; 
Datsenko and Wanner, 2000). Individual gene deletion strains for hns, cas3, cse1, cas1 were 
obtained from the Keio collection (Baba et al., 2006). The cas3, cse1 or cas1 deletions were 
moved from BW25113 ∆cas3::kan, BW25113 ∆cse1::kan or BW25113 ∆cas1::kan into 
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BW25113 Δhns or E. coli X019 using P1 phage transduction. Kanamycin resistance cassettes 
were removed for all strains using pCP20 (Cherepanov and Wackernagel, 1995), with the 
exception of the cas3::kan cassette in strain X030. The X019 strain, in which spacers 1.2-1.12 
and 2.2-2.6 were deleted was created using lambda Red recombinase, as previously described 
(Datsenko and Wanner, 2000). DNA fragments containing kanamycin resistance cassette flanked 
by FRT sites with 50-bp homology to CRISPR 1 or CRISPR 2-adjacent sequences were created 
using primers XCY302-303 and XCY304-305, respectively. 
 
Plasmid construction 
All protospacers used in this study were ligated to pACYCDuet-1or pCDF-1b between 
BgIII and XhoI or NcoI and NotI sites. For recombinant Cascade expression with different 
spacer sequences, CRISPRs bearing spacers 1.1, 1.6, 1.9 or 2.1 were generated using pWUR547 
(Jore et al., 2011a) as template through ‘round-the-horn (RTH) cloning (Moore). For 
recombinant Cascade expression and purification, the N-terminal Streptactin-tag in Cse2 of 
pWUR480 (Brouns et al., 1993) plasmid was changed to a His6-tag using HL005 and HL006 
through RTH cloning to produce pDGS010. For recombinant Cas3 expression and purification, 
the cas3 gene was amplified from the E. coli K12 genome using XCY001 and XCY002 and 
cloned into pSV272, encoding an N-terminal His6-MBP (maltose-binding protein) tag. For the 
Cas1 and Cas2 expression plasmid pX288, PCR product of native tac promoter controlled Cas1-
Cas2 was cloned using XCY255 and XCY256 in pACYCDuet-1.  
For the pACYC-GFP-tac plasmid, a tac promoter (de Boer et al., 1983) controlled GFP 
gene was PCR amplified from psfGFP using XCY413 and XCY417 and cloned into 
pACYCDuet-1. Our preliminary results indicated that the use of a native tac promoter for GFP 
expression slowed E. coli growth, changing the GFP+ and GFP- cells ratio through a non-
CRISPR related mechanism. To solve this problem, the native tac promoter was changed to a 
weaker tac-derived promoter (De Mey et al., 2007). The resulting plasmid (pACYC-GFP-pro3) 
did not increase the doubling time of E. coli compared to E. coli bearing empty pACYCDuet-1. 
Competition assays between E. coli X019 bearing either empty pACYCDuet-1 or pACYC-GFP-
pro3 further indicated that GFP expression does not affect the ratio of GFP- and GFP+ cells, as 
ratios between the two strains remained constant after 24 h growth without selection. To 
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decrease the half-life of GFP, the protease-sensitive SsrA peptide tag AANDENYALAA (Keiler 
et al., 1996) was added to the C-terminus of GFP using XCY449 and XCY452 with pACYC-
GFP-pro3 as template through RTH cloning. This final plasmid is referred to as pACYC-GFP 
throughout the text. 
pACYC-Cas3-C85Venus-Cse1-N155Venus (referred as pACYC-BiFC in the paper) was 
created by Gibson Assembly using primers XCY479-XCY486 (Gibson et al., 2009). Cas3 
contains a C-terminal fusion of the C-terminal Venus fragment and Cse1 contains a C-terminal 
fusion of the N-terminal fragment of Venus. The expression vector was assembled from 4 
separate PCR products amplified using either pACYC-Cas3-Cse1 or mVenus-pBAD vector (a 
gift from Michael Davidson (Addgene plasmid # 54845)) as template.  
 
Plasmid-loss and spacer acquisition experiments 
Plasmids were introduced into E. coli BW25113 derived strains via heat shock and single 
colonies were used to inoculate initial cultures. All strains were grown for 24 h (sub-cultured at 
12 h) in 2 mL LB in 15 mL tubes at 37ºC with shaking at 200 rpm. For passaging, 20 µl of 
culture was sub-cultured into 2 mL LB. When indicated, further periods of incubation were 
performed at the same conditions. E. coli cultures were diluted 250,000-fold and 10 µL of the 
final dilution was plated on LB plates (1.5% agar) without antibiotic. After 6 hr, 35-50 colonies 
on these plates were replicated onto LB plates supplemented with chloramphenicol to check for 
plasmid loss. For each sample, 16 colonies on the no antibiotic plates were picked randomly to 
analyze spacer acquisition by colony PCR using Taq DNA polymerase. Newly acquired spacers 
in CRISPR 1 or CRISPR 2 were detected by PCR using primers XCY076-077 or XCY152-153, 
respectively. PCR products were visualized on 2% agarose gels stained with SYBR Safe 
(Thermo Fisher Scientific). All experiments were performed for three individual cultures. 
Plasmid loss and spacer acquisition rates reflect the average of these three biological replicates, 
and errors are the standard deviation between replicates. 
 
Protein Expression and Purification 
Cascade lacking Cse1 (Cse2-Cas6e) was expressed in BL21(DE3) cells using pDGS010, 
pWUR404 and the appropriate CRISPR expression plasmid (spacer 1.1: pX238, spacer 1.6: 
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pX230, spacer 1.9: pX503, spacer 2.1: pX569,) in 1 L LB media supplemented with ampicillin, 
chloramphenicol and streptomycin. Cultures were grown to 0.5 OD600 at 37ºC, and induced 
overnight at 16ºC with 0.5 mM IPTG. His6-tagged Cse2-Cas6e was purified using HisPur Ni-
NTA affinity resin (Thermo Fisher Scientific). The eluent was concentrated to ~ 1 mL, then 
purified by size exclusion chromatograph using a Superdex 200 column (GE Life Sciences) in a 
buffer containing 20 mM Tris (pH 7.5), 100 mM NaCl, 5% glycerol and 1 mM TCEP. Cse1 was 
expressed in BL21(DE3) using the EcCse1-pSV272 expression vector, and purified as previously 
described (Sashital et al., 2011). Cas3 was expressed in BL21(DE3) using the Cas3-pSV272 
expression vector and purified as described previously with the following modifications 
(Mulepati and Bailey, 2013). During the whole Cas3 purification process, 1mM TCEP was 
added in all buffers. To maintain the activity of Cas3, the purification process was completed in 
one day. Briefly, after lysis and affinity purification using HisPur Ni-NTA resin, His6-MBP-Cas3 
was purified on a Superdex 200 column. The purified His6-MBP-Cas3 protein was cleaved by 
tobacco etch virus protease for 3 h at 4ºC. The cleaved sample was flowed through a Ni-NTA 
column, concentrated to 1 mL, and finally purified on a Superdex 200 column. 
 
DNA binding and cleavage assays 
All binding assays were performed in binding buffer: 20 mM Tris (pH 7.5), 100 mM NaCl, 
and 5% glycerol. All cleavage assays were performed in reaction buffer: 10 mM HEPES (pH 
7.5), 100 mM KCl, 5% (v/v) glycerol, 2 mM ATP, 100 µM CoCl2, and 10 mM MgCl2. 
Concentrations indicated for Cascade in Figure 1E, 3 and 12B-D are for the Cse2-Cas6e 
complex, as Cse1 was held at a constant concentration to ensure complete formation of the 
Cascade complex (Sashital et al., 2012). Cse2-Cas6e at indicated concentrations and 1000 nM 
Cse1 were pre-incubated for 20 min at 37ºC to form the Cascade complex. Samples were cooled 
on ice for 1 min prior to initiating binding or cleavage reactions. For Cascade-DNA binding, 
Cascade was incubated with 2 nM target plasmid, and samples were incubated at 37ºC for 30 
min prior to electrophoresis on a 0.8% agarose gel stained with SYBR Safe run at 15 V at 4ºC 
for 18 h. For Cas3 cleavage, Cascade was incubated with 2 nM target plasmid at 37ºC for 15 
min. Cas3 was added at the indicated concentration to initiate plasmid digestion.  Reactions were 
incubated at 37ºC for 30 min and terminated by the addition of 20 mM EDTA. Proteins were 
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removed by phenol extraction. Reactions were analyzed by electrophoresis on a 1% agarose gel 
stained with SYBR Safe.  
 
Generation of PAM and seed libraries 
To avoid sequence bias, initial libraries were constructed in DH5α by RTH cloning using 
pACYC-GFP as template. Primer locations were designed to avoid complementarity between the 
overhanging degenerate sequence and the template. However, this library design did not result in 
an unbiased library for the original spacer 1.1 seed library, so an alternative method was used for 
spacer 1.1 and 2.1 6MM seed library creation. A 24-bp protospacer (position 9 to position 32) of 
spacer 1.1 (XCY573 and XCY574) or spacer 2.1 (XCY577 and XCY578) was ligated into 
pACYC-GFP to create pX735 and pX737, and these plasmids were used as templates for RTH 
cloning of the libraries. All primers were phosphorylated using polynucleotide kinase prior to 
PCR. Primers were used to PCR amplify the pACYC-GFP, pX735 or pX737 backbone and PCR 
products were purified. PCR products were ligated and transformed into E. coli DH5α. For each 
library, over 30,000 transformants were isolated. All colonies were resuspended in LB, the 
bacteria were pelleted, and plasmids were extracted using a Promega Wizard Plus SV Miniprep 
DNA Purification kit. This procedure yielded the five original libraries, PAM of spacer 1.1, seed 
of spacer 1.1, PAM of spacer 2.1, and two seed libraries of spacer 2.1. All libraries were 
prepared in triplicate from three separate ligations and DH5α transformations. High-throughput 
plasmid loss, priming assays and sequencing were performed for all three biological replicates.  
 
High-throughput plasmid loss and priming assays 
All original libraries were transformed into X019, X019 Δcse1, and X019 Δcas1 and plated 
onto LB plates with chloramphenicol yielding around 30,000 colonies. All colonies were 
resuspended using 1 mL LB. After adjusting the concentration of the resuspended bacteria to 
OD600 of ~5.0, 20 µl of the culture was used to inoculate 2 mL LB without antibiotic in 15 mL 
tubes at 37ºC with shaking at 200 rpm for 5 growth cycles, with sub-culturing every 6 or 12 hr. 
Next, 40 µl of the each culture was used to inoculate 4 mL LB supplemented with 
chloramphenicol. These cultures were grown at 37ºC with shaking at 200 rpm for 12 h and 
plasmids were extracted, yielding an additional 12 plasmid libraries. These 12 plasmid libraries 
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and the 4 original plasmid libraries were transformed into X019 and cultured at 37ºC with 
shaking at 200 rpm for 2 cycles, sub-cultured at 6 or 12 hr. The cultures were diluted 100-fold 
and analyzed by BD FACSAria III flow cytometer. For each culture, 100,000 GFP+ and GFP- 
cells were sorted. The average percentage of GFP- cells for three biological replicates are 
reported in Figure 4D, and errors reflect the standard deviation between the three replicates. 
Spacer acquisition was analyzed for the genomic DNA of the sorted GFP- cells by PCR 
amplification using XCY076 and XCY077 for CRISPR 1 and XCY152 and XCY153 for 
CRISPR 2. PCR products were analyzed on a 2% agarose gel stained with SYBR Safe, and 
intensity of PCR bands was measured using ImageQuant TL (GE Life Sciences). Spacer 
acquisition rates were measured as the intensity of extended CRISPR PCR products relative to 
the intensity of total PCR product. The relative intensity of CRISPR 1 and CRISPR 2 were 
averaged to determine the relative spacer acquisition for each sample.  Spacer acquisition rates 
reported in Figure 4E are the average from three separate biological replicates and error bars 
reflect standard deviation between the three replicates. 
 
MiSeq Illumina sequencing  
 The PAM and seed libraries extracted from DH5α, X019, X019 Δcse1, and X019 Δcas1 
were amplified by PCR using Phusion DNA polymerase using a primer pair. Each primer 
contained a unique 6-nt barcode to differentiate between libraries and replicates. The 100-120 bp 
PCR fragments were analyzed by 2% agarose gel electrophoresis and absorbance at 280 nm. 
Based on the gel analysis and absorbance reading, equal quantities were mixed and pooled. The 
mixed samples were run on a 2% agarose gel, the band was excised and purified using a 
Promega Wizard Gel and PCR Clean-up kit. Samples were analyzed on an Agilent 2100 
Bioanalyzer and a Qubit Fluorometer (Thermo Fisher Scientific) to determine DNA size and 
concentration. Samples were prepared for Illumina Sequencing using the TruSeq Nano DNA 
Sample Preparation kit (v3) for 1× 150 bp (single-end). To increase the diversity of sequences, 
samples were spiked with ~30% of a PhiX Control v3 adapter-ligated library. Samples were 
sequenced on an Illumina MiSeq at the Iowa State University DNA Facility.   
Plasmid libraries were sequenced in three separate MiSeq runs. MiSeq run 1 contained the 
three replicates each for the PAM and seed libraries for spacer 2.1. MiSeq run 2 contained three 
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replicates for the PAM library for spacer 1.1 and three replicates for an incomplete seed library 
for spacer 1.1, which had 42 sequences with fewer than 100 reads in all libraries. Analysis of this 
library is included in Supplemental Data File 1, although this analysis was omitted in the main 
text. MiSeq run 3 contained three replicates each for the redesigned spacer 1.1 seed library and 
the spacer 2.1 6MM library.  
 
Analysis of MiSeq data 
Sequences from MiSeq output files were demultiplexed and sorted into separate files for 
each library and replicate based on the presence of specific pairs of barcodes at both ends of the 
read using a bash script. Reads corresponding to the target (forward reads) and non-target 
(reverse reads) strand of the protospacer were sorted separately. To determine read counts for all 
possible sequences in each library, the resulting files were searched for the 64 or 128 possible 
PAM/protospacer sequences for each PAM or seed library, respectively. An output file was 
generated for each replicate of each library containing the counts for each PAM/protospacer 
search sequence in the forward and reverse direction. 
Forward read counts for highly depleted sequences in the X019 ∆cas1 and X019 library 
were systematically higher than reverse read counts for the same sequences. This phenomenon 
does not appear to be a result of the demultiplexing strategy, as demultiplexing using alternative 
methods (fastx-multx command from ea-utils package (Aronesty, 2013) or sabre (Joshi, 2013)) 
produced very similar results. Overall trends in sequence depletion are the same between forward 
and reverse reads, although the absolute value of counts differs. Therefore, forward and reverse 
read counts were summed and treated as total read counts for each sequence. Read counts 
between samples were normalized by calculating a scaling factor based on the sample with the 
highest number of sequences. For seed libraries, sequences with anomalously high read counts 
(>2-fold greater than the DH5α reference library following normalization) in the X019 or X019 
∆cas1 were omitted when calculating the scaling factor. Normalized read counts from three 
biological replicates for each library were averaged and standard deviations were determined. To 
determine the relative number of counts for each sequence in the experimental libraries, average 
read counts for X019 ∆cse1, X019 ∆cas1, and X019 libraries were divided by the average read 
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count for the DH5α reference library. Standard deviations were propagated and are reported as 
errors for relative counts in Figures 5B-C, 6A-B, 7 and 8.  
 
Fluorescence Microscopy 
BiFC experiments were performed in E. coli X030 carrying pACYC-BiFC and empty 
pCDF-1, pCDF-1b bearing spacer 2.1 AAG target, or pCDF-1b bearing spacer 2.1 AGA target. 
Single colonies were grown at 37ºC in LB containing chloramphenicol (34 ug/ml) until OD600 
reached 0.05. Cultures were shifted to 18ºC for 6 h to ensure that plasmid loss of the pCDF-1b 
bearing spacer 2.1 AAG target would occur slowly, allowing for fluorescence to be observed. 
Cells were adjusted to OD600 0.5 and re-suspended in phosphate buffer (pH 7.2) and 5 µl of the 
cells were applied to poly-L-lysine covered microscope slides, and analyzed using a Leica SP5 X 
MP confocal/multiphoton microscope system with an inverted microscope front end, with a 40x 
oil immersion objective and an argon laser as the excitation source (514 nm) and detection at 
530-600 nm.  
 
Analysis of naïve PAMs and simulation of adaptation 
A data set generated by Yosef et al. was used to analyze the frequency of PAMs of targets 
for spacers acquired through naïve adaptation (Yosef et al., 2013). Spacer sequences and 
genomic or plasmid locations were reported in the original paper. PAM sequences were extracted 
from the genomic (NCBI Reference sequence NC_012947.1) or plasmid sequences (reported in 
(Yosef et al., 2012)) using the BEDtools getfasta tool (Quinlan, 2014). 
In scenario 1, pX288 (pACYC-Cas1-2) plasmid and empty pCDF-1b plasmid were co-
transformed into the X019 ∆cse1 E. coli strain. In scenario 2, pX288 plasmid and priming 
plasmid (pCDF-1b bearing a spacer 2.1 target with an AGA PAM) were co-transformed into the 
X019 strain. In scenario 3, X288 plasmid and empty pCDF-1b plasmid were co-transformed into 
the X019 strain. Single colonies were grown to saturation (OD600 of 3.5) for two cycles in LB 
supplemented with chloramphenicol to maintain pX288. The 5’-end of CRISPR 1 was PCR 
amplified from genomic DNA isolated from each culture using XCY076 and XCY077 and 
visualized on a 2% agarose gel stained with SYBR Safe to test for spacer acquisition. The 
relative amount of each band corresponding to a different number of acquired spacers was 
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determined by densitometry using ImageQuant TL software. Cultures were performed in 
triplicate and the average amount of product is plotted in Fig. 12B, with error bars reflecting the 
standard deviation between replicates. 
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CHAPTER 4 
CONFORMATIONAL CONTROL OF CASCADE INTERFERENCE AND PRIMING 
ACTIVITIES IN CRISPR IMMUNITY 
Chaoyou Xue, Natalie R. Whitis and Dipali G. Sashital 
(Published in Molecular Cell (2016) 64 (4): 826-834) 
Abstract 
During Type I-E CRISPR-Cas immunity, the Cascade surveillance complex utilizes 
CRISPR-derived RNAs to target complementary invasive DNA for destruction. When invader 
mutation blocks this interference activity, Cascade instead triggers rapid primed adaptation 
against the invader. The molecular basis for this dual Cascade activity is poorly understood. Here 
we show that the conformation of the Cse1 subunit controls Cascade activity. Using FRET, we 
find that Cse1 exists in a dynamic equilibrium between “open” and “closed” conformations, and 
the extent to which the open conformation is favored directly correlates with the attenuation of 
interference and relative increase in priming activity upon target mutation. Additionally, the 
Cse1 L1 motif modulates Cascade activity by stabilizing the closed conformation. L1 mutations 
promote the open conformation and switch immune response from interference to priming. Our 
results demonstrate that Cascade conformation controls the functional outcome of target 
recognition, enabling tunable CRISPR immune response to combat invader evolution. 
 
 
Introduction 
Clustered regularly interspaced short palindromic repeats (CRISPR) arrays are hallmarks 
of RNA-guided immune systems that protect bacteria and archaea from invasion by foreign 
genetic elements (Marraffini, 2015; van der Oost et al., 2014; Sorek et al., 2013c). CRISPR-
based immunity is initiated upon infection when a short DNA segment from the invader DNA is 
inserted into the CRISPR array. This newly acquired spacer sequence acts as a molecular 
memory of the infection and is central to host defense against the invader (Barrangou et al., 
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2007b). CRISPR RNAs (crRNAs), comprising a spacer and portions of flanking repeat 
sequences, are derived from the array and serve as guide strands for CRISPR-associated (Cas) 
proteins. This crRNA-guided surveillance complex searches invader DNA, binding to the 
cognate protospacer region through complementary base pairing with the crRNA spacer, and 
triggering the destruction of the invader DNA through CRISPR interference. 
The protein components of crRNA-guided surveillance complexes are highly diverse, and 
range from a single Cas endonuclease (Class 2 CRISPR-Cas systems) to large, multi-subunit 
complexes (Class 1 CRISPR-Cas systems) (Makarova et al., 2015). In the Type I-E CRISPR-Cas 
system, the crRNA combines with five stoichiometrically unequal proteins (Cse11-Cse22-Cas76-
Cas51-Cas61) to form the Cascade surveillance complex (Figure 1A) (Brouns et al., 1993; Hayes 
et al., 2016; Jackson et al., 2014e; Jore et al., 2011a; Mulepati et al., 2014c; Zhao et al., 2014a). 
Cascade searches for targets by locating the protospacer adjacent motif (PAM), a short sequence 
located just upstream of the crRNA-cognate sequence (Mojica et al., 2009b; Redding et al., 
2015; Semenova et al., 2011c). PAM recognition by the Cse1 subunit locally destabilizes the 
DNA duplex, enabling strand invasion and directional crRNA-DNA hybridization to form an R-
loop (Blosser et al., 2015b; Hayes et al., 2016; Redding et al., 2015; Rutkauskas et al., 2015; 
Sashital et al., 2012; Szczelkun et al., 2014c). The first several base pairs comprise a “seed” 
region that nucleates hybridization and is critical for Cascade-target binding (Semenova et al., 
2011c).  
Cascade elicits two distinct immune responses upon target binding: interference, which 
leads to the destruction of the target DNA (Brouns et al., 1993; Westra et al., 2012); or priming, 
a positive feedback mechanism for rapid spacer acquisition (Datsenko et al., 2012). During 
interference, Cse1 recruits the Cas3 endonuclease, which processively degrades the target DNA 
(Hochstrasser et al., 2014; Mulepati and Bailey, 2013; Redding et al., 2015; Westra et al., 2012). 
Priming also requires Cas3, in addition to the Cas1-Cas2 spacer acquisition complex (Datsenko 
et al., 2012; Nunez et al., 2015a; Nuñez et al., 2014b; Wang et al., 2015). Recent studies provide 
evidence for two alternative models for primed spacer acquisition. In the interference-dependent 
model, Cas3 degradation products serve as substrates for spacer acquisition by Cas1-Cas2 
(Kunne et al., 2016). Alternatively, in the interference-independent model, Cas3 is recruited only 
in the presence of Cas1-Cas2, and the putative Cas1-Cas2-Cas3 priming complex translocates 
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along the DNA in a nuclease-independent manner, potentially searching for new spacers 
(Redding et al., 2015). 
Rapid target degradation through interference limits priming by reducing the amount of 
time in which spacer acquisition can occur (Semenova et al., 2016). Therefore, target mutations 
that inhibit or block interference, especially in the seed and PAM, are required to switch the 
functional outcome of CRISPR–Cas immunity from interference to priming (Datsenko et al., 
2012). Cascade can tolerate up to two mismatches within the seed, and directs both interference 
and priming against these targets (Xue et al., 2015). Cascade can also recognize a broad set of 
PAM sequences; however, only a limited number of PAMs trigger interference, while a large set 
of PAMs block interference completely while still promoting priming (Fineran et al., 2014; Xue 
et al., 2015). Intriguingly, targets with priming PAMs can be specifically recognized and bound 
by Cascade, but Cas3 cannot be directly recruited to these targets (Redding et al., 2015). These 
results suggest that Cascade may engage targets with priming PAMs in an alternate conformation 
that blocks Cas3 binding. Similarly, recent single-molecule FRET studies indicate that Cascade 
has two distinct binding modes for bona fide and mutant targets (Blosser et al., 2015b), although 
it is unclear whether Cascade structure differs between these binding modes.  
Based on these previous results, we hypothesized that structural alterations in Cascade, 
particularly the Cse1 subunit which recruits Cas3 and recognizes the PAM, may elicit two 
separate immune responses. To test this hypothesis, we developed a fluorescence resonance 
energy transfer (FRET) system that enables the measurement of conformational changes in Cse1 
upon target binding. Using this FRET system, we demonstrate that upon Cascade-dsDNA 
binding, Cse1 is dynamic, adopting multiple conformations that correlate with the relative rates 
of interference and priming. Target mutations that inhibit interference induce an alternate Cse1 
conformation that instead promotes priming. Mutations in the Cse1 L1 motif also induce the 
priming conformation, and directly correlate Cse1 conformation with Cascade function. Overall, 
our results provide the mechanistic and structural basis for differential Cascade function upon 
mutation of target sites.  
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Results 
Direct measurement of Cse1 conformation by FRET 
Cse1 adopts three alternative conformations in apo, ssDNA-bound and dsDNA-bound 
Cascade structures (Figures 1A-D) (Hayes et al., 2016; Jackson et al., 2014e; Mulepati et al., 
2014c; Zhao et al., 2014a). When bound to ssDNA, the entire Cse1 subunit rotates by ~30º 
compared to the apo structure (Figures 1B-C) (Jackson et al., 2014e; Mulepati et al., 2014c; 
Zhao et al., 2014a). This “open” Cse1 conformation causes significant relocation of the N-
terminal domain (NTD). In contrast, when bound to dsDNA, the NTD remains in the original 
“closed” conformation observed for apo Cascade, while the CTD slides towards the NTD, 
causing a significant change in the relative orientation between the two domains and relocation 
of the CTD into a “locked” position (Figures 1B and 1D) (Hayes et al., 2016; Jackson et al., 
2014e; Zhao et al., 2014a). Based on these structures, we sought to create a FRET system that  
would enable the measurement of Cse1 NTD and CTD conformational rearrangements upon  
Cascade binding to ssDNA and dsDNA, respectively.  
We generated Cse1 and Cse22-Cas76-Cas5-Cas6-crRNA (hereafter called Cse2-Cas6) 
variants in which all structurally nonessential cysteine residues were mutated to serine or alanine 
(Figure 2). These “minimal-Cys” constructs are not alkylated by Cy3- or Cy5-maleimide dyes 
(Figures 1E-G), and retain both DNA-binding and Cas3 recruitment activity, based on in vitro 
binding and interference assays (Figures S1I-L). We then introduced cysteine residues in the 
minimal-Cys constructs (Figures 1B-D), allowing for site-specific labeling with Cy3 (Figure 1F) 
or Cy5 (Figure 1G). Dye labels were introduced in either the NTD or CTD of Cse1 to measure 
movement of each domain separately (Figures 1B-D). Incubation of Cse1Cy3 and Cse2-Cas5Cy5 
produced FRET signal, consistent with the close proximity of the two dyes in the reconstituted 
Cascade complex (Figure 1H).  
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Figure 1. Direct detection of Cse1 conformational changes by FRET. (A) Full view of apo Cascade structure (PDB 
4TVX). Cse1 NTD: dark green, Cse1 CTD: light green, Cas5: purple, Cse2 subunits: light orange, Cas7 subunits: 
light blue, Cas6: light red. (B-D) Close-up of Cse1 DNA-binding face (top) and solvent-exposed face (bottom) in 
(B) apo, (C) ssDNA-bound and (D) dsDNA-bound Cascade. PDB IDs: (B) 4TVX; (C) 4QYZ with modeled chains 
from 4TVX; (D) 5H9F. The L1 motif is shown in red, and the PAM is shown in yellow in the dsDNA bound 
structure. Cy3 (green stars) and Cy5 (red stars) labeling sites are indicated, with corresponding distances between 
sites. See also Table 1. (E-G) SDS-PAGE analysis of Cy3 and Cy5 labeling. The gel was analyzed by (E) 
Coomassie blue staining, (F) Cy3 scan at 560-580 nm or (G) Cy5 scan at ≥665 nm. Gel lanes: (1) Wild-type (WT) 
Cse1 or Cse2-Cas6, containing all native Cys residues. (2) Minimal-Cys Cse1 or Cse2-Cas6. (3) Minimal-Cys N73C 
Cse1 or Minimal-Cys Cse2-Cas6 containing K169C Cas5. See also Figure S1. (H) Fluorescence emission spectra for 
individually labeled Cse1 and Cse2-Cas6, and reconstituted FRET-enabled Cascade. Excitation wavelength = 530 
nm. (I-J) Fluorescence emission spectra for FRET-enabled Cascade containing (I) Cse1-NTDCy3 or (J) Cse1-CTDCy3 
binding to various concentrations of (I) ssDNA or (J) dsDNA. The insets show EFRET at various molar equivalents of 
the DNA substrates, error represents mean (n = 3) ± SD.  Dashed lines are spectra for Cy3-labeled Cse1 + DNA in 
the absence of acceptor, solid lines are spectra for FRET-enabled Cascade + DNA. 
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Figure 2. Development of FRET-enabled Cascade. (A-C) Development of minimal-Cys Cse1. (A) Removal of 
all cysteine residues made Cse1 unstable, resulting in MBP-Cse1 accumulation in the cell debris pellet (P) and lack 
of soluble protein in the cell lysate (Ly) and eluent (E) from Ni-NTA column. (B) The minimal-Cys construct 
restores four Cys residues that are part of a Zinc-finger motif. This construct yields soluble MBP-Cse1 protein in 
both the lysate and elution fractions. (C) Size exclusion chromatography for purified WT and minimal-Cys Cse1 
elution from a Superdex 200 10-300 column (GE Life Sciences). (D-E) Development of minimal-Cys Cse2-Cas6. 
(D) Removal of all cysteine residues from all subunits blocked complex formation, resulting in the purification of on 
His6-tagged Cse2. (E) Mutation of Cas5 Cys112 to alanine and restoration of Cas5 Cys151 restored complex 
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formation. The asterisk indicates a contaminant that co-purifies during affinity purification, but is removed through 
subsequent purification steps. (F) Size exclusion chromatography for purified WT and minimal-Cys Cse2-Cas6 
elution from a Superdex 200 10-300 column (GE Life Sciences). Although the two complexes elute at the same 
retention volume, the yield for the minimal-Cys complex is ~3x lower than that of WT. (G) Structure of Cascade 
with all Cys residues highlighted in yellow. (H) Close up of Cas5 Cys112 and Cys151. Cys112 contacts the Cas76 
subunit, and mutation to serine disrupts this interaction and blocks complex formation. However, C112A allows for 
formation of the complex. Mutation of Cys151 to serine or alanine blocks complex formation. However, this residue 
is buried and is not labeled in our Cy5 labeling protocol (Figure 1G). (I) Close-up of the Cse1 zinc finger, which is 
structurally required to produce soluble Cse1. The Cys residues of this motif are not labeled in our Cy3 labeling 
protocol (Figure 1F). (J-K) Cascade-plasmid binding assay for WT and Cy3/Cy5 labeled Cascade. (L) Cascade-
mediated Cas3 cleavage of plasmid target for WT and minimal-Cys Cascade.  
To directly measure the change in Cse1 conformation upon DNA binding, we measured 
FRET for Cse1Cy3+Cse2-Cas6Cy5 when bound to varying concentrations of single- or double-
stranded DNA targets. For Cse1-NTDCy3, we tested binding to a ssDNA substrate. Consistent 
with the expected decrease in distance between the Cy3- and Cy5-labeling positions based on the 
crystal structures of apo and ssDNA-bound Cascade (Figures 1B-C; Table 1), we observed a 
~12% increase in FRET efficiency (EFRET) upon binding to ssDNA at a 1:1 molar ratio of 
DNA:Cascade (Figure 1I). For Cse1-CTDCy3, we tested binding to a bona fide dsDNA target. We 
observed an ~7% increase in EFRET upon dsDNA binding (Figure 1J), consistent with the 
decrease in distance between Cy3- and Cy5-labeling positions based on crystal structures of apo 
and dsDNA-bound Cascade (Figures 1B and 1D; Table 1). For both ssDNA and dsDNA, energy 
transfer increases proportionally with the molar ratio of DNA to Cascade, while excess DNA has 
no additional effect on EFRET (Figures 1I-J). These results establish our FRET system as a robust 
tool for measuring conformational flexibility of Cse1 upon Cascade-target binding.  
 
Target mutations inhibit interference by altering Cse1 conformation 
 We hypothesized that PAM and seed mutations may induce an unfavorable Cse1 
conformation that inhibits Cas3 recruitment, leading to CRISPR interference defects. We first 
compared the efficiencies of interference and priming for a bona fide target (fully matching (FM) 
target and 5’-AAG-3’ PAM on the non-target strand) and several mutant targets containing either 
a seed mismatch (MM) or mutant PAM (5’-AAA-3’ or 5’-AGA-3’) (Figures 3A-F). Targets 
were introduced into a GFP-reporter plasmid, which enables detection of both complete and 
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partial plasmid loss based on decreased cellular fluorescence (Figures 3A-B) (Xue et al., 2015). 
While all mutant targets display defects in interference, plasmid loss is much more substantially 
impaired for the PAM mutant targets than for the MM target (Figures 3A-B and 3E-F). The MM 
target is either completely or partially lost in all cells after one cycle of growth (Figure 3A), 
while the AAA PAM target is fully retained in ~42% of cells and partially lost in ~12% of cells 
after two cycles of growth (Figure 3B). Most strikingly, the AGA PAM target plasmid is fully 
retained after two cycles of growth (Figure 3B), indicating that interference is blocked for this 
target in vivo, as previously demonstrated in vitro (Xue et al., 2015). These decreased rates of 
plasmid destruction are accompanied by an inverse increase in the amount of spacers acquired 
through priming (Figures 3C-F), demonstrating the change in functional outcome upon target 
mutation.  
 We next tested whether bona fide and mutant targets elicit different conformations of 
Cse1 using FRET-enabled Cascade. To compare the closed, open and locked conformations, we 
measured changes in EFRET upon Cascade binding to bona fide or mutant dsDNA targets and a 
fully matching ssDNA target. We utilized dsDNA oligonucleotides with shortened non-target 
strands, which could be bound by FRET-enabled Cascade regardless of protospacer or PAM 
sequence at the concentrations used for FRET analysis (Figures 4A-C). Changes in EFRET were 
measured using two sets of Cy3 dye positions in the NTD (N73C or H69C) or CTD (N376C or 
E445C), to ensure that the observed changes were reproducible (Table 1).  
 The changes in EFRET upon dsDNA binding display striking differences for bona fide and 
mutant targets, indicating that target mutations alter the conformation of Cse1 (Figures 3G-H). 
For the Cse1-NTDCy3 constructs, we observe a much larger change in EFRET upon binding of 
mutant dsDNA targets (Figure 3G). The relatively large increase in EFRET for the mutant targets 
is consistent with a more open conformation, as observed for Cascade bound to ssDNA. In 
addition, the ssDNA and mutant dsDNA targets elicit similar EFRET changes for the Cse1-CTDCy3 
constructs, and all exhibit relatively small EFRET changes in comparison to the FM dsDNA targets 
(Figure 3H). These changes are consistent with relative distances measured for the ssDNA- and 
dsDNA-bound structures of Cascade (Table 1), and provide further evidence that the mutant 
dsDNA targets promote the open conformation of Cse1.  
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Figure 3. Target mutations inhibit interference through alteration of Cse1 conformation. (A) Flow cytometry spectra for E. coli 
cells harboring empty GFP-reporter plasmid (–), or GFP-reporter plasmid with targets containing a canonical PAM and fully-
matching (FM) or seed mismatch (MM, position 1 rG-dG mismatch) protospacer after one growth cycle (8 h). (B) Flow 
cytometry spectra for E. coli cells harboring GFP-reporter plasmids containing fully-matching protospacer with canonical PAM 
(AAG) or mutant PAMs (AAA, AGA) after two growth cycles (12 h each). For (A-B) high GFP fluorescence (green) indicates 
full retention of plasmid, low GFP fluorescence (blue) indicates partial plasmid loss, and GFP– cells (red) indicate complete 
plasmid loss. (C-D) Primed spacer acquisition against GFP-reporter targets after (C) one 8 h or (D) two 12 h growth cycles. 
CRISPR arrays from genomic DNA were PCR amplified and visualized by gel electrophoresis to detect the acquisition of new 
spacers (+1 band) relative to original (O) product. (E-F) Quantified interference and priming efficiencies. Interference 
efficiencies are the percentage of GFP– cells in flow cytometry experiments. Priming efficiencies are quantified from CRISPR 
amplicons (see Supplemental Experimental Procedures). Error represents mean (n = 3) ± SD. (F-G) Changes in EFRET for 
Cascade containing (F) Cse1-NTDCy3 or (G) Cse1-CTDCy3 upon binding to DNA targets. For each domain, FRET was measured 
with Cy3 located at two different positions. For (F-G), error represents mean (n = 3) ± propagated SD. (H) In vitro Cascade-
dependent Cas3 cleavage of pUC19 plasmid DNA containing either a FM or MM protospacer (with AAG PAM), analyzed by gel 
electrophoresis. Cascade was bound to plasmid prior to initiation of Cas3 cleavage, and aliquots were quenched at indicated time 
points. DNA is labeled as follows: OC – Open Circle; L – Linear; nSC – Negatively supercoiled; D – Degraded.  
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Figure 4. FRET-enabled Cascade binding to dsDNA targets. (A-B) dsDNA oligonucleotides with (A) PAM, full length 
double-stranded target sequence and 20-bp flanking sequences, or (B) PAM, truncated non-target strand and 15-bp flanking 
sequence on PAM side. (C) Gel shift assay to monitor Cascade binding to DNA.  Cse1-NTDCy3 and Cse2-Cas6Cy5 were held 
constant at 150 nM. Full-length dsDNA or truncated dsDNA were titrated at 150 nM, 500 nM, 1000 nM, and 1500 nM. Targets 
with AAG or AGA PAMs are shown, although similar binding was observed for mismatch and AAA PAM targets (not shown). 
The gel was scanned using a Typhoon imager using the Cy3-Cy5 FRET method. Cascade migrates faster upon DNA binding, 
likely due to the negative charge of the DNA. Differences in migration of Cascade bound to AAG and AGA PAM targets may 
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reflect the differences in conformation observed by FRET. To ensure complete formation of Cascade-DNA complexes during 
FRET measurements, truncated DNA targets were added in 10:1 molar excess relative to Cascade based on these binding data.  
(D) Cascade binding assay for fully matched and mismatched target plasmids at conditions (150 nM Cascade) used for in vitro 
interference assays. (E-N) Fluorescence intensity spectra for FRET experiments testing effects of mutant DNA targets. (E-F) 
Acceptor fluorescence in the absence of donor with each DNA tested. Cse2-Cas6 labeled at K169C of Cas5 with Cy5 was excited 
at 530 nm to determine the background fluorescence of Cy5. Controls were performed separately for Cse2-Cas6Cy5 labeled for 
(E) N76C and N376C or (F) H69C and E445C FRET experiments. Controls were performed in the presence of each DNA to 
ensure that DNA did not affect acceptor fluorescence. (G-J) Donor fluorescence in the absence of acceptor with each DNA 
tested. Cse1 labeled with Cy3 at indicated position was excited at 530 nm to determine fluorescence intensity of the donor in the 
absence of acceptor. DNA had varying effects on donor fluorescence, as shown in the insets (close-ups of donor fluorescence 
peak). DNA effects are taken into account through the calculation of FRET efficiency through donor quenching. (K-N) FRET for 
each set of Cy3-Cy5 pairs for each DNA tested.  
For the Cse1-NTDCy3 constructs, we observed intermediate EFRET values upon Cascade-
dsDNA binding that fall between the apo closed and ssDNA-bound open conformations 
established in our initial assays (Figures 1I and 3G). These results could suggest that Cse1 adopts 
intermediate conformations between the closed and open states observed in Cascade crystal 
structures (Figures 1B-D). Alternatively, Cse1 may adopt both conformations within the bulk 
population, resulting in intermediate EFRET values that are dependent on which conformation is 
favored in the ensemble. The latter scenario may explain differences between our FRET data for 
the bona fide dsDNA target and the conformation of Cse1 observed in the dsDNA-bound crystal 
structure of Cascade (Figure 1D) (Hayes et al., 2016). In that structure, the measured distance 
between labeling sites increases by ~3 Å upon dsDNA binding, which should result in a decrease 
in EFRET (Figures 1B and 1D; Table 1). However, in our experiment, EFRET increases by ~1% 
when the FM dsDNA target is bound (Figure 3G). This discrepancy suggests that while Cse1 
favors the closed conformation, a minor subpopulation of the ensemble samples the open 
conformation. In comparison, the relatively high EFRET values when Cascade is bound to the 
mutant targets suggest that Cse1 favors the open conformation for these complexes, while a 
minor subpopulation samples the closed conformation. Notably, the AGA PAM induces EFRET 
changes that are most similar to ssDNA for the Cse1-NTDCy3 construct, and the lowest EFRET 
changes for the Cse1-CTDCy3 construct (Figures 3G-H). These data suggest that Cascade most 
strongly favors the open conformation when bound to the AGA PAM target, and strongly 
disfavors the locked conformation.  
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 Based on these FRET data, we hypothesized that interference defects observed in vivo for 
PAM and seed mutant targets may be partially caused by the alternative conformation of Cse1, 
which could block direct Cas3 cleavage (Hochstrasser et al., 2014; Redding et al., 2015). Target 
mutations decrease Cascade-dsDNA binding affinity (Semenova et al., 2011c), which likely also 
contributes to in vivo interference defects. To eliminate the contribution of Cascade-dsDNA 
binding defects, we performed in vitro interference experiments in which target plasmids bearing 
FM or MM protospacers were pre-bound to Cascade prior to initiation of Cas3 cleavage. 
Cascade and target plasmids were incubated under optimal conditions to ensure complete target 
binding (Figure 4D), and Cas3 cleavage was initiated and monitored over a time course (Figure 
3F). Under these conditions, cleavage for the FM target was rapid, while the MM target 
displayed a much slower rate of cleavage, indicating that interference is still inhibited even when 
the mutant target is fully bound by Cascade. Combined with our FRET data, these results 
strongly suggest that the conformation of Cse1 influences the rate of Cascade-dependent plasmid 
cleavage.  
 
Conformational control by the Cse1 L1 motif  
 The change from closed to open conformation exposes the L1 region of the Cse1 NTD 
(Figures 1B-D), which has previously been shown to play an important role in Cascade-target 
binding and interference (Van Erp et al., 2015; Hochstrasser et al., 2014; Sashital et al., 2012). In 
the apo and dsDNA-bound Cascade structures, L1 is buried and forms a short α-helix that 
interacts with the crRNA (Figures 1B and 1D). However, in the open conformation, L1 is 
exposed to solvent (Figure 1C). Based on these structural observations, we hypothesized that 
mutations in the L1 region may disrupt interactions that stabilize the closed conformation, 
pushing Cse1 toward the open conformation and therefore switching the functional outcome of 
Cascade-target binding from interference to priming. 
 To test this hypothesis, we introduced two mutations, F129A and N131A, within the L1 
region of the cse1 gene in the E. coli K12 chromosome (Figure 5A) and measured CRISPR 
activity for these strains against a GFP-reporter plasmid containing a bona fide target (Figures 
5B and 6A). Consistent with previous phage resistance results (Sashital et al., 2012), CRISPR 
interference against the canonical target plasmid is strongly inhibited in the F129A and N131A 
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mutant strains. In contrast, priming activity increases in the mutant strains, indicating that mutant 
Cascade can still bind the target plasmid and elicit an immune response (Figure 6A). Overall, 
interference and priming levels for these Cse1 mutants are similar to those observed for a WT 
strain harboring an AGA-target plasmid (Figure 6A). These results indicate that L1 mutations, 
like priming PAM sequences, switch the functional outcome of Cascade-target binding from 
interference to priming. 
We next tested whether in vivo interference defects are caused by decreased Cascade-
target binding affinity or a defect in direct Cas3 recruitment. Although plasmids containing a 
bona fide target can be bound by L1-mutant Cascade (Figures 5C-D), Cas3 cannot cleave the 
DNA, even at concentrations up to 2 µM Cas3 (Figure 6B). Together with our in vivo results, 
these data strongly suggest that L1 mutants block direct recruitment of Cas3. 
 Finally, to determine whether the observed phenotypes result from promotion of the open 
conformation by L1 mutations, we used our FRET system to analyze N131A Cse1 conformation 
upon DNA binding. When bound to dsDNA with a canonical AAG PAM, N131A Cse1 produced 
relatively high EFRET for the NTD and a minimal change in EFRET for the CTD (Figures 5E-I and 
6C). These changes are strikingly similar to relative EFRET changes observed for WT Cascade 
bound to a dsDNA target with the AAA priming PAM or ssDNA (Figure 6D), and indicate that 
the L1 mutants promote the open conformation leading to the observed loss of interference and 
increase in priming. Overall, these results reveal that the Cse1 L1 motif is critical for controlling 
Cse1 conformation, thereby contributing to the functional switch in Cascade activity. 
 
Table 1, related to Figures 1-3: Measured distances between residues labeled with FRET pairs 
*Distance was measured between Cα atoms of the indicated residues in UCSF Chimera. 
 
 
DNA bound PDB ID 
Inter-residue distance* Reference 
N73-K169 H69-K169 N376-K169 E445-K169  
apo 
4U7U 43.4 Å 46.2Å 44.8 Å 36.5 Å (Zhao et al., 2014a) 
4TVX 43.2 Å 46.1 Å 44.8 Å 36.5 Å (Jackson et al., 2014e) 
5CD4 42.8 Å 45.5 Å 44.5 Å 36.2 Å (Van Erp et al., 2015) 
ssDNA 4QYZ 33.3 Å 36.0 Å 39.5 Å 30.8 Å (Mulepati et al., 2014c) 
dsDNA 
5H9E 46.3 Å 49.2 Å 32.5 Å 27.0 Å 
(Hayes et al., 2016) 
5H9F 46.3 Å 48.9 Å 32.5 Å 27.0 Å 
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Figure 5. Cse1 L1 mutants affect interference and Cascade conformation. (A) Experimental design for 
introduction of cse1 point mutations in E. coli K12 genome. (B) Flow cytometry spectra for WT E. coli cells 
harboring empty GFP-reporter plasmid (–), or WT, N131A or F129A Cse1 E. coli cells harboring a GFP-reporter 
plasmid bearing a fully-matching protospacer with a canonical AAG PAM. WT spectrum is reproduced from Figure 
3A. Colored as in Figures 3A-B. (C) Cascade titration to determine plasmid binding affinity upon mutation of Cse1 
L1 motif. Cse1 concentration was held constant at 1 µM to ensure incorporation into the complex. Cse2-Cas6 was 
titrated at the indicated concentrations. N131A binds at ~5x higher concentration that WT, and F129A binds at ~10x 
higher concentration. Both defects are significantly less than those observed for dsDNA oligonucleotide, likely due 
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to the energy for dsDNA unwinding provided by the negatively supercoiled plasmid. (D) Binding gel for samples 
used in Cas3 cleavage assay. (E-I) Fluorescence intensity spectra for FRET experiments testing effects of Cse1 
N131A L1 mutant. (E) Acceptor fluorescence in the absence of donor with each DNA tested (as in Figures S3A-B) 
(F-G) Donor fluorescence in the absence of acceptor with each DNA tested. (H-I) FRET for each set of Cy3-Cy5 
pairs for each DNA tested.  
 
Figure 3. Cse1 L1 mutants switch immune response by promoting the open conformation. (A) Plasmid loss and 
spacer acquisition rates for strains expressing WT, F129A and N131A Cse1 against a GFP-reporter plasmid 
containing a bona fide target after 8 h growth. For comparison, WT activity against an AGA target after 8 h growth 
is also plotted. WT plasmid loss against the canonical target are reproduced from Figures 3B-C. Error represents 
mean (n = 3) ± SD. (B) In vitro interference assay against plasmid target. Cascade bearing WT, F129A or N131A 
Cse1 were bound to DNA prior to initiation of Cas3 cleavage. (C) Change in EFRET for Cascade containing N131A 
Cse1-NTDCy3 or N131A Cse1-CTDCy3 upon binding to a canonical dsDNA target with fully-matching protospacer 
and AAG PAM, or ssDNA with fully-matching protospacer. Cy3 labeling positions: NTD – N73C; CTD – N376C. 
(D) Change in EFRET for Cascade containing WT (minimal-Cys) Cse1-NTDCy3 or Cse1-CTDCy3 upon binding to a 
canonical dsDNA target with fully-matching protospacer and AAA PAM, or ssDNA with fully-matching 
protospacer. Values are reproduced from experiments shown in Figure 3G-H for comparison with (C). For (C-D), 
error represents mean (n = 3) ± SD propagated for subtraction. 
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Discussion 
Our FRET system enables the detection of Cse1 conformation in solution, 
complementing and expanding on the structural snapshots revealed by recently reported crystal 
structures of Cascade (Hayes et al., 2016; Jackson et al., 2014e; Mulepati et al., 2014c; Zhao et 
al., 2014a). We find that mutations in the target seed or PAM and the Cse1 L1 motif block 
rearrangements of the Cse1-CTD into the locked conformation observed in the Cascade-dsDNA 
crystal structure (Hayes et al., 2016). Rotation of the CTD relative to the NTD results in a local 
conformational change that has been proposed to be important for Cas3 recruitment based on 
proximity to the Cas3-Cse1 interaction region observed by negative stain electron microscopy 
reconstructions of the Cascade-Cas3 complex (Hayes et al., 2016; Hochstrasser et al., 2014). Our 
results support this model, based on the strong correlation between Cse1-CTD locking and 
increased interference activity. In addition, target and L1 mutations cause Cse1 to favor the open 
conformation, which strongly correlates with inhibition of interference.  
Together, these data support a model in which the Cse1 closed conformation and CTD 
locking promote interference through the direct recruitment of Cas3 (Figure 7A). Conversely, the 
Cse1 open conformation blocks direct recruitment of Cas3 but still enables priming, potentially 
by facilitating Cas1-Cas2-dependent recruitment of Cas3 (Figure 7B) (Redding et al., 2015). 
Importantly, Cas3 recruitment to targets with canonical PAMs is increased substantially in the 
presence of Cas1-Cas2 (Redding et al., 2015), suggesting that the interference-independent 
mechanism can trigger priming from both mutant and bona fide targets. It is unclear whether the 
open conformation is required for Cas1-Cas2-dependent Cas3 recruitment. We therefore propose 
that the open conformation promotes priming through the interference-independent mechanism, 
as observed for targets with priming PAMs such as AGA, while the closed and locked 
conformation may promote both interference-dependent and independent priming (Kunne et al., 
2016; Redding et al., 2015). 
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Figure 4. Model for conformational control of Cascade function. (A) When Cse1 adopts the closed conformation, 
CTD locking leads to recruitment of the Cas3 endonuclease and interference. (B) Alternatively, Cse1 adopts the 
open conformation, which may promote priming through Cas1–Cas2-dependent recruitment of Cas3 (Redding et al., 
2015). The two conformations in (A) and (B) exist in a dynamic equilibrium. Favorable interactions between the 
PAM-NTD and L1-crRNA promote the closed and locked conformation, while disruption of these interactions 
through mutation of the PAM, seed or L1 motif promote the open conformation.  
  Upon binding of bona fide dsDNA targets, Cse2 movement along the Cas7 backbone 
pushes the Cse1 CTD into the locked position, while the Cse1 NTD remains in the closed 
conformation (Hayes et al., 2016). This inter-domain rearrangement is likely energetically 
unfavorable without additional NTD-stabilizing contacts. Our findings demonstrate that PAM 
engagement by the Cse1 NTD and L1-crRNA interactions stabilize the NTD in the closed 
conformation (Figure 7A). Several residues within the Cse1 NTD read the PAM through base-
specific interactions (Hayes et al., 2016). Although these contacts allow for some plasticity in 
PAM recognition, most PAM mutations likely reduce the favorability of these interactions. 
Subtle mutations, such as AAG to AAA, are expected to only partially disrupt interactions at the 
-1 position; however, more severe mutations, such as AAG to AGA, have more substantial 
effects by disrupting PAM-NTD contacts at multiple positions (Hayes et al., 2016). This loss of 
PAM-NTD engagement may destabilize the Cse1-NTD closed conformation (Figure 7B), 
resulting in the favored open conformation observed when Cascade is bound to targets with 
AAA and AGA PAMs. Similarly, mutations in the seed may distort the PAM-proximal 
crRNA:target duplex due to the presence of mismatches, thereby destabilizing Cse1-PAM 
interactions and favoring the Cse1 open conformation. 
PAM recognition by the Cascade Cse1 subunit is a crucial step that initiates target 
binding (Hayes et al., 2016; Redding et al., 2015; Sashital et al., 2012; Semenova et al., 2011c). 
In addition, PAM authentication prevents autoimmunity through the rejection of targets 
containing the CRISPR repeat-encoded 5’-CCG-3’ PAM (Xue et al., 2015). Our results provide 
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evidence of a second PAM authentication step following Cascade-target recognition that further 
improves the fidelity of CRISPR interference. While promiscuous PAM recognition enables 
Cascade binding to a large number of PAM mutant targets (Fineran et al., 2014; Hayes et al., 
2016; Xue et al., 2015), Cse1 conformational control prevents direct Cas3 recruitment and 
interference against these targets. In addition, our results suggest that Cas3 may directly read out 
the PAM. Although PAM and seed mutations affect Cse1 conformation to a similar degree, we 
observe stronger defects in interference for PAM mutant targets. These results suggest that Cas3 
may recognize the PAM during CRISPR interference, providing an additional mechanism for 
PAM licensing downstream of Cascade-target binding. 
Our FRET data strongly suggests that a mixture of Cse1 conformers exist in the ensemble 
of Cascade structures, reflecting a dynamic equilibrium between the closed and open states in 
which one conformation is favored over the other depending on the PAM and target sequence 
(Figure 7). Bona fide targets that strongly induce the interference conformation are degraded 
rapidly, leading to low levels of priming due to lack of substrate availability (Semenova et al., 
2016). Mutant targets that strongly induce the open conformation inhibit interference, allowing 
priming to occur due to substrate persistence. Thus, a dynamic conformational equilibrium 
provides tunable control of Cascade function, allowing the CRISPR–Cas system to trigger the 
appropriate immune response depending on the specific threat that is present in the cell. 
 
 
Materials and methods 
Bacterial strains 
E. coli K12 X019 (Xue et al., 2015), a derivative BW25113 was used as background for 
all constructed strains. X019 strains bearing F129A cse1 (X031) and N131A cse1 (X032) in the 
genome were created using scar-less λ-RED-mediated chromosomal manipulation based on a 
kanamycin-resistance marker and a mPheS counter-selectable marker (Davis et al., 2011). 
 
Construction of minimal-Cys Cse1 and Cse2-Cas6 
Point mutations were introduced using site-direct mutagenesis or “round-the-horn” 
(RTH). EcCse1-pSV272 was used to create the minimal-Cys Cse1 expression plasmid pX1024. 
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Cysteine residues (19, 53, 127, 242, 252, 284 and 458) in cse1 were mutated to serine. A zinc 
metal-ion is coordinated by four cysteines (140, 143, 250 and 253) in Cse1, and these four 
cysteines were maintained but are not labeled by Cy3-maleimide. pDGS010 was used to create 
pX1169, the expression plasmid for cysteine-free His6-Cse2 and Cas7 and minimal-Cys Cas5. 
Cysteines in cse2 (22 and 64), cas7 (17 and 123) and cas5 (43, 67 and 162) were mutated to 
serine, and Cys112 in cas5 was mutated to alanine. Cys151 in Cas5 was maintained, and is not 
labeled by Cy5-maleimide (Figures 1G, 2D-F, and 2H). pWUR404 was used to create the Cys-
free Cas6 expression plasmid pX1024. All cas6 cysteines were mutated to serine. H69C, N73C, 
N376C, or E445C mutations were introduced in pX1024 for site-specific labeling of Cse1. 
K169C was introduced to the cas5 gene in the plasmid pX1169 for site-specific labeling of Cas5.  
 
Protein Expression and Purification 
Cse2-Cas6 variants, Cse1 variants and His6–MBP–Cas3 were expressed in BL21(DE3), 
with some minor adjustments (Xue et al., 2015) (see Supplemental Experimental Procedures).  
 
Preparation of dye-labeled Cse1 and Cse2-Cas6 
Cy3-maleimide and Cy5-maleimide (Lumiprobe) were dissolved in 50% DMSO to 4 
mM. All labeling reactions were performed in size exclusion buffer (20 mM Tris pH 7.5, 100 
mM NaCl, 5% glycerol and 1 mM TCEP). For Cse1 labeling, 50 µM Cse1 and 400 µM Cy3 
were mixed, with a final DMSO concentration of 5%. For Cse2-Cas6 labeling, 25 µM Cse2-Cas6 
and 200 µM Cy5 were mixed and pure DMSO was added to maintain the 5% final DMSO 
concentration. Reactions were incubated in the dark at 4ºC for 1 hour. Reactions were quenched 
by adding 10 mM DTT, and labeled Cse1 or Cse2-Cas6 were separated from free dye using a 
10K protein concentrator (Corning). For each set of experiments, proteins were labeled just prior 
to the experiment and used within 12 hours of preparation.  
 
FRET experiments  
DNA substrates for FRET assays were chemically synthesized by IDT. The non-target 
strand was annealed with the target strand at a 1.5:1 molar ratio in 1× NEB buffer 2 by heating at 
95ºC for 5 min and cooling to room temperature. All fluorescence measurements were conducted 
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in reaction buffer (20 mM Tris pH 7.5, 100 mM NaCl, 5% glycerol and 1 mM DTT). 180 nM 
Cse1Cy3 and 150 nM Cse2-Cas6Cy5 were mixed in 70 µl reactions and incubated at room 
temperature for 30 min to form Cascade complex. Cascade-ssDNA or dsDNA complexes were 
prepared by mixing Cy3/Cy5-labeled Cascade complex with the indicated concentrations 
(Figures 1I-J) or 10× molar excess (Figures 3G-H, 7C-D, 5, and 6E-I) ssDNA or dsDNA at room 
temperature for 30 min. For each sample, control experiments were performed to detect donor of 
acceptor fluorescence in the absence of their corresponding FRET pair (Figures 1I-J, 5A-F, and 
6E-G). These samples were prepared identically to FRET samples, but unlabeled Cse2-Cas6 
(donor alone) or Cse1 (acceptor alone) was substituted for the appropriate sample.  
After incubation, the fluorescence of reactions was detected at 25ºC using a 3 mm path-
length quartz cuvette and Cary Eclipse Fluorescence Spectrophotometer, using 5 nm slit widths 
and 0.2 s integration time. Samples were excited at 530 nm and emitted light was collected from 
550 -750 nm in 1 nm increments. Fluorescence measurements were performed in triplicate. 
Fluorescence intensity figures were smoothed using GraphPad Prism. 
 
FRET analysis 
In our FRET experiments, it is difficult to determine the exact distance between donor 
and acceptor because of batch-to-batch variation in Cy3- and Cy5-labeling efficiency. Distance 
measurements also require a complex set of parameters (Lakowicz, 2013), further complicating 
the precise measurement of inter-dye distances. We therefore reported change in EFRET upon 
DNA binding and used this as a qualitative measure to assess changes in Cse1 conformation. 
EFRET was only compared within the same preparation of labeled Cascade complexes to limit the 
effect of batch-to-batch variation in labeling. FRET efficiency was determined by calculating 
donor fluorescence quenching (Lakowicz, 2013): 
EFRET =1 – [(IDA – IA)/ID] 
where IDA is the donor fluorescence intensity in the presence of the acceptor, IA is the acceptor 
fluorescence in the absence of donor, and ID is the donor fluorescence intensity in the absence of 
the acceptor. IDA, IA and ID were calculated by integrating the area under the peaks from 550-
630 nm, respectively, using Prism (Figures 1I-J, 5, and 6E-I). IDA, IA and ID were calculated 
for samples collected with the same DNA concentration to ensure that fluorescence changes 
  
129 
caused by DNA were taken into account in EFRET measurements. To account for intrinsic 
acceptor fluorescence in the same wavelength range, IDA was adjusted by subtracting IA. EFRET 
reported in Figures 1I-J are the average of three replicate, with error bars representing the 
standard deviation between the replicates. Changes in EFRET reported in Figures 3G-H and 7C-D 
were calculated by subtracting the average EFRET value for apo Cascade from that of a DNA-
bound Cascade. Errors were propagated from standard deviation of each average EFRET value. 
 
Plasmid-loss and spacer acquisition experiments 
For in vivo CRISPR activity assays, we used a previously developed CRISPR-active 
strains (X019 or X019 ∆cas1 or their derivatives) and a GFP-reporter assay based on the 
pACYC-GFP plasmid (Xue et al., 2015). Plasmid loss was monitored by flow cytometry and 
spacer acquisition was monitored by PCR of the CRISPR arrays within the genomic DNA as 
described in Supplemental Experimental Procedures. 
 
DNA binding and cleavage assays 
Binding assays and cleavage assays were performed essentially as previously described 
(Xue et al., 2015). Details are provided in Supplemental Experimental Procedures. 
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CHAPTER 5 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
 
Conclusions 
 It has been proposed that Cascade searches and binds targets by first recognizing the 
PAM site. Upon recognition of the PAM, Cascade unwinds the adjacent dsDNA and the crRNA 
base pairs with the target strand of the DNA. It remains unclear how Cascade can efficiently 
search all PAM sequences to find the lone target among the vast amount of DNA in the cell. We 
used single-molecule fluorescence resonance energy transfer (smFRET) to directly visualize how 
Cascade searches the target. We found that Cascade randomly samples dsDNA through short-
lived nonspecific electrostatic contacts between two lysine-rich loops in Cas7 and the phosphate 
backbone of the dsDNA. The dsDNA is positioned close to the PAM recognition motif in Cse1 
with the guidance of a lysine-rich loop in Cse1. Cascade quickly dissociates from dsDNA 
(within 0.1s) in the absence of a PAM. For a PAM site, favorable interactions with the PAM 
recognition motif lead to longer-lived binding (~1s dwell time). Mutation of the PAM 
recognition motif or the lysine-rich loop in Cse1 reduces dsDNA binding affinity partially due to 
the slowing of target search kinetics. These findings reveal how Cascade quickly searches PAMs 
to locate targets and uncovers several motifs in Cascade that are important for this process. 
Prior to our work, the importance of the seed region and PAM motif had been studied 
only using a few spacers in E. coli K12. We have greatly expanded the number of spacer 
sequences by using 18 endogenous spacers in E. coli K12 to analyze CRISPR interference and 
priming. We found that CRISPR interference and priming are strongly influenced by spacer 
sequence identities. Our interference and priming data suggest that seed mutations in some 
spacers block interference and promote priming, while other spacers with seed mutations still 
allow interference. It is difficult to deconvolute interference and priming because newly acquired 
spacers from primed adaptation allow indirect interference. To decouple indirect interference 
driven by newly acquired spacers (priming) from direct interference driven by the original 
spacer, we created three E. coli strains to compare plasmid degradation activity when CRISPR 
immunity is fully active, when only interference is active, or when neither interference nor 
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priming is active. We used these strains to screen PAM and seed mutant libraries, allowing us to 
determine the effects of mutations in these critical regions on either interference or priming 
activity. Our seed library data indicated that up to two seed mismatches can be tolerated, but that 
each sequence had some mismatch positions that were more deleterious than others. The PAM 
library data revealed a large set of functional PAMs, which are PAMs that promote either 
interference or priming. The functional PAMs vary from one spacer to another, which again 
shows that the spacer sequence dictates functionality. The non-functional PAMs generally had a 
C at the -2 or -3 position, explaining how the CCG “repeat PAM” in the CRISPR can protect the 
genome from autoimmunity. In summary, our findings for the first time show that CRISPR 
activities strongly depend on the spacer sequence and that some spacers are better than others 
because they are more tolerant of mutations. 
Both interference and priming in the type I-E CRISPR-Cas system require Cascade-target 
binding. Once Cascade binds to a mutant target, Cas3 cannot be directly recruited although 
priming can still occur. We hypothesized that different Cascade conformations can trigger 
different immune responses. To test this hypothesis, we developed the first FRET system to 
measure different Cascade conformations upon DNA binding. Specifically, we measured the 
conformational changes of the Cse1 subunit, which is responsible for both PAM recognition and 
Cas3 recruitment by Cascade. We found that Cse1 adopts a closed conformation when bound to 
a bona fide target and an open conformation when bound to a mutant target. The open 
conformation strongly inhibits the rate of Cas3 cleavage in vitro, and strongly promotes priming 
in vivo. We found that the L1 loop may stabilize the closed conformation. We engineered a 
Cascade variant that switches immune response from interference to priming by destabilizing the 
closed conformation. Mutations in the L1 motif promote the open conformation and switches in 
vivo CRISPR activity from interference to priming. In summary, our results have shown that the 
Cse1 conformation controls CRISPR interference and priming activities. 
 
 
Future directions 
Our results have generated additional questions that will be the subject of future studies. 
The second chapter of this dissertation is about the Cascade target searching mechanism. We 
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have directly visualized how Cascade quickly dissociates from non-PAM regions and dwells 
longer at the PAM site. A similar searching question exists for how Cas1-Cas2-protospacer 
locates the CRISPR locus. It has been shown that there are three motifs (see introduction) that 
are important for Cas1-Cas2-protospacer binding at the correct CRISPR site. How this complex 
finds this site among the vast amount of DNA in the cell is still unclear. Future studies with 
similar smFRET procedure will shed light on the mechanism of how Cas1-Cas2 locates to the 
target. We have developed a smFRET assay to visualize this process described in the Appendix.  
Our structure simulation results indicate that during the Cascade searching process, the 
dsDNA helix must be bent by ~20º to accommodate all interactions enforced in our model for 
the apo-Cascade structure. However, the dsDNA helix can be accommodated in a linear 
orientation for the partial Cse1 open conformation. Whether the conformational flexibility of 
Cse1 is required to initiate target searching prior to DNA bending is still unclear.  In the future, 
real-time smFRET using the FRET system described in Chapter 4 will allow studies of which 
conformation Cse1 adopts during target searching.  
We have shown that some spacer sequences are more effective for CRISPR immunity 
than others. However, the determinants of spacer sequence efficacy are still unclear. Our 
preliminary data suggest that the local GC content in the seed region may play a role during this 
process. In the future, precisely designed spacers should be used to test this hypothesis. A recent 
study has indicated that increased GC content in the spacer is related to higher CRISPR 
interference, while very high GC content (>62.5%) can decrease interference activity. However, 
in that study, the GC content over the length of the whole spacer was evaluated. It is still unclear 
whether local GC content or GC content over the whole spacer affects CRISPR immunity. In 
addition, it remains unknown whether other factors in the spacer, such as the secondary structure 
of the spacer, play a role in CRISPR immunity. Experiments using precisely designed spacers 
should be used to study how spacer sequences affect CRISPR immunity, and why some spacers 
provide better immunity than others.  
While our work has provided important insights into the determinants for primed spacer 
acquisition, the mechanisms of priming are still unclear. Currently, there are two proposed 
pathways for primed spacer acquisition. It has been shown that Cas3 degradation products can be 
captured by Cas1-Cas2 for integration. It has also been shown that Cas1-Cas2 and Cas3 can co-
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localize at a primed target site and that the putative Cas1-Cas2-Cas3 can co-migrate along DNA, 
suggesting that the Cas1-Cas2-Cas3 complex can translocate along DNA to excise protospacers 
for primed integration. We have shown that Cse1 adopt an open conformation when bound to a 
priming target, which might relate to the recruitment of the Cas1-Cas2 and Cas3 to form the 
complex. Further study is needed to determine whether Cse1 conformation relates to the 
recruitment of Cas1-Cas2 and Cas3. It also remains unclear which mechanism, interference-
dependent or interference-independent, is the main mode for priming, or whether both contribute 
equally to primed spacer acquisition. 
Overall, the structural and biochemical insights on the type I-E CRISPR system in this 
thesis have greatly improved our understanding of the CRISPR immune system. Importantly, our 
findings also raise critical questions for future studies to further understand the CRISPR immune 
system. 
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APPENDIX 
REAL-TIME OBSERVATION OF CRISPR LOCUS SEARCH BY CAS1-CAS2 USING 
SMFRET 
 
 
Introduction 
CRISPR-Cas (Clustered regularly interspaced short palindromic repeats –CRISPR 
associated) adaptive immune system help bacteria defend against viral attack (Barrangou et al., 
2007).  CRISPR-Cas immunity is divided into three stages: spacer acquisition, CRISPR RNA 
(crRNA) biogenesis, and interference (Sorek et al., 2013). In the spacer acquisition stage, the 
Cas1-Cas2 complex captures short DNA fragments from the invader. These DNA fragments are 
integrated into the host CRISPR locus as new spacers. During the crRNA biogenesis stage, the 
transcription of the CRISPR locus generates a long pre-CRISPR RNA (pre-crRNA). Subsequent 
pre-crRNA cleavage generates mature crRNAs. Cas proteins assemble along with the crRNA to 
form the Cas-crRNA surveillance complex. During the interference stage, the Cas-crRNA 
surveillance complex identify and destroy the targets with the guidance of the crRNA. 
 CRISPR immunity begins with spacer insertion by Cas1-Cas2. In the type I-E CRISPR 
system, the Cas1-Cas2 complex, in the presence of the integration host factor (IHF), inserts 
spacers into bacterial CRISPR loci (Nuñez et al., 2016)(Nuñez et al., 2015; Wright et al., 2017). 
A minimum CRISPR locus consists of a leader sequence and a repeat (Nuñez et al., 2016; Yosef 
et al., 2012). Biochemistry assay and structures have shown that IHF bends the leader and assists 
in positioning Cas1-Cas2 to the leader-proximal repeat (Wright et al., 2017). The cryo-EM 
structure of the entire integration complex including Cas1-Cas2, protospacer, and a 130 bp target 
sequence bound by IHF has shown Cas1-Cas2 recognizes three elements for integration: the 
leader-proximal repeat region, the repeat sequence, and an upstream leader sequence (Wright et 
al., 2017). How Cas1-Cas2 locates at the CRISPR locus and how these three elements involved 
in this process are unclear. 
 Here, we have developed a smFRET assay to directly visualize this searching process in 
real time. We have successfully observed the dwelling of Cas1-Cas2 on the CRISPR locus using 
this smFRET assay.  
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Results 
Optimization of IHF induced leader bending 
 
Figure 1. Development of smFRET assay and real-time observation of CRISPR locus searching process by Cas1-
Cas2-protospacer. (A) Schematic of DNA bending induced by IHF. (B) Gel shift assay to monitor IHF-DNA 
binding (top) and bending (bottom). The binding was detected through Cy3 detection on a Typhoon imager. The 
bending was detected through the Cy3-Cy5 FRET method on a Typhoon imager. (C) Schematic of smFRET 
experiment using Cy3-leader1.1, IHF, and Cy5-Cas1-Cas2-protospacer. (D) Representative smFRET time trajectories 
of short-lived FRET events for Cy5-Cas1-Cas2-protospacer and leader1.1. 
 
DNA deformation caused by DNA supercoiling or IHF bending is essential for spacer 
integration at the leader-repeat junction. Additionally, IHF bending is required for spacer 
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integration into linear DNA in vitro. IHF binding induces a ~160° bend in the DNA. To test 
whether IHF binding leads to bending of the leader, we developed a bulk FRET assay (Fig. 1A). 
We incubated the leader DNA labeled with a Cy3 dye at the end of the leader with Cy5 labelled 
IHF. Preliminary data indicated that IHF binds the leader region with a high affinity, however, 
IHF does not bend the leader even at high IHF concentration. It has been shown that the bending 
is facilitated on a canonical IHF binding site when a nick is present within the kink position (Fig. 
1A). The IHF binding site within the leader region was replaced with the canonical IHF binding 
site and a nick was introduced to the kink position to generated leader1.0. For leader1.0, IHF 
binding induces DNA bending as observed based on Cy3-Cy5 FRET detected for the IHF-DNA 
complex (Fig. 1B).  
 
smFRET development for CRISPR locus searching by Cas1-Cas2  
We next established a system to directly observe individual Cas1-Cas2 binding events on 
the CRISPR locus within leader1.1 (contains 14bp upstream of leader1.0 and leader1.0) using 
smFRET (Fig. 1C). We immobilized biotinylated dsDNAleader 1.1 labeled with donor (Cy3) 
fluorophore at the 5’ end of one strand on a passivated quartz surface. Cas1-Cas2 loaded with 
protospacer was labeled with (Cy5) fluorophore (either one or two) in the Cas2 (E41C) subunit. 
The mixture of one or two Cy5 fluorophores in the Cas1-Cas2 complex is because there are two 
copies of Cas2 in the complex. 1 uM IHF was injected into the channel and incubated for 5 min. 
When 10 nM Cas1-Cas2-protospacer with 1uM IHF were injected, FRET was observed in real 
time (Fig. 1D). However, only 3% of all traces (77/2400 and 91/3000) contained FRET events.  
The low frequency of FRET events could be caused by the lower binding affinity of 
Cas1-Cas2-protospacer on the CRISPR locus in linear DNA. To obtain a reasonable signal-noise 
ratio, the highest Cas1-Cas2-protospacer concentration that can be used in the smFRET assay is 
20 nM and the highest concentration of the leader DNA on the slide is 0.04 nM. The low 
frequency of FRET events cannot be simply solved by increasing Cas1-Cas2-protospacer 
concentration.  
Two strategies can be used to optimize the smFRET assay. One strategy is to select a 
high-affinity leader sequence by optimizing the CRISPR locus using SELEX (systematic 
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evolution of ligands by exponential enrichment). Another strategy is to use Cas1-Cas2 from 
another organism that have higher binding affinity on the CRISPR locus in linear DNA.  
 
 
Materials and Methods 
Plasmid Construction 
cas1 was amplified from the E. coli K12 genome using XCY064 and XCY075 and 
ligated into pSV272. cas2 was amplified from E. coli K12 genome using primers XCY1378 and 
XCY1379 and ligated into pET52b. E41 in cas2 was mutated to cysteine using primers 
XCY1119 and XCY1120 in cas2-pET52b. ihf α was amplified from E. coli K12 genome using 
XCY1098 and XCY1099 and ligated into pACYCDuet-1. ihf β was amplified from E. coli K12 
genome using XCY1100 and XCY1101 and ligated into pCDF-1b. S15 in ihf β was mutated to 
cysteine using primers XCY1301 and XCY1302 in ihf β-pCDF-1b. 
 
Protein purification and Dye labeling 
All proteins were expressed in BL21(DE3) cells. cas1-pSV272, cas2-pET52b, and cas2-
pET52b with E41C were expressed in 1-2 L LB media with appropriate antibiotic. ihf α-
pACYCDuet-1 and ihf β-pCDF-1b or ihf β S15C-pCDF-1b were co-expressed. Cultures were 
grown to 0.4-0.6 OD at 37 °C, and induced overnight at 18 °C with 0.5 mM IPTG. His6-MBP-
Cas1, Cas2-TEV-His6, Cas2 41C-TEV-His6, and His6-TEV-IHF α-IHF β were purified using Ni-
NTA affinity resin, followed by tobacco etch virus protease cleavage at 4 °C overnight. The 
cleaved samples were flowed through a Ni-NTA column, concentrated to 1 ml, and further 
purified on a Superdex 75 column, aliquoted and stored at -80 ºC.   
E41C Cas2 and S15C IHF was labeled by Cy5-maleimide in the dark at 4 ºC for 2-4 hr in 
the labelling buffer (20 mM Tris [pH 7.5], 100 mM NaCl, 5% glycerol, 5% DMSO and 1 mM 
TCEP). Cy5 labeled Cas2 and IHF were separated from free dye using a 3K protein concentrator 
(Corning), concentrated to 2 µM, aliquoted and stored at -80 ºC. The labelling efficiency of 
Cas1-Cas2 and IHF were calculated by measuring the concentration of Cas1-Cas2 at 280 nm and 
the dye concentration at 650 nm after labelling. Labelling efficiency of Cas1-Cas2 was 
consistently greater than 70% assuming 2 Cy5 molecules per complex.  
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IHF binding and bending assay 
100 nM Cy3 labelled leader1.0 was incubated with increasing concentration of Cy5 
labelled IHF in buffer containing 20 mM Tris [pH 7.5], 100 mM NaCl, 5% glycerol at room 
temperature for 30 min prior to electrophoresis on a 2% agarose gel run at 15 V at 4 ̊C for 5-6 h. 
The gel was scanned using a Typhoon imager either by exciting Cy3 directly or by Cy3-Cy5 
FRET method.  
Single-molecule FRET set-up 
Leader1.1 was immobilized on the microscope slides using biotin-streptavidin. Single-
molecule FRET experiments and data analysis were performed as in Chapter 2. 
Table 1: Oligos used for smFRET 
Name Sequence (5’-3’) 
XCY1319 /5Cy3/GTTCTTATGGGAAAAAATGCTT 
XCY1338 TGCGAAAGCGGTTTATCCCCGCTGGCGCGGGGAACTCTCTAAAAGCAAACATTTGATAT
TAAAGCATTTTTTCCCATAAGAAC 
XCY1275 /5Biosg/CACGACGTTGTAAAACGACGGCCAGTGAATTC 
XCY1337 TAATATCAAATGTTTGCTTTTAGAGAGTTCCCCGCGCCAGCGGGGATAAACCGCTTTCGC
AGAATTCACTGGCCGTCGTTTTACAACGTC 
XCY1339 TGCGAAAGCGGTTTATCCCCGCTGGCGCGGGGAACTCTCTAAAAGCAAACATTTGATAT
TAAAGCATTTTTTCCCATAAGAACAACCCACCAACCTT 
XCY1340 /5cy3/AAGGTTGGTGGGTTGTTCTTATGGGAAAAAATGCTT 
 
Table 2: Leader1.0 and leader1.1. 
leader1.0 XCY1275, XCY1319, XCY1337, and XCY1338 
leader1.1 XCY1275, XCY1337, XCY1339, and XCY1340 
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